tsawon lokacin da waɗannan alamun suka faru?
kuma dole ne a bi da ciwon kirji kamar haka, musamman a shekarunka
kuma tare da zazzabi
kuma kana bukatar ka duba yawan cholesterol da kuma karfin jini
kuma kana da zazzabi yanzu?
kuma kuna da ciwon kirji yanzu?
kuma, banda haka, kuna da wahalar numfashi?
kuma za ku iya gaya mani wasu alamun da kuke da shi banda wannan?
Kuma yaya zafin jikinka yake?
kuma ina tari ma
Ina da sanyi da tari.
kuma ina da ciwon kirji sosai yau
kuma wannan shine lokacin da ya dace don allergic rhinitis
kuma yana da ciwon kirji
kuma ina tsammanin ina da zazzabi
kuma ina son ka bayyana inda ciwon kirji yake
Kuma suna da zazzabi ma
da kuma tarihin ciwon sukari
Kuma, ka sani, kamar kirji na zai fashe
Kuma, ka sani, mutane suna tari a kaina a koyaushe
kuma kuna da ciwon kirji
kuma ka ce shi ne wani matsa lamba a kan kirji
Shin wani a cikin iyalinku yana da ciwon zuciya, ciwon zuciya, ciwon zuciya, ko kuma yana da babban cholesterol ko hawan jini?
Shin akwai wata alama ko matsala da kuka lura da ita game da ciwon tsoka?
Shin akwai wasu marasa lafiya a gidanku da ke da alamun cutar da kuke da ita?
Kuna da wasu alamun cutar?
Shin ba ku da numfashi?
Har yanzu kuna da ciwon kirji?
saboda lokacin mura ne
amma kuma ba za mu iya kawar da ciwon kirji daga zuciya ba
amma matsalar da ta fi muhimmanci yanzu ita ce wannan ciwon kirji
Amma ina da wahalar numfashi
Amma na san mutane da yawa sun yi tari a kaina
amma muna bukatar mu dauki duk wani ciwon kirji da muhimmanci
Amma za ka iya numfashi da kyau yanzu, ba za ka iya ba?
Saboda wannan ciwon kirji na manta gaba daya
Shin, kamar kirjinka yana matsawa?
Har yanzu ina jin numfashi
Shin suna gunaguni cewa suna da rashin lafiya da alamun da suka yi kama da wannan?
kuna da wata cuta mai tsanani, kamar hawan jini?
kuna da wata cuta ko rashin lafiya ban da ciwon sukari?
Shin kun sha wahala daga numfashi, ban da wannan ciwon kirji?
Shin kana da hawan jini?
Kuna jin wani numfashi tare da wannan?
Shin kun san irin alamun da ta nuna?
Shin kun ga hoton?
sha ruwa mai yawa yau
A halin yanzu, ina yin gwajin ciwon sukari.
Duk da haka, ta na da alamun da suka yi kama da nawa.
Yaya yawan zafin jikinka yake?
Yaya karfin jini yake?
idan kana ci gaba da zazzabi mai zafi
idan kana da zazzabi na 38 digiri ko sama
idan ka ga alamun cututtukanka da matsalolinka suna bukatar ƙarin kulawa
Na yi zazzabi jiya
Ni ma na yi zazzabi.
Na yi zazzabi jiya
Ina da ciwo mai tsanani a cikin kirji
Ina da wuya a numfashi, ma
Zan aiko muku da hoto
Ina da ciwon kirji a yau
Ina da ciwon kai da zazzabi yau
A ganina, yana da mura.
A ganina, mura ce kawai.
Shin kana ganin kamar mutum ne mai nauyi yana zaune a kirjinka?
duk ya fara da ciwon kai da zazzabi a kusan lokaci guda
ciwon yana tsakiyar kirji na
Yana da matsi, kamar yana ciwon kirji
Yana cikin kirji na
Yana tsakiyar kirji na
yana tsakiyar kirji
Ina da ciwo a kirji
Ina matukar damuwa da wannan ciwon kirji
Ina so ka bayyana min wannan ciwon kirji
kamar hawan jini ko ciwon sukari
a tsakiyar kirji
game da zazzabi, zaka iya shan paracetamol
Maria, kwana nawa ne da ka yi kana da wadannan cututtuka?
kin ce kina da ciwon kirji
Ina jin ciwon kirji a wasu lokuta
To, kuna da wasu alamun bayyanar cututtuka tare da wannan, banda ciwo?
Ko kuma wani yana zaune a kirjinka?
Haka yake da zazzabi, tari, ciwon kai da ciwon tsoka.
a tsakiyar kirji na
nuna min a wannan hoton inda kake jin zafi
tun da kana da zazzabi
Shin kana ganin wasu cikin waɗannan cututtukan suna da alaƙa da yadda kake da ciki?
Shin yaranku suna da irin wannan alamun?
Ka gaya mani game da ciwon kirjinka
zazzabi yana ƙaruwa da dare
zazzabin da na yi a cikin kwanaki biyu da suka gabata
Zazzabi ya fara tashi a daren jiya
Wannan shi ne Dr. Porter a cibiyar tantancewa na gaggawa
To, za ka iya gaya mani game da ciwon kirjinka?
Ina jin zafi a gaban jikina, a cikin kirji.
To, na ji ciwo mai tsanani a kirji na
To, idan na sami wannan ciwo a kirji
wane irin ciwo kake da shi a kirjinka?
lokacin da wannan ciwon kirji ya fara?
Ina ciwon kirjinka?
inda kake jin wannan ciwon kirji
kana jin wani matsi a kirjinka
Ina da ciwon sukari da dai sauransu.
kin ce kina da wannan ciwon a kirji
Yawan cututtukan da ke ci gaba da saurin yaduwa na cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da Ingila, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Yawan cututtukan cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a ƙasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai da Ingila, yana tabbatar da cewa ko da yake yana cikin wani mataki daban-daban dangane da ƙasa, annobar COVID-19 tana ci gaba da sauri a kowace ƙasa.
Bisa ga kwarewar Italiya, ƙasashe, asibitoci da UTIs ya kamata su ƙara shirya don ɓarkewar marasa lafiya da COVID-19 waɗanda za su buƙaci kulawa, musamman kulawa mai tsanani.
A ranar 31 ga watan Disamba na 2019, an samu rahoton wasu masu cutar sankarar bargo da ba a san asalin su ba a Wuhan, lardin Hubei, China.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ba da rahoton cewa sabon kwayar cutar coronavirus ne, wanda yanzu ake kira coronavirus 2 mai saurin kamuwa da cutar numfashi (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da SARS-CoV-2 ana kiranta cutar coronavirus (COVID-19).
Shaidar da aka samu har zuwa yanzu ita ce kashi 80 cikin ɗari na mutanen da ke da COVID-19 suna kamuwa da cutar mai sauƙi, wato, kamuwa da cutar numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin su suna murmurewa.
A cikin kusan kashi 14 cikin ɗari na masu cutar, COVID-19 ta ci gaba zuwa wani mummunan ciwo, wanda ke buƙatar asibiti, yayin da sauran kashi 6 cikin ɗari na masu cutar suka ci gaba zuwa mummunan ciwo, wanda ke buƙatar kulawa mai tsanani.
Mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kashi 4%.
A cikin wannan binciken, mun kimanta yanayin yawan kamuwa da COVID-19 a kowace ƙasa a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da Ingila kuma mun kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta adadin masu kamuwa da COVID-19 a yanzu a ƙasashen EU/EEA da Ingila da na Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Yanayin COVID-19 a cikin ƙasashen EU/EEA da Ingila
Bayan China, COVID-19 ta bazu a wurare daban-daban, kuma yanayin annobar COVID-19 a sauran duniya yanzu haka yana bin wannan ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai, bisa ga ma'anar shari'ar WHO.
A cikin EU/EEA, Faransa ta ba da rahoton farkon mutane uku da aka tabbatar da cutar a ranar 24 ga Janairu, 2020 a cikin mutanen da suka dawo daga Wuhan, Lardin Hubei, China.
A ranar 15 ga Maris, 2020, an riga an gano cututtukan COVID-19 a duk ƙasashen EU/EEA 30 da Ingila, kuma tsakanin 31 ga Disamba, 2019 da ranar da aka ambata a sama, an ba da rahoton mutane 39,768 da mutuwar 1,727, tare da 17,750 da mutuwar 1,441 a Italiya kadai.
Samun jimlar lambobi da kuma yawan adadin masu kamuwa da COVID-19
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana sabunta adadin masu cutar COVID-19 a kowace ƙasa a duniya, wanda aka samo daga kafofin hukuma kawai, kamar ma'aikatar lafiya ta ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, kowace rana da ƙarfe 8 na safe.
An yi amfani da wannan bayanan don tantance yanayin COVID-19 a cikin EU/EEA da Ingila, da kuma kwatanta su da na Italiya.
A matsayin ƙididdigar yawan masu kamuwa da COVID-19, mun ƙididdige yawan adadin kwanaki 14 na COVID-19 da aka yanke, don haka muna la'akari da yanayin COVID-19 a kowace ƙasa ta EU/EEA da Ingila a lokacin Janairu 1 zuwa Maris 15, 2020.
Mun kuma nuna jimlar adadin masu cutar da aka ruwaito daga kowace ƙasa har zuwa 15 ga Maris, 2020 da ƙarfe 8 na safe, kuma mun kwatanta da na Italiya na lokacin daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin ƙasashen EU/EEA da Ingila
Yanayin da ake samu na kwanaki 14 na yawan kamuwa da COVID-19 a cikin ƙasashen EU/EEA da Ingila gabaɗaya ya bi na lardin Hubei na China (Hoto na 1).
Gabaɗaya, ga EU/EEA da Burtaniya, yawan kamuwa da COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu sannan ya ƙaru sosai a kusan 28 ga Fabrairu, 2020 (ƙarin bayani).
Wannan ya faru ne musamman saboda saurin karuwar shari'o'in da aka ruwaito a Italiya, amma duk sauran ƙasashen EU/EEA da Ingila sun nuna irin wannan yanayin karuwa a cikin yawan COVID-19 (abubuwan haɓaka).
Hoto na 2 ya nuna adadin adadin masu kamuwa da COVID-19 a cikin ƙasashen EU/EEA da Ingila idan aka kwatanta da Italiya na lokacin daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya ce, a ranar 15 ga watan Maris da karfe 8 na safe, wasu kasashe 15 na EU/EEA da Birtaniya sun riga sun bayar da rahoton adadin adadin masu cutar kamar na Italiya makonni 3 ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin masu kamuwa da COVID-19 da aka ruwaito suna karuwa cikin sauri a EU/EEA da Ingila.
Hanyoyin da aka lura a cikin yawan cutar COVID-19 sun nuna cewa annobar tana ci gaba da irin wannan saurin a duk ƙasashe.
Wannan ya faru duk da cewa ƙasashe suna cikin matakai daban-daban, bambance-bambance a ayyukan tsarin kiwon lafiyar jama'a na ƙasa, kuma wataƙila ma'anar shari'o'i daban-daban a cikin ƙasashe da ladabi daban-daban don zaɓar marasa lafiya waɗanda za a gwada su don tabbatar da COVID-19, gami da gwaji don sabuntawa.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa na Italiya sun bayyana halin da 10% na marasa lafiya da ke fama da COVID-19 ke buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da wuraren kula da marasa lafiya a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai kan asibiti da/ko ICU na COVID-19 a halin yanzu suna samuwa a matakin EU/EEA don kashi 6% da 1% na shari'o'i, bi da bi (ba a nuna bayanai ba).
Ya kamata, duk da haka, a tattara su a cikin tsari don haɓaka bayanan sa ido na yanzu tare da mai da hankali kan yawan lambobin da aka ruwaito da yawan mutuwar.
Wani binciken da aka gudanar tsakanin 2010 da 2011 ya nuna bambancin bambancin da ke tsakanin wadatar ICU da kuma gadajen marasa lafiya a Turai, daga gadaje 29,2 a Jamus zuwa gadaje 4,2 a Portugal a kowane mutum 100,000.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da albarkatu fiye da Italiya (12.5 ICU da gadaje na kulawa mai tsanani don yawan jama'a 100,000 tsakanin 2010 da 2011).
An samar da yanayin samfurin da ya shafi cikawar tsarin kiwon lafiya, tare da kimantawa ga kowace ƙasa ta EU/EEA da Ingila na yawan asibitocin COVID-19 da ke da haɗarin fiye da kashi 90% na ƙarfin gadaje masu kulawa mai tsanani, a cikin sabuntawa na shida na ECDC Rapid Risk Assessment on COVID-19.
Ganin cewa har yanzu an tattara lokuta a wasu yankuna na EU/EEA da UK, kuma asibitoci da cibiyoyin kulawa da gaggawa galibi suna kula da ƙayyadadden yanki na yanki, ya kamata a ba da fifiko ga samar da bayanai game da lokuta da gadajen kulawa da gaggawa a cikin Ƙididdigar Ƙungiyoyin Ƙasa don Bayanai 2 (NUTS-2).
Misalin Italiya da kuma yanayin da ke faruwa a wasu ƙasashe ya nuna cewa annobar COVID-19 tana ci gaba da sauri a cikin EU/EEA da Ingila.
Saboda haka, ƙasashe, asibitoci da UTIs dole ne su shirya don yanayin ci gaba da yaduwar SARS-CoV-2 a cikin al'umma da kuma ƙaruwar yawan marasa lafiya da COVID-19 waɗanda ke buƙatar kulawa ta likita, musamman kulawa mai tsanani, kamar yadda yake a yankunan da cutar ta shafa a Italiya.
Kamar yadda aka nuna a cikin saurin kimanta haɗarin ECDC, hanzari, mai saurin aiki da kuma cikakkiyar hanya yana da mahimmanci don jinkirta yaduwar SARS-CoV-2, tare da sauyawa daga hanyar hanawa zuwa hanyar ragewa, saboda saurin ƙaruwa a cikin adadin shari'o'in da aka yi hasashen zai iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da daidaita ayyukan su yadda ya kamata idan ba a aiwatar da su ba.
Har ila yau, ƙididdigar haɗarin gaggawa ta lissafa matakan kiwon lafiyar jama'a don rage tasirin annobar.
Akwai ɗan gajeren lokaci da ƙasashe za su iya ƙara ƙoƙarin hana yaduwar SARS-CoV-2 da rage matsin lamba a kan tsarin kiwon lafiya.
Idan ba su yi nasara ba, tsarin kiwon lafiya na sauran ƙasashen EU/EEA na iya samun ƙarin marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar annobar coronavirus ta 2019 (COVID-19), wadda cutar coronavirus ta 2 (SARS-CoV-2) ta haifar da mummunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Kamar dai kwayar cutar SARS-CoV, wacce ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 kuma ana iya watsa shi daga jemage kuma yana haifar da irin wannan alamun ta hanyar irin wannan hanyar.
Koyaya, COVID-19 yana da ƙananan tsanani da mutuwa fiye da SARS, amma yana da saurin yaduwa, kuma yana shafar tsofaffi fiye da matasa, da maza fiye da mata.
A sakamakon haka, yawancin littattafai da aka wallafa game da wannan sabuwar cuta sun ƙaru sosai.
Za mu tattauna game da ainihin abubuwan da ke tattare da cututtuka da cututtuka da cututtuka da cututtuka da cututtuka da kuma yadda za a magance su.
Ko da yake akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan binciken zai taimaka wajen fahimtar wannan muguwar cuta da kuma kawar da ita.
Bikin bazara a ranar 25 ga Janairun 2020 ya zama abin tunawa na musamman da ba za a iya mantawa da shi ba ga duk Sinawa waɗanda aka tilasta musu su kasance cikin keɓewa a duk hutun kuma na makonni da yawa masu zuwa saboda barkewar sabuwar cutar kwayar cuta.
Kwayar cutar tana da kamanni da kwayar cutar coronavirus (CoV) wacce ta haifar da mummunar cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututut
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma ta bazu cikin sauri a fadin kasar da kuma kusan wasu kasashe 50 a duniya.
Har zuwa 2 ga Maris, 2020, cutar ta haifar da sama da mutane 80,000 da suka kamu da COVID-19, tare da sama da marasa lafiya 40,000 da suka warke kuma sama da marasa lafiya 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 "maƙiyi na farko na jama'a" ne, kuma yana da iko fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga labarai sama da 200 game da COVID-19, gami da ilimin ƙwayoyin cuta, cututtukan cututtuka, ilimin cututtuka, ganewar asali da magani, tun lokacin da aka fara bayar da rahoto a ranar 7 ga Janairu, 2020, wanda ya ƙaddara jerin ƙwayoyin cuta da aka ware daga marasa lafiya da yawa.
Wannan talifin yana so ya taƙaita ci gaban bincike a wannan sabon yanki mai saurin ci gaba.
A duk lokacin da ya dace, za mu kwatanta COVID-19 da SARS da kuma wata cuta da CoV ke haifarwa, wato Middle East respiratory syndrome (MERS, annobar shekara ta 2012).
Za mu kuma tattauna abin da muka koya game da rigakafi da kuma yadda za a magance cutar da kuma wasu batutuwa masu muhimmanci.
CoVs an ɗauka a matsayin ƙwayoyin cuta marasa mutuwa ga mutane, galibi suna haifar da kusan 15% na sanyi.
Amma a wannan karni, mun sami sau biyu na cutar CoVs masu cutarwa ga mutane, wato SARS-CoV da MERS-CoV, waɗanda suka haifar da annobar da ta samo asali daga China a 2003 da Saudi Arabiya a 2012, kuma nan da nan suka bazu zuwa wasu ƙasashe da yawa tare da mummunan rashin lafiya da mutuwa.
Saboda haka, COVID-19 na yanzu shine annobar CoV ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a Fig. Fig.1,1, an fara ba da rahoton wasu cututtukan cututtukan huhu da ba a san asalin su ba a Wuhan a ranar 31 ga Disamba, 2019, ga Hukumar Lafiya ta Kasa ta China.
Bayan kwana bakwai, an buga jerin kwayoyin cutar CoV.
A ranar 15 ga Janairun 2020, an ba da rahoton farkon mutuwar Wuhan.
A wannan lokacin, annobar ta bazu cikin sauri zuwa birane, larduna da ƙasashe maƙwabta.
A ranar 20 ga Janairu, an sanar da cewa ma'aikatan kiwon lafiya sun kamu da cutar, wanda hakan ya nuna cewa ana iya samun kamuwa da cutar tsakanin mutane.
A ranar 23 ga Janairu, an rufe birnin Wuhan, kuma an dakatar da zirga-zirgar jama'a.
A ranar 24 ga Janairu, binciken asibiti na farko game da cutar ya ba da rahoton cewa daga cikin marasa lafiya 41 da ke da tabbacin shari'ar 21 ne kawai suka taɓa tuntuɓar kasuwar abincin teku ta Wuhan, wanda aka ɗauka cewa asalin asalin dabba ne ya fara kamuwa da cutar.
A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta ayyana cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin wannan rahoton, cutar ta riga ta bazu zuwa China da kusan wasu ƙasashe 50 a duniya (Fig. (Fig.2).2).
Tun da halin da ake ciki yana kara muni cikin sauri, har yanzu ba a tantance girman cutar da kuma tsananin cutar ba.
A ranar 11 ga Fabrairu, 2020, wani bincike da aka yi a cibiyoyi da yawa tare da marasa lafiya 8,866, gami da marasa lafiya 4,021 da aka tabbatar da COVID-19, ya ba da ƙarin hoto game da annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane masu shekaru daban-daban, musamman masu shekaru 30 zuwa 65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, wasu sun kasance 'yan ƙasa da shekaru 20, kuma 14 ne kawai ke da cutar da shekarunsu ba su kai 10 ba.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya bazu cikin rukuni, musamman a Hubei da kewayenta.
COVID-19 an ba ta matsakaicin kwanaki 5 (2 zuwa 9) don ganewa bisa ga bayyanar cututtuka.
Matsakaicin lokacin incubation ya kasance kwanaki 4.8 (3.0 zuwa 7.2).
Matsakaicin lokacin mutuwa dangane da bayyanar cututtuka shine kwanaki 9.5 (4.8-13).
Yawan yawan haifuwa (R0) ya kasance 3.77 (95% CI: 3.51 zuwa 4.05), kuma R0 da aka daidaita ya kasance 2.23 zuwa 4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin ranar 23 ga Janairu, 2020, daidai da lokacin da aka yi tafiye-tafiye da yawa kafin bikin bazara a China.
Mutuwar marasa lafiya tare da tabbatar da shari'ar ya kasance 1.44% (95% CI: 1.10% zuwa 1.86%), kuma daidaitaccen mutuwar dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02% zuwa 4.59%).
Manyan abubuwan haɗari guda uku don COVID-19 sune jinsi (maza), shekaru (sama da shekaru 60), da ciwon huhu mai tsanani.
Kwayoyin cuta na CoVs ƙananan ƙwayoyin cuta ne masu girma da ƙarancin ƙwayoyin cuta waɗanda ke ɗauke da sarkar RNA guda ɗaya da ke da ma'ana.
Ana iya raba su zuwa jinsuna huɗu, wato: alpha, beta, gamma, da delta, waɗanda aka san cewa alpha coronaviruses da beta coronaviruses suna cutar da mutane.
Glycoprotein spike (S) na envelope yana haɗuwa da masu karɓar ƙwayoyin salula na enzyme mai canza angiotensin 2 (ECA2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, kuma a cikin jerin, haɗuwa da membrane yana faruwa.
Ana sakin kwayoyin RNA na kwayar cutar a cikin kwayar halitta; bayan kwayar cutar ta kwayar cutar ta kwayar halitta, RNA na genomic tare da glycoproteins da aka rufe da kuma nucleocapsid sunadaran suna samar da vesicles wanda ke dauke da virins, wanda ke haɗuwa da membrane plasma kuma ya saki kwayar cutar.
An fara rahoton jerin kwayoyin halittar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in betacoronavirus tare da sama da kashi 99.98 cikin ɗari na asalin kwayoyin halitta tsakanin samfuran 10 da aka tattara daga wurin da cutar ta fara, Kasuwar 'Ya'yan Ruwan Huanan a Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar amfani da na'urar daukar hotan takardu, an gano kwayoyin SARS-CoV-2 a cikin ƙananan sassan ƙwayoyin cuta na iska.
An gano cewa ECA2 na mutum mai karɓar SARS-CoV-2 ne, da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana ɗaure da furotin ECA2 na ɗan adam cikin rauni fiye da furotin na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta mai tsanani a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma na iya samar da sabon ƙaramin furotin wanda aka tsara ta hanyar orf3b da furotin da aka ɓoye wanda aka tsara ta hanyar orf8.
SARS-CoV-2 orf3b na iya taka rawa a cikin cutar kwayar cuta da hana bayyanar IFNβ; duk da haka, orf8 ba ta da wani yanki ko dalili na aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., ya ba da rahoton tsarin cryo-EM na ECA2 na ɗan adam mai tsayi duka zuwa ƙudurin 2,9 Å a cikin hadadden tare da jigilar amino acid B0AT1.
An gano cewa hadaddun, wanda ke da buɗe da rufe ƙira, an haɗa shi kamar dimer, kuma hadaddun ECA2-B0AT1 na iya haɗa sunadarai biyu na S, wanda ke ba da shaida don ganewa da kamuwa da cutar CoV.
B0AT1 na iya zama maƙasudin magani don tantance magunguna don kawar da kamuwa da SARS-CoV-2.
Mai watsa shiri na asali da mai shiga tsakani
An san cewa duka SARS-CoV da MERS-CoV sun samo asali ne daga jemage kuma an watsa su ga mutane ta hanyar civets da raƙuma, bi da bi.
Ta hanyar kwatanta tsarin halittar SARS-CoV-2 da sauran CoVs, an yi la'akari da cewa jemage ne ke daukar nauyin SARS-CoV-2 saboda sabon kwayar cutar ta kasance daidai da kashi 96% ga CoVs biyu na SARS-kamar bat bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma, ba a san wanda ya taimaka wa kwayar cutar ta ƙetare iyakar jinsin da kuma cutar da mutane ba, kuma ba a san hanyar da za ta iya yaduwa ba.
Ji, et al., ya nuna cewa macizai suna ɗaukar kwayar cutar daga jemage zuwa mutane, wanda ya shafi sake haɗuwa a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China sun nuna cewa pangolins, dabbobi masu shayarwa masu dogon baki da ke cin tururuwa kuma ana amfani da su sau da yawa a maganin gargajiya na kasar Sin, sune masu karɓar bakuncin SARS-CoV-2, bisa ga kamannin kwayoyin halitta na 99% tsakanin CoV da aka gano a pangolins da SARS-CoV-2.
Duk da haka, bambanci na 1% a cikin kwayoyin halitta biyu babban bambanci ne; saboda haka ana jiran sakamako mai mahimmanci don gwaji na musamman (Fig. (Fig.33).
Abubuwan da ke tattare da SARS-CoV-2 ba a san su ba tukuna.
SARS-CoV da MERS-CoV na iya rayuwa a cikin gwaje-gwaje na tsawon awanni 48 a cikin bushewa da har zuwa kwanaki 5 a ƙarƙashin 20 °C tare da danshi 40% zuwa 50%.
SARS-CoV-2 na iya samun irin wannan kaddarorin.
An ba da rahoton cewa SARS-CoV-2 yana da ƙarancin haske da zafi na 56 °C na mintuna 30; ether, 75% ethanol, chlorine disinfectant, peracetic acid, chloroform da sauran abubuwan narkewa na kwayoyin amma ba chlorhexidine ba suna da tasiri wajen kashe kwayar cutar.
Gabaɗaya, duk mutanen da ke cikin duniya ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, ba a ba da rahoton cikakken bincike game da amsar rigakafi ga SARS-CoV-2.
Saboda haka, zamu iya duba kawai binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig.4).4).
Gabaɗaya, bayan kwayar cuta ta mamaye mai masaukin, tsarin garkuwar jiki na asali na mai masaukin ya fara gane ta ta hanyar masu karɓar karɓar ƙirar (PRRs), gami da masu karɓar lectin na nau'in C, mai karɓar nau'in Toll (TLR), mai karɓar nau'in NOD (NLR) da mai karɓar nau'in RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar abubuwan kumburi, balaga na ƙwayoyin dendritic da kuma samar da nau'in interferons na I (IFNs), wanda ke iyakance yaduwar kwayar cutar da kuma hanzarta phagocytosis na macrophages na kwayar cutar.
Amma, furotin N na SARS-CoV zai iya taimaka wa kwayar cutar ta tsere daga amsawar rigakafi.
Ba da daɗewa ba, tsarin garkuwar jiki zai soma yaƙi da ƙwayar.
Kwayoyin T, ciki har da CD4+ da CD8+ T cells suna taka muhimmiyar rawa wajen kariya.
Kwayoyin CD4+ T suna motsa ƙwayoyin B don samar da ƙwayoyin rigakafi na musamman ga kwayar cutar, kuma ƙwayoyin CD8+ T suna kashe ƙwayoyin cutar kai tsaye.
Kwayoyin T masu taimakawa suna samar da kwayoyin cytokines masu taimakawa wajen kare kwayoyin.
Koyaya, CoV na iya hana ayyukan T-cell ta hanyar haifar da apoptosis na T-cell.
Tsarin rigakafi na humoral, gami da kari kamar su C3a da C5a, ma yana da mahimmanci don yaƙar kamuwa da kwayar cuta.
Alal misali, ƙwayoyin cuta da aka ware daga mai haƙuri da ya warke sun kawar da MERS-CoV.
A wani ɓangare kuma, sa'ad da tsarin garkuwar jiki ya yi tsananin aiki, yakan haifar da ƙwayoyin cuta da yawa da za su iya lalata huhu da sauran gabobin jiki, kuma a mafi munin yanayi, gabobin jiki da yawa za su kasa aiki, har ma da mutuwa.
Kamuwa da cutar SARS-CoV-2, wanda ke nuna bayyanar cututtuka a cikin rukuni na mutane, ya fi shafar tsofaffi da ke fama da cututtuka da mata masu ciki.
Mutane da yawa da ke fama da ƙwayoyin cuta da yawa ko kuma waɗanda suke da lahani a cikin tsarin garkuwar jiki suna iya kamuwa da cutar fiye da sauran mutane.
Matsakaicin lokacin kamuwa da cutar SARS-CoV-2 ya kai kwanaki 1 zuwa 14 kuma mafi yawan lokuta kwanaki 3 zuwa 7 bisa nazarin farko na mutane 425 da suka kamu da cutar a Wuhan.
Amma, wani bincike da aka yi a kan mutane 1,099 ya nuna cewa tsawon lokacin da suke yin ciki ya kai kwana uku, kuma ya kai daga kwana 0 zuwa 24.
Wani sabon bincike, kamar yadda aka bayyana a sama, ya nuna cewa lokacin incubation ya kasance kwanaki 4.8 (3.0 zuwa 7.2) bisa ga yawan mutane 8,866.
Yana da mahimmanci hukumomin kiwon lafiya su daidaita lokacin keɓewar da ya dace bisa ga lokacin ɓoyewa mafi dacewa, don haka hana mutane masu cutar waɗanda ba su da alamun cutar daga yada kwayar cutar ga wasu mutane.
A matsayin al'ada, mutane da suka kamu da cutar ko kuma suka kamu da ita, yawanci suna bukatar su keɓe kansu na kwanaki 14.
Shin za a ƙara kwana 24 a keɓewar?
Zazzabi yawanci shine farkon kuma babban alamar COVID-19, wanda zai iya zuwa shi kaɗai ko tare da wasu alamun, kamar bushewar tari, numfashi, ciwon tsoka, zazzaɓi, ciwon kai, ciwon makogwaro, zazzaɓi, ciwon kirji, zawo, tashin zuciya da amai.
Wasu marasa lafiya sun sami dyspnea da/ ko hypoxemia mako guda bayan bayyanar cututtukan cutar.
A cikin mawuyacin hali, marasa lafiya sun ci gaba da sauri zuwa cututtukan numfashi, damuwa, acidosis na metabolism da clotopathy.
Marasa lafiya da zazzabi da/ko cututtukan numfashi da zazzabi mai tsanani, koda ba su da wata cuta a cikin binciken hoto na huhu, ya kamata a tantance su don cutar don samun ganewar asali.
Wani binciken alƙaluma a ƙarshen Disamba 2019 ya nuna cewa kashi 98 cikin ɗari na alamun cutar sun kasance zazzabi, kashi 76 cikin ɗari na tari mai bushe, kashi 55 cikin ɗari na dyspnea, da kashi 3 cikin ɗari na zawo; kashi 8 cikin ɗari na marasa lafiya sun buƙaci tallafin numfashi.
An bayar da rahoton irin wannan sakamakon a cikin binciken biyu na kwanan nan na ƙungiyar iyali da ƙungiyar da ke da watsawa daga mutum mara alama.
A kwatankwacin haka, binciken alƙaluma a cikin 2012 ya nuna cewa marasa lafiyar MERS-CoV suma suna da zazzabi (98%), tari mai bushewa (47%) da dyspnea (55%) a matsayin manyan alamun.
Koyaya, kashi 80% na marasa lafiya sun buƙaci tallafin numfashi, fiye da marasa lafiyar COVID-19, wanda ya ƙunshi mafi yawan mutuwar MERS idan aka kwatanta da COVID-19.
Diarrhea (26%) da ciwon makogwaro (21%) an kuma lura dasu a cikin marasa lafiya tare da MERS.
A cikin marasa lafiya tare da SARS, zazzabi (99% zuwa 100%), bushewar tari (29% zuwa 75%), dyspnea (40% zuwa 42%), zawo (20% zuwa 25%) da ciwon makogwaro (13% zuwa 25%) an nuna su a matsayin manyan alamun bayyanar cututtuka, kuma ana buƙatar tallafin numfashi don kusan 14% zuwa 20% na marasa lafiya.
Har zuwa 14 ga Fabrairu, mutuwar COVID-19 ta kai kashi 2%, lokacin da aka tabbatar da mutane 66,576 a duniya.
Idan aka kwatanta, mutuwar SARS har zuwa Nuwamba 2002 ya kai kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar.
Ga MERS, bisa ga binciken yawan jama'a na Yuni 2012, mutuwar ta kasance kashi 37 cikin dari na mutane 2,494 da aka tabbatar.
Wani sabon bincike ya ba da rahoton cewa yawan R0 na SARS-CoV-2 ya kai 6.47 tare da rabon amincewa (CI) na 95%, 5.71 zuwa 7.23, yayin da R0 na SARS-CoV ya bambanta daga 2 zuwa 4 kawai.
An kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV dangane da alamun cututtuka, mutuwa da R0 a cikin Tebur Tebur1.1.
Hotunan da ke sama sun nuna cewa SARS-CoV-2 yana da ƙarfin yaduwa fiye da MERS-CoV da SARS-CoV, amma ba shi da kisa kamar waɗannan biyun.
Saboda haka, yana da ƙalubale sosai don sarrafa annobar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Aukuwa a cikin rukuni na mutane yawanci yakan faru ne a cikin iyali ɗaya ko kuma a cikin rukuni ɗaya ko abin hawa, kamar jirgin ruwa.
Masu cutar galibi suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da cutar ta shafa, ko kuma hulɗa da mutane ko marasa lafiya da suka kamu da cutar a cikin makonni biyu kafin bayyanar cututtukan.
Koyaya, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar sama da makonni biyu ba tare da nuna alamomi ba, kuma marasa lafiya da suka warke waɗanda aka sallama daga asibitoci na iya sake kamuwa da kwayar cutar, wanda ke haifar da faɗakarwa don tsawaita lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin farin jini (musamman ƙwayoyin lymphocytes) a farkon matakin.
Misali, an gano cutar lymphopenia da ke dauke da ƙwayoyin farin jini da ke ƙasa da 4 x 109/L ciki har da ƙwayoyin lymphocyte da ke ƙasa da 1 x 109/L, da kuma yawan aspartate aminotransferase da viremia a cikin marasa lafiya 1,099 da ke da COVID-19.
Enzymes da myoglobins a cikin tsoka da hanta sun kasance sun karu a cikin jinin wasu marasa lafiya, kuma C-reactive protein da erythrocyte settlement sun karu a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, matakin dimer-D, wani samfurin lalacewar fibrin a cikin jini, ya kasance mai girma, kuma ƙididdigar lymphocyte ya nuna raguwa.
Abubuwan da ba daidai ba a cikin radiography na kirji suna cikin yawancin marasa lafiya da COVID-19, kuma suna nuna inuwa mara kyau ko kuma tabarau mai haske a cikin huhu.
Yawancin lokaci marasa lafiya suna ci gaba da ciwon huhu, lalacewar huhu da kuma ciwon ciwon huhu (ARDS).
Sa'ad da cutar ADD ta taso, ƙonewa da ruwa da kuma ci gaba da ciwon ƙwayoyin jiki suna ɓata ma'aunin gas.
Rashin aiki na nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Saboda haka, sakamakon da ya fi tsanani a cikin sashin kirji na X-ray yawanci yana nuna yanayin da ya fi tsanani.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna ɓarnawar huhu, samuwar membrane na hyaline, shiga cikin ƙwayoyin lymphocytes da ƙwayoyin syncytial a cikin huhu na wani mai haƙuri wanda ya mutu daga cutar, wanda ya dace da cututtukan cututtukan ƙwayar cuta da ARDS, kuma yayi kama da cututtukan marasa lafiya tare da SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar polymerase  reverse transcriptase chain reaction (RT-PCR) an yi amfani da shi azaman babban ma'auni don gano COVID-19.
Duk da haka, saboda yawan ƙarancin ƙarya, wanda zai iya hanzarta yaduwar cutar, an fara amfani da bayyanar asibiti don ganewar asali (wanda ba a samo shi daga RT-PCR kawai ba) a China a ranar 13 ga Fabrairu, 2020.
Haka ma ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwajen gwaje-gwaje da kuma sakamakon radiology yana da mahimmanci kuma dole ne don isa ga ganewar asali mai tasiri.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana wata yarjejeniya ta amfani da fasahar SHERLOCK, wacce ta dogara da CRISPR, don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 a cikin 20 x 10-18 mol/L zuwa 200 x 10-18 mol/L (10 zuwa 100 kwafi a kowace microliter na shigarwa) ta amfani da sandar a cikin ƙasa da awa ɗaya, ba tare da buƙatar kayan aiki mai rikitarwa ba.
Muna fatan cewa wannan sabuwar fasahar za ta iya ƙara ƙwarewa da dacewa idan aka gwada ta a cikin samfurin asibiti.
Saboda rashin gogewa da sabon CoV, likitoci na iya samar da mafi kyawun maganin COVID-19 ga marasa lafiya yayin da suke gwada magungunan da aka yi amfani da su ko kuma aka ba da shawarar su don magance wasu CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table (Table2).2).
Waɗannan magungunan sun haɗa da maganin riga-kafi da magungunan hana yaduwar cuta, magungunan hana kamuwa da cuta, magungunan steroid, jini na marasa lafiya da aka warkar, maganin gargajiya na ƙasar Sin da kuma taimakon tunani.
Har ma an ba da shawarar yin amfani da jini na marasa lafiya da suka warke.
Kamfanonin harhada magunguna suna fama da lokaci don samar da rigakafi da alluran rigakafi da za su magance cutar.
SARS-CoV-2 ya fi kai hari ga huhu a farkon, kuma mai yiwuwa ma yana kai hari, a cikin ƙaramin mataki, wasu gabobin da ke nuna ECA2, kamar tsarin hanji da kodan.
Amma, rashin numfashi da kuma gazawar gabobin jiki su ne manyan barazanar da ke addabar marasa lafiya da kuma manyan abubuwan da ke kashe su.
Saboda haka, taimakon numfashi yana da muhimmanci wajen rage alamun cututtuka da ceton rayuka, kuma ya haɗa da maganin oxygen gaba ɗaya, oxygen mai yawa, numfashi mara ƙarfi da kuma numfashi mai ƙarfi, dangane da tsananin cutar.
Marasa lafiya da ke fama da mummunan cututtukan numfashi suna buƙatar samun iskar oxygen ta hanyar membrane (ECMO), wata hanyar canzawa ta zuciya da na numfashi da ake amfani da ita don magance mummunan zuciya ko rashin ƙarfi.
Bugu da ƙari, kiyaye daidaiton electrolyte, rigakafi da kula da cututtukan na biyu da harin septic, da kare ayyukan gabobin rayuwa ma suna da mahimmanci ga marasa lafiya tare da SARS-CoV-2.
An san cewa ruwan cytokine yana haifar da mummunan halayen tsarin rigakafi a cikin marasa lafiya tare da SARS da MERS.
Cytokine cascade wani nau'i ne na tsarin kumburi, wanda aka nuna ta hanyar sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan cytokines suna sa ƙwayoyin jikinmu su saki ƙwayoyin ƙwayoyin cuta da yawa, waɗanda suke haddasa cutar ADD da kuma rashin aiki na gabobin jiki.
Magungunan rigakafi yana da mahimmanci wajen magance ruwan sama na cytokine, musamman a cikin marasa lafiya masu tsanani.
Ana amfani da kwayoyin cuta da kuma tocilizumab, wanda shine kwayar cutar IL6 don magance cutar.
Sauran maganin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin
Ana amfani da kwayoyin steroid, kamar masu hana kamuwa da cutar, wajen maganin SARS don rage tsananin cutar.
Koyaya, steroids a manyan allurai ba su da fa'ida ga mummunan raunin huhu a cikin marasa lafiya tare da SARS da COVID-19.
Suna iya haifar da mummunan sakamako, musamman osteonecrosis avascular, yana shafar hangen nesa sosai.
Koyaya, an ba da shawarar gajeren lokaci na maganin corticosteroids a ƙananan zuwa matsakaitan allurai don amfani da hankali a cikin marasa lafiya masu COVID-19 masu rauni.
A lokacin da ake rubuta wannan talifin, babu wani magani mai amfani da ƙwayoyin cuta da aka tabbatar.
Koyaya, an gano cewa yin amfani da remdesivir a cikin jijiya, analog na nucleotide, ya yi tasiri a cikin wani mai haƙuri na Amurka tare da COVID-19.
Remdesivir wani sabon magani ne da Gilead ta samar domin maganin cutar Ebola da Marburg.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta na RNA mai sauƙi, gami da ƙwayoyin cuta na MERS da SARS.
Bisa ga wannan, Gilead ta ba da mahaɗin ga China don yin wasu gwaje-gwaje a kan mutanen da ke da cutar SARS-CoV-2, kuma ana jiran sakamakon sosai.
Bugu da ƙari, baricitinib, interferon-α, lopinavir/ ritonavir, da ribavirin an ba da shawarar su zama magunguna masu yuwuwa ga marasa lafiya da ke fama da cututtukan numfashi.
Zazzabi, tashin zuciya, vomiting, lalacewar hanta da sauran halayen da ba su dace ba na iya faruwa bayan maganin haɗin lopinavir / ritonavir.
Ya kamata a kula da hulɗar waɗannan magungunan tare da sauran magungunan da aka yi amfani da su a cikin marasa lafiya.
Plasma na marasa lafiya da aka warkar da su da kuma samar da ƙwayoyin cuta
Ana ɗaukan jini daga marasa lafiya da suka warke daga wata cuta don a kula da wasu marasa lafiya da suke fama da wannan cutar ko kuma don a kāre lafiyayyu daga kamuwa da cutar.
Hakika, marasa lafiya da suka warke suna da yawan ƙwayoyin cuta a cikin jinin su.
Kwayoyin rigakafi suna da immunoglobulin (lg) wanda kwayoyin B ke samarwa don yaƙar ƙwayoyin cuta da sauran ƙwayoyin waje, kuma suna gane kwayoyin halitta na musamman a cikin ƙwayoyin cuta kuma suna kawar da su kai tsaye.
Bisa ga wannan, an tattara jini daga rukunin marasa lafiya da suka warke daga COVID-19, kuma an yi musu allurar rigakafi a cikin marasa lafiya 10 da ke cikin mawuyacin hali.
Alamun cututtukan sun inganta cikin sa'o'i 24, tare da rage kumburi da ƙwayoyin cuta, da kuma ingantaccen oxygen a cikin jini.
Duk da haka, ana bukatar bincike da kuma bayani kafin a iya yin amfani da wannan hanyar a kan babban sikelin kafin a samu takamaiman magunguna.
Bugu da ƙari, saboda tasirin maganin, wasu rashin amfani da ke tattare da plasma ya kamata a yi la'akari da hankali.
Alal misali, ƙwayoyin cuta suna iya sa jikin mutum ya riƙa saurin kamuwa da cutar kuma hakan yana iya sa mutum ya kamu da cutar da ake kira cytokine release syndrome.
Yawan ƙwayoyin cuta a cikin jini yawanci ƙasa ne, kuma ana bukatar jini sosai don kula da marasa lafiya masu tsanani.
Yana da wuya a yi amfani da ƙwayoyin cuta na musamman da sauri don magance cutar a dukan duniya.
Saboda haka, yana da muhimmanci kuma ya fi dacewa a ware ƙwayoyin B daga marasa lafiya da aka warkar da su kuma a gano lambobin kwayoyin da ke ƙunshe da ƙwayoyin cuta masu tasiri ko kuma a bincika su don ƙwayoyin cuta masu tasiri ga sunadarai masu mahimmanci na kwayar cutar.
Ta hakan, za mu iya ƙara yawan ƙwayar rigakafi da sauri.
An yi amfani da maganin gargajiya na kasar Sin, wato TCM, na dubban shekaru don magance cututtuka daban-daban a kasar Sin.
Amma, sakamakon yana dogara ne da haɗuwa da abubuwa da yawa a cikin wani tsari wanda ya bambanta dangane da ganewar asali na cutar bisa ka'idodin TCM.
Yawancin abubuwan da ke aiki ba a san su ba, ko kuma ba su da ma'ana, saboda yana da wuya a cire su kuma a tabbatar da waɗannan abubuwan ko kuma haɗuwa da su.
A halin yanzu, saboda rashin takamaiman magani mai tasiri don COVID-19, TCM ya zama ɗayan manyan magunguna masu madadin marasa lafiya tare da alamun rashin lafiya ko masu matsakaici, ko marasa lafiya da suka warke daga mawuyacin yanayin cutar.
Alal misali, an gano cewa capsules na Shu Feng Jie Du da Lian Hua Qing Wen suna da tasiri wajen magance COVID-19.
An lura da mafi kyawun ƙimar warkarwar marasa lafiya na COVID-19 a larduna da yawa a China waɗanda suka yi amfani da TCM a cikin kashi 87% na marasa lafiya, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da Lardin Hubei, wanda ya yi amfani da TCM a cikin kusan kashi 30% na marasa lafiyar COVID-19, ya sami mafi ƙarancin ƙimar warkarwa (13%).
Amma wannan kwatancen yana da wuya, domin akwai abubuwa da yawa da za su iya shafar mutum, kamar yawan marasa lafiya da kuma tsananin cutar.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike mai kwatanta tsakanin maganin da ake yi da magungunan Yammacin Turai da kuma maganin da ake yi da magungunan Yammacin Turai da kuma TCM.
An gano cewa lokacin da ake bukata don warkewa daga zafin jiki, bayyanar cututtuka da kuma asibiti ya yi ƙasa sosai a rukunin da ake amfani da magungunan Yammacin Turai da kuma magungunan TCM fiye da rukunin da ake amfani da magungunan Yammacin Turai kaɗai.
Yawan ciwon cututtuka (daga mai laushi zuwa mai tsanani) ya kasance ƙasa da ƙasa ga ƙungiyar da aka yi amfani da shi da magungunan gargajiya da magungunan gargajiya kawai (7.4% da 46.2%), kuma mutuwar ta kasance ƙasa da ƙungiyar da aka yi amfani da shi da magungunan gargajiya da magungunan gargajiya fiye da ƙungiyar da aka yi amfani da shi kawai (8.8% da 39%).
Duk da haka, inganci da amincin TCM har yanzu suna jiran ƙarin gwaji da aka sarrafa a cikin manyan wurare da cibiyoyi.
Hakanan zai zama da amfani a bayyana hanyoyin aiki da kuma bayyana ingantattun abubuwan haɗin maganin TCM ko haɗuwa da su idan ya yiwu.
Marasa lafiya da aka tabbatar da cutar COVID-19 ko kuma waɗanda ake zargi da cutar suna jin tsoron cutar mai saurin yaduwa da kuma cutar da za ta iya kashe su, kuma mutanen da ke keɓewa suna jin gundura, kaɗaici da fushi.
Ƙari ga haka, cututtukan da ke tattare da kamuwa da cuta kamar zazzabi, rashin ƙarfi, da tari da kuma wasu cututtuka da ake samu daga jinya kamar rashin barci da ake samu daga shan magungunan da ake kira corticosteroids suna iya sa mutum ya ƙara damuwa da kuma baƙin ciki.
A farkon lokacin barkewar cutar SARS, an ba da rahoton cututtukan ƙwaƙwalwa da yawa, gami da ci gaba da baƙin ciki, damuwa, fargaba, tashin hankali, alamun psychosis, hauka, har ma da son kashe kansa.
Bukatun bin diddigin lamba da keɓewa, a matsayin ɓangare na ayyukan tsarin kiwon lafiyar jama'a game da annobar COVID-19, na iya sa mutane su ƙara damuwa, kuma suna iya jin laifi game da tasirin kamuwa da cuta, keɓewa, da kuma ƙyama da aka ɗora wa danginsu da abokansu.
Saboda haka, ya kamata a ba da kulawar lafiyar kwakwalwa ga marasa lafiya da ke da COVID-19, mutanen da ake zargi da cutar da kuma mutanen da suka taɓa hulɗa da su, da kuma jama'ar da ke cikin bukata.
Tallafin tunani ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiyar hankali da yawa, sadarwa mai kyau tare da sabuntawa na yau da kullun da kuma daidaito game da barkewar cutar SARS-CoV-2 da tsare-tsaren magani, da amfani da na'urori da aikace-aikacen lantarki na ƙwararru don kauce wa hulɗa kai tsaye tsakanin mutane.
Alluran rigakafi masu tasiri suna da mahimmanci don dakatar da sarkar watsawa daga dabbobi da mutane masu kamuwa da cuta zuwa masu karɓar baƙi, kuma galibi suna haɓaka maganin rigakafi a cikin kula da annoba da ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari don haɓaka alluran rigakafi na S-protein don samar da ƙwayoyin cuta masu ƙarfi da daɗewa da kuma kariya daga SARS-CoV.
An gwada alluran rigakafi a cikin samfuran dabbobi don SARS.
Koyaya, ingancin in vivo na waɗannan 'yan takarar allurar rigakafi a cikin tsofaffi da ƙirar ƙalubalen kisa da kariya daga kamuwa da ƙwayoyin cuta na dabbobi har yanzu suna buƙatar ƙaddara kafin fara gwajin asibiti.
Wannan wataƙila saboda SARS ya ɓace shekaru 17 da suka shige kuma ba a sami wani sabon mutum da ya kamu da cutar ba.
A gefe guda kuma, wasu lokuta da kuma ɓarkewar MERS na ci gaba da faruwa a Gabas ta Tsakiya kuma suna yaduwa zuwa wasu yankuna saboda ci gaba da tushen cututtukan dabbobi a yankunan da ke fama da cutar.
An tsara dabarun allurar rigakafi don MERS ta amfani da ƙwayoyin cuta marasa aiki, plasmids na DNA, masu ɗaukar hoto, nanoparticles, ƙwayoyin cuta masu kama da ƙwayoyin cuta da ƙwayoyin ƙwayoyin cuta masu haɗuwa, kuma an gwada wasu a cikin samfuran dabbobi.
Samar da ingantaccen allurar rigakafin SARS-CoV-2 ga mutanen da ba su da rigakafi aiki ne na gaggawa da mahimmanci don sarrafa annobar da ke faruwa.
Duk da haka, yana da ƙalubale don shawo kan wahalar saboda tsawon lokaci (watanni 18, a matsakaita) da ake buƙata don haɓaka allurar rigakafi da bambance-bambancen yanayin CoVs.
A matsayin sabuwar cuta, COVID-19 ta fara nuna cikakkiyar ci gabanta na asibiti, yana shafar dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna murmurewa a hankali ba tare da ciwo ba.
Koyaya, kamar SARS da MERS, COVID-19 kuma yana da alaƙa da yawan rashin lafiya da mutuwa a cikin marasa lafiya masu fama da cutar.
Saboda haka, gina samfurin tsinkaya don cutar yana da mahimmanci ga hukumomin kiwon lafiya don fifita ayyukansu, musamman a yankunan da ba su da albarkatu.
Dangane da nazarin asibiti da aka ruwaito zuwa yanzu, abubuwan da ke tafe na iya shafar ko alaƙa da tsinkayen marasa lafiya da COVID-19 (Table (Table33)):
Shekaru: Shekaru sune mafi mahimmancin abu don tsinkayar SARS, wanda kuma ya shafi COVID-19.
COVID-19 ya fi shafar mutane tsakanin shekaru 30 zuwa 65, tare da kashi 47.7 cikin ɗari na marasa lafiya da ke sama da shekaru 50, a cikin binciken da aka yi na mutane 8,866, kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani suna da damar samun cututtuka da rikitarwa, kuma sun fi tsofaffi fiye da marasa lafiya da ba su buƙatar kulawa mai tsanani (tare da matsakaicin shekaru 66 da shekaru 51), yana nuna cewa shekaru shine babban abin da ke haifar da rashin lafiya ga marasa lafiya tare da COVID-19.
Maza: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 maza da 0.27/100,000 mata), kamar yadda aka bayyana a sama.
Cutar da ke tattare da cutar da kuma rikitarwa: marasa lafiya da ke da COVID-19 da ke buƙatar kulawa mai tsanani suna da damar samun rauni na zuciya ko arrhythmia.
Cutar zuciya ita ce babbar hanyar mutuwa a cikin marasa lafiya da ke fama da SARS.
An ba da rahoton cewa SARS-CoV-2 na iya ɗaure kansa ga kwayoyin ECA2 masu kyau, wanda zai iya haifar da rashin aiki na hanta a cikin marasa lafiya da COVID-19.
Yana da muhimmanci a lura cewa shekaru da cututtuka suna da nasaba sosai kuma suna iya shafan juna.
Sakamakon gwaje-gwaje na yau da kullun: matakin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko lalacewar nama kuma an ba da shawarar a matsayin mai yiwuwa mai hangen nesa ga cutar, amsawar magani da kuma dawowa.
An kuma ba da shawarar alaƙar matakin CRP da tsananin cutar da kuma tsinkayar COVID-19.
Bugu da ƙari, lactate hydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) masu yawa zasu iya taimakawa wajen hango sakamakon.
Waɗannan ƙwayoyin suna da yawa a cikin gabobin jiki, musamman a zuciya da hanta, kuma ana sakin su sa'ad da ake lalata nama.
Saboda haka, alamun gargajiya ne na ciwon zuciya ko na hanta.
Babban alamun asibiti: X-ray na kirji da ci gaban lokaci na alamun asibiti dole ne a yi la'akari tare da wasu batutuwa don hango ƙarshen COVID-19/rikitarwa.
Amfani da steroid: kamar yadda aka bayyana a sama, steroids sune masu hana rigakafi waɗanda aka saba amfani dasu azaman maganin kariyar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Saboda an yi amfani da magungunan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Don haka, idan ya cancanta, ya kamata a yi amfani da kwayoyin steroids a cikin ƙananan allurai da gajeren lokaci a cikin marasa lafiya da ke da COVID-19.
Matsalolin tunani: Kamar yadda aka bayyana a sama, a lokacin annobar COVID-19, marasa lafiya da yawa suna fama da matsanancin damuwa yayin da suke fuskantar tsawan lokacin keɓewa da rashin tabbas, da kuma ganin mutuwar ƙaunatattun danginsu da sauran marasa lafiya.
Yana da muhimmanci a ba da shawara da kuma taimako na dindindin don taimaka wa irin waɗannan marasa lafiya su daina damuwa kuma su koma rayuwa ta yau da kullum.
Dangane da nazarin alƙaluma har zuwa yanzu, COVID-19 ya bayyana yana da halaye na annoba daban-daban daga halaye na SARS.
Baya ga yin kwafi a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwafi cikin inganci a cikin hanyoyin numfashi na sama kuma baya haifar da alamomi a farkon lokacin kamuwa da cuta (ko kuma yana haifar da alamomi masu sauƙi), kamar sauran CoVs da ke haifar da sanyi.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokaci ko lokacin ɓoyewa na iya samar da kwayar cutar da yawa yayin ayyukan yau da kullun, yana haifar da babbar matsala ga kula da annobar.
Koyaya, an ɗauka cewa watsa SARS-CoV yana faruwa ne lokacin da marasa lafiya ke da rashin lafiya, tare da yawancin watsawa ba a farkon matakin ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS tsanani da kuma wahalar sarrafawa.
Ana yin ƙoƙari sosai a yanzu a China, ciki har da kulle Wuhan da biranen da ke kewaye da ita, da kuma keɓe kusan dukan mazauna ƙasar, da fatan dakatar da yaduwar SARS-CoV-2.
Duk da cewa waɗannan matakan sun yi tasiri sosai ga tattalin arzikin ƙasar da sauran fannoni, yawan sabbin marasa lafiya na raguwa, wanda ke nuna cewa annobar ta ragu.
A cewar wani mai hasashen, annobar za ta ƙare a watan Maris, kuma za a rage yawan annobar na tsawon watanni uku zuwa huɗu.
Amma, wasu masana ba su da bege.
Paul Hunter, et al., sun kiyasta cewa COVID-19, wanda ya bayyana ya fi SARS kamuwa da cuta sosai, ba zai ƙare a cikin 2020 ba.
Ira Longini, et al., sun kafa wani tsari don hango sakamakon annobar kuma sun ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiya a Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin maƙogwaro da ƙuƙwalwar ƙwarƙwarar marasa lafiya waɗanda suka warke kuma aka sallame su daga asibiti a cikin makonni 2 da suka gabata, wanda ke nuna cewa sabon ƙwayoyin cuta da aka gano na iya zama wani abu mai kama da mura.
Amma, a China akwai alamun da ke nuna cewa ana samun karuwar sabbin masu cutar, kuma hakan ya nuna cewa dabarun da ake amfani da su a yanzu suna aiki.
An yi hasashen cewa cutar Ebola za ta kai mutum miliyan ɗaya, kuma mutane miliyan biyar za su mutu.
Amma, da keɓewar da aka yi da kuma keɓewa, an samu nasarar hana cutar.
Zai yiwu cewa SARS-CoV-2, kamar SARS-CoV, zai iya zama mai rauni game da kamuwa da cuta kuma a wani lokaci ya zama ƙarancin cutar da ke rayuwa tare da mutane.
Kwatanta cutar COVID-19 da SARS da MERS ana iya samun su a ƙasa (Fig. (Fig.55)).
SARS-CoV-2 yana yaduwa sosai ta tari da hancinsa kuma mai yiwuwa ta hanyar tuntuɓar kayan da cutar ta shafa.
An kuma gano kwayar cutar a cikin bargo, wanda ke haifar da wata sabuwar dama: watsawar baki da bargo.
Wani bincike da aka yi kwanan nan a kan mutane 138 ya nuna cewa kashi 41 cikin ɗari na waɗanda suka kamu da cutar sun kamu da cutar, har da 17 da ke fama da cututtuka da yawa da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, ya kamata a ɗauki ƙarin kariya don kare mutane, musamman ma ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, dangin iyali, abokan aiki da kuma mutanen da ke hulɗa kai tsaye da marasa lafiya ko mutane masu kamuwa da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska; amfani da abin rufe fuska na tiyata da abin rufe fuska na N95 (jerin 1860s) yana taimakawa sarrafa yaduwar kwayar cutar.
Masks na tiyata suna hana ruwa daga mutum mai cutar daga hawa ko mannewa da abubuwa, inda zai iya cutar da wasu mutane.
Koyaya, kawai masks na N95 (jerin 1860s) suna karewa daga shan kwayar cutar da ke da girman 10 nm zuwa 80 nm, tare da kashi 5% na ƙwayoyin cuta ne kawai ke iya shiga ciki gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girman, kuma duka suna da kusan 85 nm.
Tun da yake ƙwayoyin suna iya shiga cikin masks na tiyata har zuwa biyar tare, ma'aikatan kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya ya kamata su sa masks na N95 (jerin 1860s), amma ba masks na tiyata ba.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya su sanya rigunan keɓewa don rage hulɗa da kwayar cutar.
Ƙari ga haka, ƙwayoyin cuta suna shafar mutum ta idanunsa.
A ranar 22 ga Janairun 2020, wani likita ya kamu da SARS-CoV-2, duk da cewa yana sanye da abin rufe fuska na N95; ƙila kwayar cutar ta shiga jikinsa ta idanunsa masu kumburi.
Saboda haka, ma'aikatan kiwon lafiya su sa rigunan kariya na fuska ko kuma tabarau na kariya yayin kula da marasa lafiya.
Ga jama'a a yankunan da cutar ta shafa ko kuma za a iya kamuwa da ita, an ba da shawarar sosai cewa kowa ya wanke hannayensa da sabulu mai kashe ƙwayoyin cuta sau da yawa fiye da yadda ya saba, yi ƙoƙarin zama a gida a keɓe, kuma iyakance hulɗa da mutanen da za su iya kamuwa da cutar.
Ana ganin mita ɗaya ya dace da nisantar da mutum daga mai haƙuri.
Waɗannan ayyuka hanyoyi ne masu tasiri don rage haɗarin kamuwa da cutar da kuma hana yaduwar kwayar cutar.
Kodayake SARS-CoV-2 ya fito ne a matsayin sabon kwayar cuta ga mutane, babban kamaninsa da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya haifar da babbar faɗakarwa ga China, bisa ga tarihinta na kwanan nan tare da annobar SARS a 2003.
Amma a ranar 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya tabbatar wa jama'a cewa sabon kwayar cutar ba ta da saurin yaduwa da kuma iyakancewar haifuwa tsakanin mutane, kuma ba shi da wuya a hana da kuma hana cutar.
Wannan saƙon ya sa mutane sun ɗan sami kwanciyar hankali, musamman ma a lokacin da ƙasar ke shirin bikin bazara, kuma an rasa lokacin da ya dace don hana cutar a Wuhan a ƙaramin sikelin.
Hukumomin kula da cututtuka a China za su iya koyon darasi daga wannan mummunan labari kuma su yi gyara mai muhimmanci a nan gaba.
Misali, waɗannan hukumomin dole ne: (1) su kasance da hankali yayin yin maganganun jama'a, saboda duk abin da suke faɗi yana shafar 'yan ƙasa kuma yana iya tasiri halayensu da yanke shawara; (2) su zama masu saurin ji da amsawa ga bayanan da ba a saba gani ba daga asibitoci, maimakon jiran sanarwar hukuma daga likitoci da hukumomi; (3) su kasance masu ƙuntatawa don hana wata annobar da ke faruwa a farkon matakinta, maimakon ƙoƙarin ta'azantar da jama'a; da (4) fitar da ƙarin lokuta da yawa da kuma ingantaccen kwaikwayon don haɓaka wayar da kan jama'a game da cututtukan cututtuka da kuma gwadawa da haɓaka tsarin amsawar al'umma akai-akai.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya bazu ko'ina cikin ƙasar Sin da kuma kusan ƙasashe 50 a duniya a lokacin da nake rubuta wannan.
Tun da cutar ta yi kama da SARS-CoV, kuma alamun cutar sun yi kama da na COVID-19 da SARS, annobar COVID-19 ta haifar da jin cewa SARS ya dawo.
Koyaya, akwai manyan bambance-bambance tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don hana yaduwar cutar da kula da marasa lafiya.
COVID-19 tana shafar tsofaffi fiye da matasa, kuma maza fiye da mata, kuma tsananin cutar da yawan mutuwa ma sun fi girma a cikin tsofaffi fiye da matasa.
SARS yana da yawan mutuwa fiye da COVID-19 (10,91% da 1,44%).
Marasa lafiya da COVID-19 suna watsa kwayar cutar lokacin da ba su da alamomi, yayin da marasa lafiya da SARS galibi ke watsa ta lokacin da suke rashin lafiya, wanda ke haifar da ƙalubale a hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana, a wani ɓangare, dalilin da yasa SARS-CoV-2 ke yaduwa da sauri kuma yana shafar yankuna da yawa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiya da COVID-19.
A wani ɓangare kuma, marasa lafiya da suka warke za su iya sake yin gwajin cutar.
Wadannan sakamakon sun kara yawan hadarin yaduwar cutar.
Ganin saurin ci gaba a binciken COVID-19, wasu mahimman tambayoyi har yanzu suna buƙatar warwarewa kamar haka:
Daga ina ne SARS-CoV-2 ya fito?
Kodayake an sami daidaiton kwayoyin halitta na 96% tsakanin SARS-CoV-2 da CoVs biyu na SARS-like, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya samo asali daga jemage ba.
Wane dabba ne ya zama ɗan tsakiya da ya ɗauki kwayar cutar daga ɗan'uwansa na asali, wato, daga ƙuda zuwa mutane?
Idan ba mu san amsoshin tambayoyi na 1 da 2 ba, ba za mu iya hana yaduwar cutar ba, kuma za a iya sake barkewar cutar a kowane lokaci.
Ko da yake samfurin kwayoyin halitta da gwaje-gwaje na ilimin halittu sun nuna cewa SARS-CoV-2 ya haɗu da ECA2, ta yaya kwayar cutar ke shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na rashin lafiya?
Shin kwayar cutar tana ɗaure kanta ga ƙwayoyin ECA2 a wasu gabobin jiki?
Idan ba mu san amsoshin waɗannan tambayoyin ba, ba za mu iya samun magani mai kyau da kuma saurin ganewa ba.
Har yaushe ne annobar za ta ci gaba?
Ta yaya kwayar cutar ke juyin halitta yayin yaduwa tsakanin mutane?
Shin za ta zama annoba a duniya, ko kuma za ta ɓace kamar SARS, ko kuma za ta sake dawowa kamar mura?
Yana da muhimmanci, amma zai ɗauki lokaci kafin ka sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Amma duk da kokarin da ake bukata, ba mu da wani zabi sai dai mu dakatar da annobar da wuri-wuri kuma mu koma rayuwarmu ta yau da kullun.
Asalin dabbobin da ke dauke da kwayar cutar coronavirus
Juyin halitta da daidaitawa sun haifar da juyin halitta na coronaviruses (CoVs) da masu karɓar su, gami da mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa mutum biyu CoVs (HCoVs) suna haifar da rashin lafiya mai sauƙi, kamar sanyi.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake sanya CoVs cikin haske kuma ya ba kowa mamaki da yawan yaduwar su da kuma rage cututtukan cutar idan aka kwatanta da ɗan'uwansa SARS-CoV.
Cutar HCoV tana da haɗari, kuma fahimtar asalin HCoVs yana da amfani sosai.
Yawancin HCoVs sun samo asali ne daga jemage, wanda ba su da cutar.
An kuma san masu karɓar bakunan ajiyar wasu HCoVs.
Gano dabbobi masu karɓar dabbobi yana da tasiri kai tsaye kan rigakafin cututtuka a cikin mutane.
Binciken hulɗar mai karɓar CoV a cikin dabbobi na iya samar da mahimman bayanai game da cutar CoV a cikin mutane.
A cikin wannan binciken, mun ba da cikakken bayani game da bayanan da ke akwai game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da kuma asalin su na dabbobi da watsawar jinsuna.
Wani muhimmin bincike shi ne kwatanta da kuma bambanta HCoVs daban-daban daga yanayin juyin halitta na kwayar cutar da kuma sake haɗuwa da kwayoyin halitta.
An tattauna annobar cutar CoV 2019 (COVID-19) a halin yanzu a wannan mahallin.
Bugu da ƙari, ana kuma nuna buƙatun don sauyawa cikin nasara tsakanin masu karɓar baƙi da kuma tasirin ci gaban kwayar cutar a kan tsananin cutar.
Coronaviruses (CoVs) suna cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ƙarancin ƙarfi, masu ƙarancin ƙarfi, da RNA mai sauƙi.
Waɗannan ƙwayoyin cuta waɗanda ke da mafi girman kwayoyin halitta, tsakanin kilobases 26 zuwa 32, a cikin ƙwayoyin cuta na RNA an kira su "CoVs" saboda siffar kambi lokacin da aka lura da su a cikin madubin lantarki.
Game da tsarin, CoVs suna da kwayoyin halittar da ba a rarraba su ba waɗanda ke da tsari iri ɗaya.
Kimanin kashi biyu cikin uku na kwayoyin halitta suna dauke da tsarin karatun budewa guda biyu (ORF1a da ORF1b), wanda aka fassara a cikin pp1a da pp1ab polyproteins.
Ana sake canza polyproteins kuma suna samar da sunadarai 16 marasa tsari, wanda aka kira nsp1 zuwa nsp16.
Sauran sashin kwayoyin halitta yana dauke da ORFs don sunadarai na tsarin, ciki har da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
Wasu ƙwayoyin cuta na ƙayyadaddun ƙwayoyin cuta suna ƙunshe da ƙwayoyin CoV daban-daban.
Bisa ga bambanci a cikin jerin sunayen sunadarai, an rarraba CoVs zuwa jinsi huɗu (alphaCoV, betaCoV, gammaCoV, da deltaCoV), daga cikinsu jinsi betaCoV ya ƙunshi yawancin HCoVs kuma an raba shi zuwa layi huɗu (A, B, C, da D).
Shaidar ilimin halitta ta nuna cewa jemage da rodents suna ba da tushen kwayoyin halitta ga yawancin alphaCoVs da betaCoVs, yayin da tsuntsaye sune babban taskar gammaCoVs da deltaCoVs.
A cikin dubban shekaru, CoVs sun ci gaba da ƙetare iyakokin jinsuna, kuma wasu sun zama manyan cututtukan ɗan adam.
A halin yanzu, an san mutane bakwai da ke dauke da cutar korona (HCoVs).
Daga cikin su, HCoV-229E da HCoV-NL63 sune alphaCoVs.
Sauran betaCoVs biyar sun haɗa da HCoV-OC43, HCoV-HKU1, SARS-CoV, MERS-CoV, da SARS-CoV-2.
Kwayoyin cutar HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da alamun rashin lafiya kamar sanyi da / ko zawo.
A akasin wannan, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 suna da cutar cuta sosai kuma suna haifar da mummunan kamuwa da cututtukan ƙananan numfashi a cikin yawancin marasa lafiya, tare da babban damar ci gaban cutar rashin jin daɗin numfashi (ARDS) da bayyanar cututtuka.
An ware HCoV-229E na farko, B814, daga jikin marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar cikakken nazarin HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun ƙuntatawa.
A gaskiya ma, ra'ayin cewa kamuwa da HCoVs ba shi da lahani har zuwa barkewar cutar SARS.
Cutar SARS da ta ɓarke a shekara ta 2003 tana ɗaya daga cikin cututtuka mafi muni a tarihinmu, ta harba mutane fiye da 8,000, kuma yawan mutanen da suka mutu a sakamakon cutar ya kai kusan kashi 10.
Shekaru goma bayan haka, annobar cutar murar numfashi ta Gabas ta Tsakiya (MERS) ta zama wata annoba mai ci a yankin Larabawa, kuma ta bazu a wasu wurare a duniya.
Sabuwar HCoV ta 2019 (2019-nCoV), wacce daga baya aka sake masa suna SARS-CoV-2, ita ce mai haifar da annobar cutar coronavirus ta 2019 (COVID-19), wacce ta kashe rayuka sama da 3,120 kuma ta harba mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
Ana faɗakarwa, kuma duniya tana buƙatar shirya don cutar SARS-CoV-2 da ke zuwa.
Dukkanin HCoVs bakwai sun samo asali ne daga dabbobi a cikin jemage, beraye ko dabbobin gida.
Bayanai da yawa sun tabbatar da asalin juyin halitta na dukkanin HCoVs daga jemage, inda ƙwayoyin cuta suka dace sosai kuma ba su da cutar amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta kawo kalubale masu yawa na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da sauran duniya.
Binciken asalin HCoVs na dabbobi yana ba da tsari don fahimtar tarihin halitta, ƙarfin motsawa da kuma abubuwan da ke hana ƙaura daga kwayar cutar zuwa wasu nau'ikan.
Wannan kuma na iya jagorantar da sauƙaƙa bincike don masu riƙewa, matsakaici da masu haɓaka SARS-CoV-2, tare da mahimman bayanai game da hana ƙaurawar kwayar cutar tsakanin nau'ikan.
A cikin wannan labarin, mun ba da cikakken bayani game da asalin dabbobi, watsawar jinsuna da kuma cutar HCoVs.
Musamman, mun nuna kuma mun tattauna batun gama gari cewa ƙwayoyin cuta na iyaye na HCoVs ba su da cutar a cikin masu karɓar bakunan su na halitta, amma sun zama masu cutar bayan watsawa tsakanin jinsuna zuwa sabon mai karɓar baƙi.
Mun kuma sake nazarin yanayin juyin halitta na HCoV, inda yawan kamuwa da cuta ke zuwa tare da raguwar cutar.
Hakanan ana tattauna sakamakon annobar SARS-CoV-2 ta yanzu a cikin wannan mahallin.
An san CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin a fara ware HCoV-229E B814 daga jikin marasa lafiya da suka kamu da mura, an ware CoVs daban-daban a cikin dabbobi da yawa da suka kamu da cutar, gami da turkey, linzamin kwamfuta, saniya, alade, cat da kare.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
A takaice dai, tarihin gano HCoV a cikin tsari na lokaci (Table 1) zai zama mai fa'ida da kuma koyarwa.
An ware HCoV-229E na farko daga hanyoyin numfashi na marasa lafiya da ke fama da cutar cutar ta sama a shekara ta 1966, kuma daga baya an daidaita shi don haɓaka cikin layin ƙwayoyin huhu WI-38.
Marasa lafiya da ke dauke da HCoV-229E sun nuna alamun sanyi na yau da kullun, gami da ciwon kai, hancin, rashin jin daɗi da ciwon makogwaro, tare da zazzabi da tari a cikin kashi 10 zuwa 20 cikin ɗari na lokuta.
Daga baya, a cikin 1967, an ware HCoV-OC43 daga al'adun gabobin jiki da kuma hanyar serial a cikin kwakwalwar berayen nono.
Alamun asibiti na kamuwa da cutar HCoV-OC43 suna kama da waɗanda HCoV-229E ke haifarwa, waɗanda ba za a iya rarrabe su da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
HCoV-229E da HCoV-OC43 suna da rarraba a duniya, kuma suna iya yaduwa a lokacin hunturu a cikin yanayin zafi.
Gabaɗaya, lokacin ɓoyewa na waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, tare da cutar ta kusan makonni biyu.
A cewar wani bincike da aka yi da masu sa kai, mutane masu lafiya da ke dauke da HCoV-229E sun kamu da sanyi mai sauƙi.
Sai kawai wasu marasa lafiya masu fama da cututtuka sun nuna mummunan cututtukan ƙananan numfashi.
SARS, wanda aka fi sani da "mummunan ciwon huhu", shine farkon cutar da aka rubuta ta haifar da HCoV a tarihin ɗan adam, kuma mahaliccin cutar shine SARS-CoV, HCoV na uku da aka gano.
An fara samun cutar SARS a shekara ta 2002 a lardin Guangdong na kasar Sin.
Cutar ta SARS ta haifar da rahotanni 8,096 da mutuwar 774, ta bazu cikin ƙasashe da nahiyoyi da yawa.
Ban da "masu yaduwa", an kiyasta cewa kowane mutum mai cutar zai iya cutar da wasu biyu, tare da lokacin kwashe kwanaki 4 zuwa 7, kuma tare da bayyanar ƙarancin ƙwayar cuta a rana ta goma ta cutar.
Marasa lafiya da ke dauke da SARS-CoV suna fara nuna ciwon zuciya, ciwon kai, zazzabi, rashin jin daɗi da sanyi, sannan alamun rashin jin daɗi, tari da wahalar numfashi.
Lymphopenia, rashin aiki na hanta da haɓaka creatine kinase sune abubuwan da suka faru na SARS a cikin gwaje-gwajen gwaji.
Hakanan ana ganin lalacewar alveolar da yawa, ƙwayoyin ƙwayoyin ƙwayoyin cuta da ƙaruwar ƙwayoyin cuta a cikin marasa lafiya tare da SARS.
Kimanin kashi 20 zuwa 30 cikin ɗari na marasa lafiya suna bukatar jinya mai tsanani da kuma numfashi mai ƙarfi a wani lokaci.
Baya ga ƙananan hanyoyin numfashi, gabobin da yawa, gami da gastrointestinal tract, hanta da kodan, suma suna iya shafar waɗannan mawuyacin yanayi, yawanci tare da fitowar cytokine, wanda zai iya zama mai kisa, musamman a cikin marasa lafiya marasa lafiya.
An fara gano kwayar cutar ne a cikin kwayar cutar huhu daga dangin mai cutar da ke tafiya daga Guangzhou zuwa Hong Kong.
Tun daga lokacin, an yi ƙoƙari sosai wajen bincike game da HCoV.
An ware HCoV-NL63 daga jariri ɗan wata 7 a Netherlands a ƙarshen 2004.
Da farko an gano cewa kwayar cutar ta fi yawa a cikin yara ƙanana, tsofaffi da marasa lafiya masu fama da cututtukan numfashi.
Alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wani bincike da aka yi ya nuna cewa an gano wannan kwayar cutar daga hancin wani jariri mai wata takwas da ke fama da ciwon huhu a ƙasar Holland.
Ko da yake an gano shi a ƙasar Holland, amma ya bazu ko'ina a duniya.
An kiyasta cewa HCoV-NL63 yana da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma yawanta yana ƙaruwa a lokacin hunturu, bazara da farkon bazara.
HCoV-NL63 yana da alaƙa da cututtukan laryngitis, wanda aka fi sani da croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da haihuwa da ke asibiti da ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
Bugu da ƙari, cutar sankarar bargo da cutar sankarar bargo, an ba da rahoton cewa HCoV-HKU1 yana da alaƙa da ɓarkewar asma mai tsanani.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an sami HCoV-HKU1 a duk duniya, yana haifar da cututtukan numfashi masu laushi.
Dukkanin waɗannan HCoVs huɗu da aka samo daga al'umma sun dace da mutane kuma galibi ba su da damar canzawa da haifar da cututtuka masu saurin kamuwa da cuta, kodayake haɗari sun faru ne saboda dalilan da ba a sani ba a cikin ƙaramin yanayin mafi ƙarancin cutar HCoV-NL63, wanda kwanan nan aka ba da rahoton yana haifar da mummunan kamuwa da ƙananan numfashi a China.
A gaba ɗaya, idan waɗannan HCoVs sun sami ikon watsawa yadda ya kamata kuma su ci gaba da kasancewa a cikin mutane, suma sun zama marasa ƙarfi da ƙarancin cututtuka.
An fara gano MERS-CoV a shekarar 2012 daga cikin huhu na wani mai shekaru 60 da haihuwa wanda ya kamu da ciwon huhu da kuma ciwon koda a Saudiyya.
Yayin da yawancin cututtukan da aka tabbatar da su a dakin gwaje-gwaje suka samo asali ne daga Gabas ta Tsakiya, an ba da rahoton wasu cututtukan da aka shigo da su tare da yaduwar na biyu na yau da kullun zuwa ga abokan hulɗa a cikin ƙasashen Turai da yawa da Tunisia.
Wani annobar ta biyu ta faru a Koriya ta Kudu a 2015 tare da tabbatar da shari'o'i 186.
Alamun asibiti na MERS suna kama da na SARS, wanda ke nuna ci gaban ciwon huhu mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da MERS suma suna haɓaka ciwon koda mai tsanani, wanda saboda haka ya zama na musamman ga MERS, tsakanin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun cututtukan hanji, kamar zawo da amai.
Har zuwa 14 ga Fabrairu, 2020, an ba da rahoton sama da mutane 2,500 da aka tabbatar da su a cikin dakin gwaje-gwaje tare da yawan mutuwar da aka tabbatar da kashi 34.4 cikin ɗari, wanda ya sa MERS-CoV ya zama ɗaya daga cikin ƙwayoyin cuta mafi muni da aka sani ga ɗan adam.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano rukunin marasa lafiya da cutar huhu, wanda aka sani a baya cewa yana da alaƙa da kamuwa da cutar SARS-CoV-2, a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana ci gaba da yaduwar cutar cututtukan numfashi ta ƙasa ta SARS-CoV-2 a matsayin gaggawa ta Kiwon Lafiyar Jama'a mai Mahimmancin Duniya kuma ta kuma sanya sunan cutar COVID-19.
Har zuwa 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duniya, tare da yawan mutuwar da ke tattare da cutar da kashi 3.4 cikin ɗari.
An lura cewa yawan mutuwar da ke da alaƙa da ƙwayoyin cuta da aka tabbatar a Hubei, China ya kai kashi 4.2%, yayin da yawan mutuwar da ke wajen wannan birni ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da mummunar kamuwa da cuta ta numfashi, kamar SARS-CoV da MERS-CoV, tare da zazzabi, tari da dyspnea.
Wasu marasa lafiya kuma suna fama da zawo.
Ciwon huhu yana ɗaya daga cikin cututtuka masu tsanani kuma yana iya saurin tasowa zuwa ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda yawan daidaito na kashi 82% a cikin jerin nucleotides, suna haɗuwa a cikin rassan daban-daban a cikin itacen asalin.
SARS-CoV-2 a bayyane yake ba shi da cutarwa amma yana da saurin yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
An bayar da rahoton mutane marasa alamun kamuwa da SARS-CoV-2, kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
Kwatanta da bambancin SARS-CoV-2 da sauran HCoVs shida sun nuna kamanceceniya da bambance-bambance masu mahimmanci.
Da farko dai, lokacin ɓoyewa da tsawon lokacin ci gaban cutar HCoV suna kama da juna.
A wannan yanayin, SARS-CoV-2 yana bin tsarin sauran HCoVs shida.
Na biyu, tsananin alamun COVID-19 yana tsakanin tsananin SARS-CoV da tsananin HCoVs huɗu da aka samu ta hanyar al'umma (HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halaye da aka fi gani yayin kamuwa da HCoVs na al'umma, gami da kasancewar alamun bayyanar cututtuka, masu laushi ko ma babu alamun bayyanar cututtuka.
A gefe guda, ana iya lura da ƙaramin ƙaramin ƙaramin ƙaramin COVID-19 mai tsanani, kamar yadda yake a cikin cutar SARS-CoV, kodayake rabo ya ɗan ragu.
Na uku, watsa SARS-CoV-2 kuma yana nuna halaye masu ban sha'awa, duka a cikin HCoVs da aka samu a cikin al'umma da kuma SARS-CoVs.
A gefe guda, watsawar SARS-CoV-2 yana da girma kamar na HCoVs da aka samu a cikin al'umma.
A gefe guda, ya kamata a tabbatar ko watsawar SARS-CoV-2 ya ragu bayan ya wuce ga mutane, kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin kayan ƙwari.
Har yanzu ba a bayyana ba a cikin nazarin gaba idan watsa SARS-CoV-2 ta baki yana taka muhimmiyar rawa, kamar yadda yake a cikin SARS-CoV, aƙalla a wasu yanayi.
Hakanan yana da matukar sha'awa don gano ko SARS-CoV-2 na iya nuna yanayi, kamar yadda yake a cikin yanayin HCoVs da aka samu a cikin al'umma.
Ko ta yaya, halayen SARS-CoV-2, gami da watsawa, cututtukan cututtuka da ci gaba da yaduwa bayan wucewa zuwa mutane, zai tasiri sakamakon annobar COVID-19 ta yanzu.
Dukkanin HCoVs da aka samo daga al'umma waɗanda ke haifar da alamun rashin lafiya sun dace da mutane.
A wani hangen nesa, yana iya zama gaskiya cewa mutane sun dace da waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyun na iya zama waɗanda suka tsira daga tsoffin annoba na HCoV.
An kawar da HCoVs da ke haifar da mummunan cuta a cikin mutane da kuma mutanen da ke ci gaba da mummunan cuta daga HCoVs.
Don wannan ya faru, HCoVs suna buƙatar yin kwafi a cikin mutane zuwa isa don ba da damar tara canjin canji wanda zai kawar da abubuwan ƙuntatawa.
A wannan yanayin, idan cutar SARS-CoV-2 ta daɗe, mutane da yawa za su kamu da ita, kuma za a iya samun ƙarin damar cutar ta zama ta ɗan adam.
Idan an daidaita shi da kyau, watsa shi ga mutane zai yi wuya a sarrafa shi ta hanyar keɓewa ko wasu matakan kula da kamuwa da cuta.
Shekaru da dama yanzu, waɗannan CoVs huɗu da aka samo daga al'umma suna yawo a cikin mutane, suna haifar da sanyi a cikin mutane marasa lafiya.
Waɗannan ƙwayoyin cuta ba sa bukatar wani dabba.
A akasin wannan, SARS-CoV da MERS-CoV, masu cutarwa sosai, ba su dace da mutane ba, kuma ba za a iya ci gaba da yaduwar su tsakanin mutane ba.
Suna buƙatar ci gaba da yaduwa a cikin wuraren ajiyar dabbobi da kuma amfani da damar yin hijira zuwa maƙasudin mutane, mai yiwuwa ta hanyar ɗaya ko fiye da masu watsawa da masu haɓaka.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV, MERS-CoV da HCoVs huɗu da aka samo daga al'umma.
An gano cewa cutar ta kamu da cutar a cikin mutane da yawa.
Koyaya, ya fi cutar HCoVs da aka samu ta hanyar al'umma kuma ba shi da cutarwa kamar SARS-CoV da MERS-CoV.
Har yanzu ba a gano ko zai iya zama cikakke ga mutane ba kuma ya yi tafiya a tsakaninmu ba tare da mai karɓar dabba ko mai shiga tsakani ba.
Kafin tattauna asalin dabbobi na HCoVs, zai zama da amfani a tattauna ma'anoni da halaye na masu karɓar halitta, na halitta, masu riƙewa, masu tsaka-tsaki da masu haɓaka HCoVs.
Wani dabba yana aiki a matsayin mai karɓar HCoV na juyin halitta idan yana da kakanni na dangi kai tsaye, yana raba babban daidaituwa a matakin jerin nucleotide.
Kwayar cutar ta asali yawanci tana da kyau kuma ba ta da cutarwa ga wannan mai masaukin.
Hakazalika, mai karɓar bakuncin yana riƙe da HCoV a cikin ci gaba da daɗewa.
A cikin duka biyun, masu karɓar baƙi suna kamuwa da cutar ta halitta kuma sune masu karɓar HCoV ko kuma kwayar cutar iyayensu.
A akasin wannan, idan HCoV ya shigo cikin wani mai watsa shiri kafin ko kusa da lokacin da ya shigo cikin mutane, ba zai dace da sabon mai watsa shiri ba, kuma yawanci yana haifar da cuta.
Wannan mai karɓar bakuncin na iya zama tushen cutar ɗan adam kuma ya yi aiki a matsayin mai karɓar bakuncin, yana ba da damar kwayar cutar ta ninka ta ɗan lokaci sannan kuma ya watsa ta ga mutane kuma ya haɓaka sikelin kamuwa da cutar ɗan adam.
HCoV na iya samun kamuwa da cuta idan ba zai iya ci gaba da watsawa a cikin mai watsa shiri ba.
A gefe guda, HCoVs na iya daidaitawa zuwa mai watsa shiri na tsakiya kuma su kafa ƙarancin lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na halitta.
Bayanan cututtuka sun nuna cewa mara lafiyar SARS ba shi da tarihin haɗuwa da dabbobi.
Binciken da aka yi a baya game da yaduwar cutar ya nuna cewa masu sayar da dabbobi suna da yawan IgG anti-SARS-CoV, idan aka kwatanta da yawan jama'a.
An gano cewa wasu ƙwayoyin cuta masu kama da SARS-CoV sun kamu da cutar a cikin shekarun da suka gabata.
An tabbatar da ganowa ta hanyar cewa babu wani SARS da aka sanar bayan an kashe dukkan civets a kasuwanni.
Koyaya, an ba da rahoton cewa civets na dabino masu ɓoyewa na daji ko daga gonaki ba tare da fallasa su ga kasuwannin dabbobi masu rai ba suna da mummunan sakamako ga SARS-CoV, yana ba da shawarar cewa civets na dabino masu ɓoyewa na iya zama kawai mai karɓar matsakaiciyar mai karfafawa, amma ba mai riƙe da SARS-CoV na halitta ba.
An lura cewa kashi 80% na dabbobi daban-daban a kasuwannin Guangzhou suna da ƙwayoyin rigakafin SARS-CoV; ba za a iya hana yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa da yawa na iya zama masu karɓar bakuncin SARS-CoV ba.
Duk waɗannan dabbobin suna kama da masu karɓar SARS-CoV.
Binciken da aka yi na SARS-CoV a cikin dabbobi ya nuna cewa akwai wata kwayar cutar da ke da alaƙa da SARS, wato SARS-related bat HKU3 (SARSr-Rh-BatCoV HKU3) da ke cikin ƙwaryar da ke da alaƙa da SARS.
Waɗannan ƙudaje suna da kyau ga ƙwayoyin anti-SARS-CoV da jerin kwayoyin SARSr-Rh-BatCoV HKU3.
Wannan da sauran CoVs na jemage suna da kashi 88% zuwa 92% na daidaituwa tare da SARS-CoV a cikin jerin nucleotides.
Waɗannan binciken sun zama tushen sabon ra'ayi cewa jemage ne ke ɗauke da cututtukan da ke tattare da mutane.
An kuma gano wasu CoVs masu kama da SARS (SL-CoVs) a cikin jemage, amma babu CoV sai wanda aka sanya WIV1 da za a iya warewa a matsayin kwayar cuta mai rai.
An san cewa enzyme mai canza angiotensin 2 (ECA2) na ɗan adam shine mai karɓar SARS-CoV.
An nuna cewa WIV1 da aka samo daga ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Abin mamaki, maganin SARS ya iya kawar da cutar WIV1.
Ya zuwa yanzu, WIV1 ya wakilci magabatan da suka fi kusa da SARS-CoV a cikin jemage, suna da kashi 95% na daidaituwa a cikin jerin nucleotides.
Duk da irin kamanceceniya tsakanin waɗannan ƙwayoyin cuta biyu, ana tsammanin cewa WIV1 ba ita ce kwayar cutar iyaye ta SARS-CoV ba, kuma cewa jemage ba su da makamancin makaman SARS-CoV.
Bayan haka, a cikin wannan binciken, an gano cewa cutar MERS-CoV ta kamu da cutar a cikin nau'in CoV-HKU4 na bat da CoV-HKU5 na bat.
Kwayar cuta ta CoV-HKU4 da MERS-CoV suna amfani da mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar.
Tsarin RNA polymerase na RNA na MERS-CoV yana da kusanci da kwayoyin halitta ga takwarorinsu a cikin betaCoVs na bat da aka gano a Turai da Afirka.
Har zuwa yanzu, ba a sami MERS-CoV mai rai a cikin jemage na daji ba.
MERS-CoV da danginsa mafi kusa, CoV-HKU25 na jemage, suna da kashi 87% na daidaituwa a cikin jerin nucleotides.
Saboda haka, ƙuda ba za ta iya zama mai karɓar MERS-CoV ba.
A gefe guda kuma, nazarin Gabas ta Tsakiya ya nuna cewa dabbobin camel suna da ƙwayar cutar antibodies na MERS-CoV, kamar yadda raƙuma na Gabas ta Tsakiya a ƙasashe da yawa na Afirka.
An ware MERS-CoV mai rai, wanda yayi kama da kwayar cutar da aka samo a cikin mutane, daga hancin dromedary, yana ƙara shaidar cewa raƙuma suna aiki a matsayin mai riƙe da MERS-CoV.
Hakanan yana da kyau a lura cewa alamun cutar da ke da laushi amma tare da yaduwar kwayar cutar an lura da su a cikin raƙuman da ke kamuwa da gwajin MERS-CoV.
Abin lura shi ne cewa raƙuma da suka kamu da cutar ba kawai suna yada ƙwayoyin cuta ta hanyar numfashi ba amma kuma ta hanyar ƙwayoyin cuta na bakin ciki, wanda kuma shine babbar hanyar watsa ƙwayoyin cuta a cikin jemage.
Duk da haka, har yanzu ba a sami amsoshi ba, saboda yawancin shari'o'in da aka tabbatar na MERS ba su da tarihin haɗuwa da raƙuma kafin bayyanar cututtuka, wanda za a iya danganta shi da yiwuwar watsawa tsakanin mutane ko hanyoyin watsawa da suka shafi nau'in dabbobi da ba a gano ba waɗanda ke dauke da MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na nucleotide homology tare da CoV RaTG13 na bat, wanda aka ware daga bat Rhinolophus affinis.
Kamar yadda yake tare da SARS-CoV da MERS-CoV, bambancin jerin tsakanin SARS-CoV-2 da RaTG13 ya yi yawa sosai don danganta dangantaka da iyaye.
Wato, ƙuda ba za su iya zama masu karɓar SARS-CoV-2 ba, sai dai idan an gano CoVs masu kama da ƙuda a nan gaba.
Ana tsammanin cewa dabbobi masu karɓar SARS-CoV-2 na tsaka-tsaki dole ne su kasance tsakanin nau'ikan dabbobin daji da aka siyar da su kuma aka yanka a Kasuwar Kasuwancin Ruwan Ruwan Ruwan Huanan, wanda yawancin shari'o'in COVID-19 na farko ke da alaƙa da shi, yana nuna yiwuwar faruwar watsawa daga dabbobi zuwa mutane.
Yawancin nazarin kwanan nan da suka danganci jerin metagenomic sun ba da shawarar cewa rukunin ƙananan dabbobi masu shayarwa masu haɗari da aka sani da pangolins (Manis javanica) na iya kasancewa da asalin betaCoVs da suka danganci SARS-CoV-2.
Waɗannan sabbin kwayoyin halittar CoV na pangolin suna da kashi 85% zuwa 92% na daidaituwa a cikin jerin nucleotides tare da SARS-CoV-2.
Duk da haka, su ma suna da alaƙa da RaTG13 tare da kusan 90% na daidaituwa a matakin jerin nucleotide.
Suna haɗuwa cikin ƙananan ƙwayoyin cuta kamar SARS-CoV-2 a cikin bishiyar asalin, ɗayan ɗayan yana da yanki mai ɗaure mai karɓar mai karɓa (DLR) tare da SARS-CoV-2, tare da 97.4% na ainihi a cikin jerin amino acid.
A cikin bambanci mai ban mamaki, DLRs na SARS-CoV-2 da RaTG13 sun fi banbanci, kodayake suna nuna babban matakin daidaito a cikin kwayoyin halitta.
Wani binciken kwanan nan akan pangolins marasa lafiya ya kuma ba da rahoton gano jerin ƙwayoyin cuta na yarjejeniya daga samfuran huhu, waɗanda ke da alaƙa da SARS-CoV-2.
Wannan binciken ya ɗauki hanyoyi daban-daban na saiti da sarrafawa ta hannu don samar da jerin kwayoyin halittar ɗan adam, wanda ya dace da kusan kashi 86.3 na kwayar cutar a cikin jimlar girman.
Ba za mu iya kawar da yiwuwar pangolin ya kasance ɗaya daga cikin dabbobi masu watsawa na SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da ke tabbatar da asalin SARS-CoV-2 kai tsaye daga pangolin saboda bambancin tsari tsakanin SARS-CoV-2 da betaCoVs masu alaƙa da SARS-CoV-2 daga pangolins.
Bugu da ƙari, tazara tsakanin SARS-CoV-2 da RaTG13 ta fi tazara tsakanin SARS-CoV-2 da betaCoVs masu alaƙa da SARS-CoV-2 na pangolins.
Har yanzu ba a bayyana hanyar juyin halitta na SARS-CoV-2 a cikin jemage, pangolins da sauran dabbobi masu shayarwa ba.
Duk da yake an sami mafi girman daidaituwa a cikin DLRs tsakanin SARS-CoV-2 da pangolin, betaCoVs masu alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girman daidaituwa ta hanyar tsarin kwayoyin halitta.
Yana da matukar zato cewa babban kamanceceniya tsakanin DLRs na pangolin betaCoVs masu alaƙa da SARS-CoV-2 da SARS-CoV-2 ya samo asali ne daga juyin halitta mai haɗuwa ta hanyar zaɓaɓɓu.
Wani hujja da ke nuna cewa babu cutar SARS-CoV-2 da ke da alaƙa da cutar pangolin betaCoV da kuma RaTG13 a cikin dabba ta uku.
A matsayin mai motsa juyin halitta, sake haɗuwa yana da yawa a cikin betaCoVs.
An ci gaba da bincike kan asalin SARS-CoV-2 daga dabbobi.
Baya ga HCoVs masu cutarwa sosai, asalin dabbobi na ƙwayoyin cuta HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1 an kuma bincika su.
Shaidar ilimin halitta ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs na bat, yayin da aka gano ƙwayoyin cuta na iyaye na HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An ba da rahoton cewa CoV na bat da ake kira ARCoV.2 (Appalachian Ridge CoV) wanda aka gano a cikin ƙwaryar ƙwaryar Amurka ta Arewa yana da alaƙa kai tsaye da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da wata ƙwayar cuta ta CoV mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, kuma ana tsammanin cewa camelliids ne ke ɗaukar nauyinta.
Don ƙarin haske, ilimin yanzu game da asalin dabbobi na sanannun HCoVs an taƙaita su a cikin Hoto 1 da Tebur 2.
Bayan haka, a cikin wannan yanayin, HCoVs suna da yawa a cikin kwayoyin halitta.
Lokacin da HCoV-OC43 ya ƙetare jinsuna kuma ya kamu da mutane daga dabbobin gida a kusan 1890, an sami cutar sankarar iska.
Tarihin watsa HCoV-229E tsakanin jinsuna bai da haske sosai.
An gano alphaCoVs daga jemage da ke da alaƙa da HCoV-229E.
Daga cikin su akwai alphaCoV daga alpacas.
Akwai shaidu da dama da suka nuna cewa cutar ta yadu kai tsaye daga jemage zuwa mutane.
Na farko, mutane, amma ba alpacas ba, za su iya saduwa da jemage a cikin wani wuri mai tsabta.
Amma, mutane suna da dangantaka ta kai tsaye da alpacas.
Na biyu, alphaCoVs na Batman da ke da alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a cikin bats, yayin da alphaCoVs na alpacas sun haifar da annobar cutar numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a sami alphaCoV na alpacas a cikin dabbobin daji ba.
Saboda haka, ba za a iya kawar da yiwuwar alpacas su sami alphaCoV mai alaƙa da HCoV-229E daga mutane ba.
A gaskiya, jemage ne tushen ƙwayoyin cuta da ke cutar da mutane, har da cutar zazzabin cizon sauro, Ebola, Nipah da kuma Hendra.
Saboda haka, ba abin mamaki ba ne cewa jemage suna watsa HCoV-229E kai tsaye ga mutane.
A madadin haka, yayin da alphaCoVs ke aiki a matsayin kogin kwayoyin HCoV-229E, alpacas da dromedaries na iya zama matsakaitan runduna waɗanda ke watsa ƙwayoyin cuta ga mutane, kamar yadda yake a cikin MERS-CoV.
MERS-CoV ya zama misali mai kyau na yaduwar jinsuna daga jemage zuwa dromedaries da dromedaries zuwa mutane.
An san asalin MERS-CoV daga jemage a farkon gano shi kuma an tabbatar da shi ta hanyar binciken da aka yi.
A bayyane yake cewa jemage suna samar da tarin nau'in ƙwayoyin cuta don musayar ɓangarorin kwayoyin halitta da kuma watsawa tsakanin jinsuna.
Rayuwa mai tsawo, yawan mazauna gida, dangantaka mai kyau da mutane, da kuma iya yin yawo suna sa su zama masu yaduwar ƙwayoyin cuta.
A gefe guda kuma, an yi shekaru da yawa da MERS-CoV ya shiga cikin dabbobin camel.
Ya saba da waɗannan raƙuman, kuma ya yi hijira daga mai watsa shiri zuwa mai watsa shiri na halitta da kuma barga.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan canjin canji a cikin waɗannan dabbobin.
Yaduwar sa zuwa ga mutane ba zato ba tsammani, kuma mutane sun kasance masu karɓar MERS-CoV na ƙarshe, saboda ba za a iya ci gaba da watsa shi ba.
Sabanin rawar raƙuma wajen watsa MERS-CoV, rawar pangolins, idan akwai, wajen watsa SARS-CoV-2 ta bambanta.
Musamman, betaCoVs na pangolin suna da cutarwa sosai a pangolins.
Suna iya zama mai karɓar bakuncin betaCoVs masu alaƙa da SARS-CoV-2, kamar civets, a cikin yanayin SARS-CoV.
Akwai yiwuwar sauyawar SARS-CoV-2 daga dabbobi zuwa mutane a cikin binciken da za a yi a nan gaba.
Na farko, ƙuda na iya zama mai riƙe da kwayar cutar da ke da alaƙa da SARS-CoV-2, kusan iri ɗaya da SARS-CoV-2.
Mutane za su iya raba wurin zama da jemage ta hanyar kashe dabbobi ko kuma hakar ma'adinai.
Na biyu, pangolins na iya zama ɗaya daga cikin masu karɓar bakuncin matsakaici, wanda sabon ƙwayar cuta mai alaƙa da SARS-CoV-2 ya shigo ciki.
Mutane suna kamuwa da cutar ta hanyar yanka da cin naman farauta.
Yana yiwuwa dabbobi masu shayarwa da yawa, gami da dabbobin gida suna da saukin kamuwa da SARS-CoV-2.
Ana bukatar bincike kan rigakafin da aka samar daga dabbobi da kuma dabbobin daji.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in na uku wanda ke da alaƙa da duka bat da pangolin.
Binciken asalin SARS-CoV-2 a cikin dabbobi har yanzu yana gudana.
Baya ga nau'ikan nau'ikan dabbobi daban-daban, manyan abubuwa uku a cikin kwayar cutar suna da mahimmanci wajen sauƙaƙa CoVs don ƙetare shingen jinsuna.
Na farko, yawan canjin da suke samu a cikin kwayar RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA mai sauƙi, ƙididdigar canjin canjin CoVs za a iya ɗauka daga "matsakaici" zuwa "mai girma" tare da matsakaicin canjin canji na kusan sau 10-4 a kowace shekara, ta wurin, dangane da matakin daidaitawar CoV zuwa sabbin runduna.
CoVs suna da exorribonuclease tare da tsarin bita, cirewa wanda ke haifar da canji mai yawa da raguwa, ko ma rashin rayuwa.
Abin sha'awa shine cewa kwayar nucleotide analog remdesivir tana hana kwayar cutar ta hanyar hana wannan exorribonuclease da RNA polymerase.
Remdesivir yana daya daga cikin magungunan anti-SARS-CoV-2 masu matukar alfanu da aka gwada a gwajin asibiti.
Amma, yawan canjin kwayoyin cutar CoV ya kai sau miliyan ɗaya fiye da na waɗanda suke da ita.
Bugu da ƙari, yawan canjin jini yakan yi yawa idan CoVs ba su dace da mai gidan ba.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan canjin halittar kwayoyin halitta, yawan canjin halittar SARS-CoV-2 ya yi ƙasa, wanda hakan ya nuna cewa ya fi dacewa da mutane.
Wataƙila ya riga ya saba da wani mai gidansa da ke sha'ani da 'yan Adam.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da camel.
A ka'idar, ba zai yiwu ba cewa canjin kwayoyin halitta zai sa alluran rigakafi da magungunan rigakafi na SARS-CoV-2 su zama marasa tasiri cikin sauri.
Na biyu, babban RNA genome a cikin CoVs yana da ƙarin filastik a cikin gyaran kwayoyin halittar don maye gurbi da sake haɗuwa, don haka yana ƙaruwa da yiwuwar coevolution tsakanin jinsuna, wanda ke da fa'ida ga fitowar sababbin CoVs lokacin da yanayi ya dace.
Wannan yana tabbatar da cewa akwai wasu siffofi na musamman da kuma ayyukan gina jiki da aka tsara a cikin ƙananan ƙananan ƙananan ƙananan ƙwayoyin halitta.
Na uku, CoVs suna sauya samfura a bazuwar kuma sau da yawa yayin yin kwafin RNA ta hanyar hanyar "zaɓar kwafi" ta musamman.
A cikin mai karɓar baƙi wanda ke aiki a matsayin jirgin ruwa na haɗuwa, sauya faifai yana faruwa sau da yawa yayin fassarar RNA na CoV.
RNA mai tsayi mai yawa da kuma subgenomic na iya sake haɗuwa don samar da sabon CoVs.
An sami shaidar ilimin halitta na sake haɗuwa ta halitta a cikin duka HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabbobi kamar SL-CoV na bats da batCoV-HKU9.
Hadin gwiwar kwayar cutar da mai karɓar baƙi dangane da watsawa
Baya ga abubuwan da ke tattare da kwayar cutar guda uku da aka ambata a sama, hulɗar kwayar cutar da mai karɓar baƙi wani muhimmin abu ne wanda ke tasiri watsawar jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna shaidar zaɓi mai kyau yayin abubuwan watsawa tsakanin jinsuna.
Bisa ga nazarin kwatancen tsakanin SARS-CoVs na mutum da na civet, an yi imanin cewa SARS-CoV yana saurin daidaitawa a cikin baƙi daban-daban, musamman tare da maye gurbi a cikin DLR na furotin S.
Gabaɗaya, DLR a cikin furotin S na CoV yana hulɗa da mai karɓar ƙwayoyin cuta kuma ana zaɓar shi sosai ta hanyar amsawar ƙwayoyin cuta na mai masaukin.
A cikin SARS-CoV, DLR yana cikin amino acid 318th zuwa 510th a cikin S1 yanki, wanda ke ɗaure da ECA2 na ɗan adam, da kuma masu karɓar sa don shigarwar kwayar.
DLR na SARS-CoV na iya gane masu karɓar ECA2 na dabbobi da yawa, gami da jemage, civets, mice da karnukan gwaggon sa, yana ba da damar watsa kwayar cutar tsakanin jinsuna.
A zahiri, an lura cewa ragowar amino acid guda shida ne kawai suka bambanta da na mutum da na civet a cikin DLR, kuma huɗu daga cikinsu suna cikin hanyar haɗin mai karɓar don hulɗa tare da mai karɓar ECA2.
SARS-CoV daga civet yana da maye gurbi K479N da S487T a cikin DLR ɗin sa, wanda zai iya haɓaka ƙimar hulɗar furotin ɗin spike tare da mai karɓar ECA2 na ɗan adam.
Watau, waɗannan amino acid biyu da aka sauya za su iya zama da muhimmanci wajen daidaita ƙwayoyin cuta a cikin mutane.
Yana da kyau a lura cewa SARS-CoV-2 yana da mai karɓar ƙwayar cuta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein yana nuna cewa haɗin haɗin S-protein ɗin su zuwa ECA2 na ɗan adam na iya canzawa.
A zahiri, binciken da aka yi da lantarki na cryomicroscopy ya nuna kusancin 10 zuwa 20 sau da yawa na wannan haɗin fiye da tsakanin ECA2 na ɗan adam da furotin S na SARS-CoV.
Hakanan zai taimaka wajen tantance ko wasu masu karɓar ra'ayi na iya zama dole don watsa SARS-CoV-2.
Abin mamaki, HCoV-NL63 kuma yana ɗaure kansa da ECA2, amma da wani ɓangaren S-protein.
Akwai wasu masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E da 9-O-acetyl sialic acid don HCoV-OC43.
Hakanan zasu iya amsawa don ingantaccen daidaita waɗannan CoVs a cikin mutane bayan watsawar jinsuna daga masu karɓar dabbobi.
Bayan masu karɓar ƙwayoyin cuta, sakamakon watsawar HCoVs tsakanin jinsuna yana kuma ƙarƙashin wasu abubuwan ƙuntatawa da dogaro da mai masaukin.
A cikin wannan yanayin, a cikin yanayin da ya dace, ƙwayoyin cuta na HCoVs suna da yawa.
HCoVs suna buƙatar maye gurbin abubuwan dogaro da mai masaukin baki da kuma kawar da abubuwan ƙuntatawa na mai masaukin baki don ingantaccen watsawar jinsuna.
A wannan yanayin, ƙayyadaddun kwayoyin halitta a cikin wannan muhimmin yanki na hulɗar ƙwayoyin cuta da mai masauki har yanzu ba a gano su ba kuma ba a bayyana su ba.
Binciken da ba shi da son kai tare da isa ga matakin kwayoyin halitta na dogara da mai masauki da kuma ƙuntatawa ga SARS-CoV-2 ta amfani da fasahar zamani ta CRISPR na iya haifar da kyakkyawan sakamako.
An sake gano wasu HCoVs a cikin wannan labarin.
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs da ke cikin ƙwayoyin cuta na HCoVs suna da yawa.
A wannan yanayin, CoVs daga jemage suna aiki a matsayin tarin kwayoyin HCoVs.
Bugu da ƙari, saurin maye gurbi da sake haɗuwa da kwayoyin halitta suna motsa juyin halittar HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan aikin.
Alal misali, samun ko rasa sababbin kwayoyin halittar gina jiki yana iya canza yanayin kwayar cutar.
Daga cikin sunadarai masu amfani da SARS-CoV, an yi imanin cewa ORF8 yana da mahimmanci wajen daidaita shi ga mutane, tunda an ware ƙwayoyin cuta na SARS-CoV, amma an gano cewa suna ɓoye furotin ORF8 daban.
An gano wata alama ta cire nucleotide 29 daga SARS-CoVs a cikin ƙwayoyin da aka ware a farkon cutar ɗan adam.
Ana ganin cewa wannan canjin ya haifar da sauye-sauyen masu karɓar bakuncin.
Bugu da ƙari, SARS-CoV yana da tarihin sake haɗuwa tare da layin alphaCoVs da gammaCoVs, inda aka gano yawancin ƙananan yankuna masu haɗuwa a cikin RNA-da ke dogara da RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin nsp9, yawancin nsp10 da sassan nsp14.
Hakazalika, an nuna cewa cutar MERS-CoV ta kamu da cututtuka tsakanin jinsuna daban-daban, wanda ya faru a cikin camel shell a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan sake haɗuwa a cikin wasu HCoVs, inda HCoVs ke sake haɗuwa da sauran CoVs na dabbobi a cikin kwayoyin halittar su.
Ya kamata a kuma yi gargadin cewa zabin wucin gadi na iya taimakawa ga canje-canje da ba a so a cikin kwayoyin halittar kwayar cutar, wanda zai iya haifar da sauƙaƙewar matsin lamba akan ƙwayoyin cuta, kamar matsin lamba daga tsarin rigakafin mai karɓar baƙi.
Misali na irin wannan tasirin shine asarar dogon ORF4 a cikin samfurin samfurin HCoV-229E, saboda cire nucleotides biyu.
Yayin da ORF4 ba tare da lalacewa ba ana iya gani a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCoV-229E, alphaCoV na alpaca yana nuna shigar da nucleotides mai sauƙi, wanda ke haifar da canji a cikin hotunan.
A ƙarshe, amma ba mafi mahimmanci ba, juyin halitta na sabon HCoVs kuma ana motsa shi ta hanyar zaɓin zaɓi a cikin masu karɓar su.
Ba a gano alamun cutar ko kuma kawai alamu masu laushi a cikin jemage lokacin da suka kamu da CoVs, wanda ke nuna daidaitawa tsakanin CoVs da jemage.
Wataƙila waɗannan ƙudaje sun saba da ƙwayar cuta ta CoVs.
Alal misali, kurakurai a kunna amsawar ƙwayoyin cuta a cikin jemage suna rage cututtukan da CoV ke haifarwa.
Bugu da ƙari, aikin ƙwayoyin halitta na halitta a cikin bat an dakatar da shi saboda ƙirar mai karɓar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Bugu da ƙari, babban matakin ƙwayoyin oxygen masu aiki (ERO) da aka samar daga babban aikin ƙwayoyin cuta na ƙudaje na iya hana kwayar cutar CoV da kuma shafar bita ta hanyar exorribonuclease, don haka samar da matsin lamba don samar da ƙwayoyin cuta masu cutarwa sosai lokacin da aka gabatar da su cikin sabon mai masaukin.
Ƙarin ƙwayar cuta na CoV na iya haɓaka ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don karɓar bakuncin.
Saboda haka, ba zato ba tsammani ba ne cewa sababbin HCoVs uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar, ko kuma suna haifar da alamun rashin lafiya a cikin masu riƙe su, kamar su jemage da raƙuma.
Suna iya yin yawa ba tare da haifar da amsawar rigakafi ba.
Wannan takaddar ta bayyana yadda ake gano masu dauke da cutar ba tare da alamomi ba da kuma dalilin manyan cututtukan da ke tattare da cutar a cikin mutane.
Babban alamun cututtuka sune saboda yawan amsawar rigakafi da kuma ruwan cytokine, inda mafi girman amsawar rigakafi, mafi girman lalacewar huhu.
A akasin wannan, a cikin masu ɗauke da alamun cutar, an kashe amsar rigakafi daga kwayar cutar CoV.
Wannan dabarar ta kashe amsar rigakafi na iya samun sakamako mai amfani a maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a cikin jemage.
Saboda haka, bayar da nau'in interferon na farko a farkon lokacin kamuwa da SARS-CoV-2 a cikin mutane ya kamata ya zama mai amfani.
Bugu da ƙari, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
A sakamakon haka, hana NLRP3 tare da MCC950 zai iya zama da amfani wajen maganin COVID-19.
Tashin SARS-CoV-2 ya bi ka'idodin da SARS-CoV da MERS-CoV suka samo asali.
Yayin da aka gano cewa betaCoV na jemage yana da kashi 95% na nucleotide homology tare da SARS-CoV, akwai CoV na jemage wanda ke da kashi 96% na nucleotide homology tare da SARS-CoV-2.
Ko da yake an gano cewa civets da sauran dabbobi a kasuwanni suna dauke da ƙwayoyin cuta iri ɗaya da SARS-CoV, ba a gano matsakaitan runduna don SARS-CoV-2 ba.
An gano betaCoVs daga pangolins, tare da babban kamannin SARS-CoV-2, wanda ke nuna cewa pangolins na iya zama ɗaya daga cikin masu karɓar baƙi, ko kuma pangolin betaCoVs na iya ba da gudummawar ɓangarorin kwayoyin halitta don sigar ƙarshe ta SARS-CoV-2.
Ko da yake tambayoyi sun rage, babu wata hujja da ta nuna cewa SARS-CoV-2 mutum ne ya samar da shi ba da gangan ba.
CoVs sun sake dawowa cikin hankalin duniya saboda barkewar cutar SARS-CoV-2 kwanan nan.
Nazarin CoVs a cikin jemage da sauran dabbobi ya canza ra'ayinmu game da mahimmancin asalin dabbobi da kuma wuraren adana HCoVs a cikin watsa tsakanin mutane.
Shaida mai yawa ta nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun samo asali ne daga jemage kuma ana watsa su ga mutane ta hanyar masu watsawa.
Tun da yake kamuwa da SARS-CoV ya samo asali ne daga hulɗar mutane da civets a kasuwanni, rufe kasuwannin ruwa da kashe civets a waɗannan kasuwanni na iya kawo ƙarshen annobar SARS.
A cikin wannan tunani, ya kamata a cire pangolins daga kasuwannin da ke da danshi don hana yaduwar cutar ta dabbobi, saboda gano yawancin layin betaCoVs na pangolin da ke da alaƙa da SARS-CoV-2.
Koyaya, har yanzu ba a bayyana ba a cikin nazarin gaba ko SARS-CoV-2 yana yaduwa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa, da kuma yadda ake yaduwar.
A gefe guda kuma, MERS-CoV ya daɗe yana cikin dabbobi masu kama da rakumi.
Waɗannan raƙuman suna da muhimmanci wajen sufuri, kuma suna ba da nama, madara, fata, da ulu ga mutanen yankin.
An rarraba su sosai a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a kashe dukan raƙuma don a shawo kan MERS ba, kamar yadda aka yi a kasuwannin dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake barkewar cutar MERS, ya kamata a ɗauki cikakkiyar hanyar haɓaka alluran rigakafin MERS-CoV masu tasiri ga raƙuma, a hade tare da sauran matakan kula da kamuwa da cuta.
Idan ba mu iya kawar da waɗannan ƙwayoyin cuta ba, za su iya haifar da sabon ƙwayoyin cuta.
Akwai wasu ƙwayoyin cuta masu kama da dabbobi da ke yawo a cikin yanayi.
Musamman, CoVs na jemage tare da yiwuwar cutar dabbobi sun bambanta sosai.
Akwai dama da yawa cewa waɗannan CoVs na dabbobi zasu iya haɓaka da sake haɗuwa, wanda zai haifar da fitowar sababbin CoVs waɗanda ke da saurin yaduwa da / ko kisa ga mutane a nan gaba.
Dole ne a daina al'adar cin namun daji a wasu wurare a kasar Sin don rage hulɗar da ba dole ba tsakanin mutane da dabbobi.
Tare da rikicin SARS, MERS da COVID-19, za a buƙaci ingantaccen shirin amsawa da shiri.
A gaskiya, akwai ƙwayoyin cuta da yawa da suka daɗe suna wanzuwa a duniya.
Suna zama a cikin tafkunan su na halitta har sai akwai damar ƙaura zuwa wata halitta.
Ko da yake jemage suna da halaye da yawa da ke sa su iya yaɗa cutar, amma za a iya rage haɗarin mutane su kamu da jemage da kuma wasu dabbobin daji idan aka koya wa mutane su guji su.
Ana buƙatar ci gaba da sa ido a cikin dabbobi masu shayarwa don samun kyakkyawar fahimta game da yanayin halittu na CoVs da kuma rundunansu na halitta, wanda zai taimaka wajen hana watsawa daga dabbobi zuwa mutane da kuma barkewar annoba a nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar ƙwayoyin cuta ita ce mutane su guji wuraren da ƙwayoyin cuta ke ɓoyewa.
Har yanzu akwai wasu abubuwa da ba a gano ba game da asalin SARS-CoV-2 daga dabbobi.
Na farko, idan jemage suna watsa kwayar cutar SARS-CoV-2 zuwa pangolins, yana da mahimmanci a gano a wane yanayi jemage da pangolins zasu iya raba wuri ɗaya.
Na biyu, idan jemage suna taka rawa kai tsaye wajen watsawa ga mutane, ya kamata a tantance yadda mutane ke hulɗa da jemage.
Na uku, idan dabba ta uku tana da matsayin mai karɓar bakuncin na gaskiya, dole ne a bayyana yadda yake hulɗa da nau'ikan halittu daban-daban, gami da mutane, jemage da pangolins.
A ƙarshe, tunda dabbobi masu shayarwa da yawa, gami da dabbobin gida, na iya zama masu saukin kamuwa da SARS-CoV-2, yakamata a gudanar da sa ido da kamuwa da gwaji.
Idan jemage ne, pangolin ko wani dabba mai shayarwa, ana sa ran za a gano SARS-CoV-2 ko kuma kwayoyin iyayensa da suka yi kama da juna a cikin masu karɓar su a nan gaba.
Ci gaba da bincike a wannan fannin zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman bayanai game da rigakafi da sarrafa COVID-19 a cikin mutane.
Wajibi ne a sabunta ka'idojin ganewar asali na "wanda ake zargi" da "wanda aka tabbatar da cutar COVID-19".
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar saurin jagora don ganewa da kula da kamuwa da cutar 2019 (2019-nCoV) ta sabuwar coronavirus. Wannan jagorar tana ba da kwarewarmu kuma tana da kyau ga magance wannan annoba ta duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwa ce. Fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga ci gaba da binciken bincike da gogewa a cikin aikin asibiti; saboda wannan, hanyoyin bincike da magani suma ana sabunta su koyaushe.
A cikin wannan wasiƙar, mun amsa wani bayani game da jagorarmu kuma mun ba da sababbin ka'idodin ganewar asali na "al'amarin da ake zargi" da "al'amarin da aka tabbatar" bisa ga sabon Jagoran Gano da Kula da COVID-19 (siffa ta bakwai) da Kwamitin Kiwon Lafiyar Jama'ar Sin ya buga.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu ake kira cutar coronavirus ta 2019 (COVID-19), kuma ana kiran kwayar cutar coronavirus mai saurin numfashi mai tsanani 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta rarraba COVID-19 a matsayin annoba.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta tsara jagorar jagora mai sauri da aka buga akan layi a cikin Binciken Likita na Soja a ranar 6 ga Fabrairu, 2020.
Ya jawo hankali sosai tun lokacin da aka buga shi.
Koyaya, lura cewa COVID-19 sabuwar cuta ce. Fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga ci gaba da binciken bincike da gogewa a cikin aikin asibiti; saboda wannan, hanyoyin bincike da magani suma ana sabunta su koyaushe.
Alal misali, Jagoran Bincike da Kula da COVID-19 da Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya wallafa tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020 ya ƙunshi jimillar bugu bakwai tare da canje-canje masu yawa a cikin wasu.
Jagorarmu ta karɓi bayani daga Zhou et al., wanda ya ba da shawara mai sauƙi bisa ga kwarewar asibiti.
Wannan aikin ya ƙara sabon shaida ga jagorarmu kuma ya ba da mahimman bayanai game da wannan annobar ta duniya.
Mun amince da aikin da suke yi kuma mun nuna godiya.
Koyaya, aikin su yana buƙatar sabuntawa daidai da sabon Jagoran Ganowa da Kula da COVID-19 (siffa ta bakwai na gwaji) da kuma binciken kwanan nan.
A cewar bugu na bakwai (3 ga Maris 2020), don tabbatar da yanayin da ake zargi, ya zama dole a haɗa ɗayan abubuwan tarihin cututtukan cuta tare da abubuwa biyu na bayyanar cututtuka don yin cikakken bincike, ko kuma abubuwa uku na bayyanar cututtuka suna buƙatar cika idan babu bayyanar cututtuka:
Tarihin cututtuka: (1) tarihin tafiya ko zama a Wuhan da kewaye ko a wasu al'ummomin da aka samu rahoton cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (2) tarihin tuntuɓar masu kamuwa da cutar SARS-CoV-2 (wanda gwajin nucleic acid ya nuna tabbatacce); (3) tarihin tuntuɓar marasa lafiya da zazzabi ko cututtukan numfashi daga Wuhan da kewaye ko daga wasu al'ummomin da aka samu rahoton cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (4) tarihin tuntuɓar rukuni na mutane da aka tabbatar da cutar (fiye da ko daidai da mutane biyu da zazzabi da/ko cututtukan numfashi a cikin makonni 2 a cikin ƙananan wurare kamar gida, ofis, aji, da sauransu).
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da damar gano hoto na kamuwa da COVID-19; (3) yawan adadin farin jini yana nuna al'ada, rage ko rage ƙididdigar ƙwayoyin lymphocytes a farkon farkon bayyanar cututtuka.
Gano tabbataccen yanayin ya kamata ya dogara ne akan yanayin da ake zargi da kowane ɗayan waɗannan abubuwa masu zuwa na serological ko pathogenic: (1) gwajin PCR mai kyau don SARS-CoV-2; (2) cikakken tsarin kwayoyin halittar kwayar cutar wanda ke nuna babban daidaito game da sabbin cututtukan coronavirus da aka sani; (3) tabbatacce ga ƙwayoyin cuta na IgM da IgG na SARS-CoV-2 a cikin gwajin ƙwayar cuta; ko wani canji na ƙwayoyin cuta na IgG na SARS-CoV-2 daga mara kyau zuwa tabbatacce ko ƙaruwa a cikin taken sama da sau huɗu a lokacin murmurewa sama da na lokacin matsananci.
Za mu iya lura cewa an ƙara gwajin PCR na ainihi don nucleic acid a cikin jini ko samfurin numfashi a bugu na biyu da na uku (daga 18 da 22 ga Janairu, 2020, bi da bi).
An ƙara gano cututtukan cututtukan jini a bugu na huɗu da na biyar (daga Janairu 27, 2020 da Fabrairu 8, 2020, bi da bi), kuma an ƙara shaidar serological a bugu na bakwai.
Waɗannan canje-canjen sun dogara ne akan ci gaba da aikin masu bincike don neman mafi kyawun kayan aikin gano nucleic acid don saurin ganewa da kuma samfurori na numfashi, gami da ɗaukar jini, wanda ya haɓaka wadatar samfuran daban-daban kuma ya taimaka wajen kawo sakamako mai kyau na ƙwayoyin cuta na musamman ga ƙa'idodin da aka tabbatar.
Bugu da ƙari, akwai ƙarin shaida da ke tunatar da mu mu mai da hankali ga marasa lafiya masu alamun cututtuka da marasa alamun cututtuka.
Saboda haka, ya kamata a sabunta tsarin Zhou et al. saboda ya sanya mutum ba tare da alamun asibiti a matsayin "mai hadari ba".
Hakanan ana buƙatar tabbatar da tsarin ƙididdigar a cikin ƙarin bincike da ayyukan asibiti.
A ƙarshe, muna fatan ƙarin hujjoji na kai tsaye sun fito kuma muna roƙon masu karatu su ba da ra'ayoyinsu.
Don ganewar asali na "wanda ake zargi" da "wanda aka tabbatar da shi", muna ba da shawarar cewa ku bincika kuma ku bi sababbin jagororin ƙasarku.
Ƙungiyarmu za ta kuma sabunta jagorarmu a kan lokaci don taimaka muku.
Bangladesh ta samu karin mutane biyar da suka mutu sakamakon COVID-19, mafi yawan mutane a kowace rana
A jiya, Bangladesh ta tabbatar da sabbin mutuwar mutane biyar sakamakon COVID-19 a ranar.
Wannan shi ne adadin mutane da suka mutu a rana guda sakamakon cutar.
A ranar jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton cewa adadin mutanen da aka tabbatar da su sun haɗa da masu cutar 114 da kuma 33 da suka warke da ke gida.
An samu mutuwar mutane 17.
A wani rahoto da aka wallafa a yanar gizo, darektan hukumar IEDCR, Dakta Meerjady Sabrina Flora, ta ce wadanda suka mutu sun hada da maza hudu da mace daya.
Dokta Meerjady ta ce, mutane biyu sun fi shekara 60, biyu kuma suna tsakanin shekara 51 da 60, ɗaya kuma yana tsakanin shekara 41 da 50.
Ta kuma ce biyu daga cikin wadanda aka kashe daga Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu Agency cewa daya daga cikin wadanda aka kashe shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengali, wanda aka yi wa jinya a asibitin Kuwait Maitree.
A ranar Asabar, a cikin wata sanarwa ta bidiyo ta yanar gizo, Ministan sufuri na hanyoyi da gadoji na Bengal Obaidul Quader ya ce za a dakatar da zirga-zirgar jama'a na tsawon lokaci fiye da yadda aka tsara tun farko, har zuwa ranar Asabar mai zuwa.
Wannan dakatarwar zirga-zirgar jama'a ta fara ne a ranar 26 ga Maris kuma an shirya ta ƙare a ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyaki masu mahimmanci (kayan magani, mai da abinci).
An fara samun mutane da suka kamu da COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar ɗaya daga cikinsu.
A ranar 19 ga Maris, dukan ukun sun warke.
SARS-CoV-2 ya wuce kamuwa da cutar miliyan a duniya
A ranar Alhamis, jimlar adadin masu kamuwa da cutar SARS-CoV-2 a duniya ya wuce miliyan daya, in ji bayanan Jami'ar Johns Hopkins.
Akalla mutane 52,000 ne suka mutu sakamakon cutar COVID-19, wadda cutar korona ke haifarwa.
Wannan muhimmin abu ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cutar coronavirus ta farko kuma Zambia ta sami mutuwar farko da ta shafi cutar.
Koriya ta Arewa ta ce a ranar Alhamis, tana ɗaya daga cikin ƙasashe kalilan da ba su da cutar coronavirus.
Har zuwa jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da suka kamu da cutar, ciki har da mutane 79,332 a cikin sa'o'i 24 kafin karfe 10 na yammacin Turai ta Tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu sama da mutane 244,000 da suka kamu da cutar korona, kuma an yi asarar rayuka akalla 5,900.
CBS News ta ruwaito, ta ambato bayanan Jami'ar Johns Hopkins, cewa akwai mutuwar sama da 1,000 a Amurka sakamakon kamuwa da cutar coronavirus a ranar Laraba.
A dukan duniya, ƙasashe sun sanar da cewa za su tsai da shawara don su hana cutar yaɗuwa.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin ya tsawaita dokar rufe birnin har zuwa ranar 1 ga watan Mayu.
A bangaren kasa, Shugaba Vladimir Putin ya bayyana cewa za a ci gaba da biyan 'yan Rasha albashi ba tare da sun zo aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci ta kasa da kwana 15 ta amince da kuri'u 215 da suka goyi bayan dokar, da kin amincewa da kuri'u 10 da kuma kada kuri'a daya.
Saudiyya ta kara dokar hana fita a cikin biranen alfarma na Makka da Madina zuwa rana guda, daga karfe 3 na yamma zuwa 6 na safe.
Thailand ta shirya dokar hana fita daga karfe 10 na dare zuwa karfe 4 na safe
Gwamnan Ohio Mike DeWine ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga Mayu.
Shaguna a Ostareliya sun rage yawan takardar wanka da ake amfani da ita
A daren Asabar da Lahadi, manyan shagunan Australiya Woolworths da Coles sun rage takunkumin sayen takarda na bayan gida zuwa fakiti biyu da fakiti ɗaya a kowane ma'amala a duk shagunan ƙasar.
A ranar Litinin, ALDI ta kuma sanya iyaka kan wani kunshin.
An sanar da waɗannan iyakokin ta hanyar saƙonni a cikin akwatunan da kuma shafukan Facebook na cibiyoyin sadarwa.
Domin tsoron COVID-19, ana zargin masu sayayya suna tara kaya don idan akwai bukatar keɓewa.
A ranar Laraba, Woolworths ta kuma iyakance sayen takarda na gidan wanka zuwa kunshin daya a kowace bukata.
Waɗannan canje-canjen sun biyo bayan ƙuntatawa na kunshin huɗu a kowane ma'amala da Woolworths da Coles suka aiwatar a ranar 4 da 5 ga Maris, bi da bi.
Coles a cikin sanarwar manema labarai ta 8 ga Maris ya ba da rahoton cewa duk da ƙuntatawa na fakiti huɗu, "shaguna da yawa har yanzu suna ƙarancin kaya a cikin ƙasa da awa ɗaya bayan isarwa" kuma ya kira buƙatar "ba a taɓa gani ba", yayin da ALDI ta kira ta "ba zato ba tsammani" a cikin rubutun Facebook a ranar Talata.
An samu "ƙaruwar tallace-tallace" a makon da ya gabata, in ji wani kakakin kamfanin sayar da kayayyaki na Woolworths.
Shagon Costco a Canberra ya kuma iyakance adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ta ba da umarnin manyan fakiti daga masu samar da kayayyaki kuma ta ƙara yawan isar da kayayyaki, Woolworths ta ba da umarnin ƙarin kaya, yayin da ALDI ta ba da kaya a gaba daga ci gaban da aka shirya a ranar Laraba.
Russell Zimmerman, babban darektan Ƙungiyar Masu Sayarwa ta Australiya, ya ce masu sayarwa suna ƙoƙari su tara kaya, amma ƙuntatawa na hukumar a kan yawan jigilar kaya ta mota yana hana su yin hakan.
Yana tsammanin farashin samarwa ya yi yawa yayin da masu samar da kayayyaki ke ƙoƙarin biyan buƙatun, kuma ba a ƙara tallata su ba.
A ranar Talata, ALDI ta sanar da cewa bayan an saki kaya da wuri, wasu shaguna ba za su iya gudanar da tallace-tallace na ranar Laraba ba.
A wani rahoto da News.com.au ta bayar, Dr. Gary Mortimer, masanin sayar da kayayyaki a Queensland University of Technology, ya ce shagunan suna cika kaya a kowane dare.
Ya ce takardar wanka abu ne mai girma da ke da karancin kaya, kuma idan ta ƙare, sai ta bar ɗakunan ajiya da yawa, hakan yana sa mutane su ji kamar ba su da yawa.
Coles da Woolworths suna da ra'ayin cewa idan akwai wadataccen abu a kan ɗakunan ajiya, idan za a iya [saya] kayayyaki kamar takarda na bayan gida da kuma maganin kashe ƙwayoyin cuta kuma suna can a cikin adadi, za ku iya rage tsoro, Russell Zimmerman ya gaya wa ABC News.
Kamfanin da ke kera takardar bayan gida mai suna Who Gives a Crap ya ce a ranar Laraba da ta gabata ba su da kayayyaki.
Kamfanin Kimberly-Clark, wanda ke kera takardar wanka ta Kleenex, da Solaris Paper, wanda ke kera Sorbent, sun jaddada cewa suna aiki 24 hours a rana, 7 days a mako don ci gaba da samarwa, a cewar rahoton News.com.au.
Shafin yanar gizo na domain.com ya ruwaito cewa wasu masu siyar da gidaje suna ba da takarda na kyauta ga masu neman fara gwanjon gwanjon a Melbourne, lokacin da ake gudanar da gwanjon gwanjo tare da masu siye da ke shiga hutu a ƙarshen ƙarshen ranar aiki.
A ranar Alhamis, jaridar NT News, jaridar Darwin ta wallafa wani shafi takwas da aka saka a ciki don a yanke shi a yi amfani da shi a matsayin takarda.
Da farko, shagunan ba su son sanya takunkumi, a cewar rahoton ABC Australia a ranar 3 ga Maris inda suka ce ba su da shirin sanya takunkumi kan sayayya.
Russell Zimmerman ya daɗa cewa wasu kayayyaki ma suna da bukatar gaske, kamar su masks, maganin kashe ƙwari, kayan bushe, sabulu na hannu da gari.
Kamar yadda yake a Ostiraliya, a daren Lahadi, babban kanti na kan layi na Burtaniya Ocado ya iyakance sayen takardar bayan gida Andres zuwa fakiti biyu na 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana cewa barkewar cutar COVID-19  cutar da kwayar cutar coronavirus SARS-CoV-2  ke haifarwa a halin yanzu annoba ce.
Ko da yake kalmar "annoba" tana nufin yadda cutar ta yadu ne kawai, ba yadda hatsarin ke ba, WHO ta nanata bukatar sa gwamnatoci su ɗauki mataki:
Duk ƙasashe na iya canza yanayin wannan annoba.
Idan kasashe za su iya ganowa, gwadawa, magance, warewa, bin diddigin mutane da kuma tattara jama'a don amsawa, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna matukar damuwa game da yawan yaduwar cutar da kuma yadda ta zama ruwan dare gama gari da kuma rashin aiki.
Dokta Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amirka, ya ce wannan annoba "ba ta taɓa faruwa ba".
A wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce "ban da mura, ba a lura da wata kwayar cutar numfashi ba tun lokacin da ta fara zuwa ci gaba da yaduwa a duniya".
Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa "ba mu taɓa ganin annoba da cutar coronavirus ta fara ba".
Ya ci gaba da cewa, "kuma ba mu taɓa ganin annoba da za a iya sarrafa ta ba a lokaci guda".
Sabon matsayin annobar ya biyo bayan shawarar da WHO ta yanke a watan Janairu na ayyana barkewar cutar a matsayin gaggawa ta lafiyar jama'a da ke da damuwa a duniya.
Darakta na Cibiyar Kula da Cututtuka da Cututtuka ta Ƙasa ta Amirka, Dokta Anthony Fauci, ya ce wannan annoba "za ta ƙara muni".
A ranar Alhamis, Associated Press ta ba da rahoton cewa akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duk duniya, tare da mutuwar sama da 4,600.
Cutar annobar coronavirus ta 201920 annobar cutar annobar cutar coronavirus ce ta 2019 (COVID-19), wacce cutar coronavirus mai saurin kamuwa da cutar numfashi mai tsanani 2 (SARS-CoV-2) ke haifarwa.
An gano barkewar cutar a Wuhan, China a watan Disamba na 2019, an ayyana ta a matsayin gaggawa ta lafiyar jama'a ta duniya a ranar 30 ga Janairu, 2020 kuma an gane ta a matsayin annoba a ranar 11 ga Maris, 2020.
Har zuwa 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da COVID-19 a ƙasashe 210 da yankuna, tare da mutuwar mutane 97,000.
Mutane kusan 364,000 sun warke.
An kiyasta yawan mutuwar ya kai kashi 4 cikin dari a kasar Sin, yayin da a duniya ya bambanta daga 13.04 cikin dari a Algeria zuwa 0.08 cikin dari a New Zealand.
Alamun cututtuka na yau da kullum sun haɗa da zazzabi, tari, da kuma numfashi.
Matsaloli na iya haɗawa da ciwon huhu da ciwon numfashi mai tsanani.
Lokaci daga lokacin kamuwa da cutar zuwa farkon bayyanar cututtuka shine kimanin kwanaki biyar, amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Babu wani maganin rigakafi ko maganin rigakafi da aka sani.
Maganin farko shine maganin alamomi da tallafi. Matakan rigakafin da aka ba da shawarar sun haɗa da wanke hannu, rufe baki lokacin tari, nisantar mutane da saka idanu da keɓe mutanen da ake zargi da kamuwa da cutar.
Hukumomi a duk faɗin duniya sun amsa da aiwatar da ƙuntatawa na balaguro, keɓewa, dokar hana fita, kula da haɗarin wurin aiki da rufe shaguna.
Cutar ta haifar da mummunan rikicewar tattalin arziki da zamantakewar duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu da kuma ƙarancin kayayyaki da aka ƙara ta hanyar cinikin firgici.
Makarantu da jami'o'i sun rufe a ƙasashe 193 ko a yankuna, wanda ya shafi kusan kashi 99.4 na ɗaliban duniya.
Bayanai marasa kyau game da cutar sun bazu a kan layi kuma akwai abubuwan nuna kyamar baki da nuna bambanci ga Sinawa, mutanen da ke da asalin Gabas da kudu maso gabashin Asiya da kuma sauran mutanen da ke yankunan da ke da manyan cututtukan cutar.
Saboda rage tafiye-tafiye da kuma rufe masana'antun masana'antu, an rage gurɓatar iska da kuma iskar carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton tarin cututtukan ciwon huhu da ba a san dalilinsa ba a ranar 31 ga Disamba, 2019 kuma an fara bincike a farkon Janairu, 2020.
Yawancin lokuta, an danganta su da kasuwar sayar da kayan kifin Huanan, don haka ana tsammanin cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ke haifar da barkewar cutar an san ta da SARS-CoV-2, kwayar cutar da aka gano kwanan nan kuma tana da alaƙa da ƙwayoyin cuta na bat, pangolin da SARS-CoV. Mutumin farko da aka sani da alamun cutar ya kamu da rashin lafiya a ranar 1 ga Disamba, 2019 kuma ba shi da alaƙa da ƙungiyar abincin teku.
Daga cikin rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019, an gano cewa kashi biyu bisa uku suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya nuna cewa an samu wani mutum mai shekaru 55 a lardin Hubei a ranar 17 ga Nuwamba, 2019, wanda zai iya zama na farko. A ranar 26 ga Fabrairun, 2020, WHO ta ba da rahoton cewa, yayin da sabbin cututtukan da aka ruwaito ke raguwa a China, amma ba zato ba tsammani suka karu a Italiya, Iran da Koriya ta Kudu, yawan sabbin cututtukan da ke wajen China ya zarce adadin sabbin cututtukan China a karon farko.
Akwai yiwuwar rashin rahoto mai yawa, musamman tsakanin mutanen da ke da ƙananan alamun.
Har zuwa ranar 26 ga watan Fabrairu, an samu karancin mutane da suka kamu da cutar a tsakanin matasa 'yan shekara 19 zuwa kasa, wanda ya kai kashi 2.4 cikin 100 na masu kamuwa da cutar a duniya.Babban mai ba da shawara kan kimiyya a Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60 cikin 100 na mutanen Burtaniya za su buƙaci kamuwa da cutar kafin a samu rigakafin garken.
Yanayin yana nufin yawan mutanen da aka gwada su don COVID-19 kuma waɗanda aka tabbatar da gwajin su daidai da ƙa'idodin hukuma.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma ƙasashe da yawa suna da manufofin da ba su gwada mutanen da ke da alamun cutar ba, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka buga a ranar 16 ga watan Maris ya gano cewa a China, a ranar 23 ga watan Janairu, an kiyasta cewa kashi 86 cikin dari na kamuwa da COVID-19 ba a gano su ba kuma waɗannan kamuwa da cutar da ba a rubuta ba sune tushen kamuwa da kashi 79 cikin dari na masu kamuwa da cutar.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa yawan mutanen da ke dauke da cutar a Italiya ya fi yawan wadanda aka ruwaito.
Ƙididdigar farko na ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar.
Wani bincike da Cibiyar Kula da Cututtuka ta Amirka ta wallafa ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna murmurewa.
Ga waɗanda ba su warke ba, lokaci daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, tare da kwanaki 14 mafi yawanci.
Har zuwa 10 ga Afrilu, 2020, kusan mutuwar 97,000 an danganta su da COVID-19.
A China, har zuwa ranar 5 ga watan Fabrairu, kusan kashi 80 cikin 100 na mutuwar sun faru ne a cikin mutanen da suka haura shekaru 60 da haihuwa, kuma kashi 75 cikin ɗari suna da cututtukan da suka riga sun kamu da su, ciki har da cututtukan zuciya da ciwon sukari. Yawan mutuwar da annobar COVID-19 ta yi ya fi dacewa da mutanen da suka mutu kuma suka gwada tabbatacce ga COVID, bisa ga ƙa'idodin hukuma.
Adadin ainihin mutanen da suka mutu daga COVID-19 na iya zama mafi girma, saboda ba zai haɗa da mutanen da suka mutu ba tare da yin gwaji ba, misali, waɗanda suka mutu a gida, gidajen tsofaffi, da sauransu.
Bayanai na Italiya sun nuna cewa ƙarin adadin mutuwar a lokacin annobar ya wuce adadin mutuwar COVID na hukuma da kashi 4-5x.
Wata mai magana da yawun cibiyar kula da cututtuka da rigakafi (CDC) ta Amurka ta yarda cewa "mun san cewa [adadin mutuwar hukuma] an rage shi", wata sanarwa da rahotanni na rashin rahoto a Amurka suka tabbatar. Wannan rashin jin daɗin yana faruwa sau da yawa a cikin annoba, kamar annobar cutar sankarar naman alade H1N1 a 2009.
Mutuwar farko a wajen China ta faru ne a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta faru ne a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen China, an riga an samu mutuwar mutane fiye da dozin a Iran, Koriya ta Kudu da kuma Italiya.
A ranar 13 ga Maris, fiye da ƙasashe da yankuna arba'in sun ba da rahoton mutuwar a kowace nahiya sai Antarctica.
Waɗannan lambobi sun bambanta dangane da yanki da lokaci kuma suna shafar yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar da kuma halayen jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
Dangane da ƙididdigar Jami'ar Johns Hopkins, ƙimar mutuwar gaba ɗaya ita ce 6.0% (97.039/1.617.204) har zuwa 10 ga Afrilu, 2020.
Adadin yana dabam dabam a yankuna dabam-dabam.
A China, ƙididdigar mutuwar ta ragu daga kashi 17.3% (a cikin mutanen da suka fara bayyanar cututtuka tsakanin 1 zuwa 10 ga Janairu, 2020) zuwa kashi 0.7% (ga mutanen da suka fara bayyanar cututtuka bayan 1 ga Fabrairu, 2020).Sauran matakan sun haɗa da ƙimar mutuwa (CFR), wanda ke wakiltar yawan mutanen da aka gano sun mutu saboda cutar, da kuma yawan kamuwa da cutar (IFR), wanda ke wakiltar yawan masu kamuwa da cuta (wanda aka gano da wanda ba a gano ba) waɗanda suka mutu saboda cutar.
Waɗannan ƙididdigar ba su tsayawa a kan lokaci ba kuma suna bin takamaiman yawan kamuwa da cutar ta hanyar warware matsalar.
Wasu masana sun yi ƙoƙari su lissafa waɗannan adadi don wasu mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan kamuwa da cutar da ke haifar da cutar a cikin duniya yana tsakanin kashi 0.1 zuwa 0.39%.
Ƙididdigar sama na wannan zangon ya dace da sakamakon gwajin farko na bazuwar COVID-19 a Jamus da kuma nazarin ƙididdigar da ya bincika tasirin gwaje-gwaje akan ƙididdigar CFR.
Hukumar Lafiya ta Duniya ta ce za a iya sarrafa annobar.
Ba a san lokacin da za a kai ga ƙaruwa da kuma tsawon lokacin da za a kai ga ɓarkewar cutar ba kuma hakan zai iya canjawa daga wuri zuwa wuri.
Maciej Boni na Jami'ar Pennsylvania ya ce: "Idan ba a sarrafa su yadda ya kamata ba, cututtuka sukan kai ƙarshensu kuma su ragu idan babu sauran masu ɗauke da cutar.
Amma kusan ba zai yiwu ba a yi hasashen lokacin da hakan zai faru".
Babban mai ba da shawara kan lafiya ga gwamnatin kasar Sin, Zhong Nanshan, ya ce "za a iya kawo karshen ta a watan Yuni" idan dukkan kasashen duniya suka yi aiki don bin shawarwarin WHO kan matakan dakile yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magungunan Yankin Gashi na London ya bayyana cewa SARS-CoV-2 "mai yiwuwa zai ci gaba da yawo har shekara ɗaya ko biyu".
A cewar binciken kwalejin Imperial, wanda Neil Ferguson ya jagoranta, za a buƙaci nisantawa da sauran matakan "har sai an samu allurar (mai yiwuwa cikin watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce: "Ina ganin ba zai yiwu wannan kwayar cutar ta coronavirus ta ɓace gaba ɗaya ba, tun da yake tana da saurin yaduwa" kuma "za ta iya zama cuta ta yanayi, tana sake dawowa kowace shekara".
Yadda cutar ta sake dawowa zai dogara ne akan rigakafin garken da kuma girman maye gurbi.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma mutanen da ke dauke da cutar na iya zama marasa alamun cutar.
Alamomin biyu da suka fi yawa sune zazzabi (88%) da bushewar tari (68%).
Alamomin da ba a saba gani ba sun haɗa da gajiya, samar da ɓoyayyen numfashi (zazzabi), rashin jin ƙamshi, numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, haemoptysis, zawo ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) na Amurka sun lissafa alamun gaggawa sune wahalar numfashi, ciwo ko matsin lamba a kirji, rikicewa kwatsam, wahalar tafiya da fuska ko lebe tare da launin shuɗi. Ana ba da shawarar neman taimakon likita idan waɗannan alamun suna nan. Ci gaban cutar na iya haifar da ciwon huhu mai tsanani, cututtukan numfashi mai tsanani, sepsis, septic shock, da mutuwa.
Wasu daga cikin mutanen da suka kamu da cutar ba za su iya nuna alamun cutar ba, amma za su iya samun sakamakon gwajin da ya tabbatar da cutar, don haka masu bincike sun ba da shawarar cewa waɗanda suka yi kusanci da mutumin da ke da cutar su kula da su sosai kuma su bincika su don kawar da cutar.
Ƙididdigar China game da yawan marasa alamun cutar ya bambanta daga wasu zuwa 44%.
Lokacin da aka saba da shi (lokacin da ke tsakanin fara kamuwa da cutar da bayyanar cututtuka) ya bambanta daga kwana ɗaya zuwa 14 amma yawanci kwanaki biyar ne. A matsayin misali na rashin tabbas, ƙididdigar yawan mutanen da ke da COVID-19 waɗanda suka rasa ƙamshi da farko ya kasance 30% kuma daga baya ya ragu zuwa 15%.
Har yanzu ana ci gaba da tantance wasu bayanai game da yadda cutar ke yaduwa.
An yi imanin cewa ana yada wannan cutar ne ta hanyar kusanci da ƙananan ɗigon ruwa da aka samar yayin yin tari, hancinsa ko magana, kuma ana ɗaukar kusanci da mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Bincike ya nuna cewa yin tari ba tare da rufe baki ba zai iya sa ɗigon ruwa ya kai tsawon kafa 15 zuwa 8.2.
Wasu mutane sun ba da shawarar cewa ana iya watsa kwayar cutar ta hanyar saukad da ruwa wanda ke kasancewa na dogon lokaci a cikin iska, wanda zai iya haifar da shi yayin tattaunawa. Ana iya samar da saukad da numfashi yayin numfashi, gami da magana, kodayake kwayar cutar ba ta kasance a cikin tsawaitawa ba.
Za a iya samun ruwa a cikin hanci da baki na mutane kusa da su ko kuma a sha cikin huhu.
Wasu hanyoyin likita kamar intubation da CPR na iya haifar da ɓoyewar ɓoyewar numfashi, wanda ke haifar da yaduwa ta iska.
Hakanan yana iya yaduwa lokacin da mutum ya taɓa wani abu mai ƙazanta, gami da fata, sannan ya taɓa idanunsa, hanci ko bakinsa.
Ko da yake akwai damuwa cewa zai iya yaduwa ta hanyar ƙura, ana ganin cewa haɗarin hakan ba shi da yawa.
Gwamnatin China ta musanta yiwuwar yaduwar SARS-CoV-2 ta baki. Kwayar cutar tana da saurin kamuwa da cuta a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya watsawa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
An yi gwajin cutar har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya yaduwa kafin bayyanar cututtuka.
Akwai rahotanni kaɗan na alamun cutar da aka tabbatar a cikin dakin gwaje-gwaje, amma an gano watsawar alamun cutar a wasu ƙasashe yayin binciken binciken lamba.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar ke yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa daga awanni zuwa kwanaki a kan abubuwa.
Musamman, an gano cewa kwayar cutar tana iya ganowa har zuwa kwanaki uku a cikin filastik (polypropylene) da bakin karfe 304, kwana ɗaya a cikin kwali da har zuwa awanni huɗu a cikin jan ƙarfe.
Wannan, duk da haka, ya bambanta dangane da zafi da zafin jiki. Dabbobin gida da sauran dabbobi sun riga sun gwada tabbatacce ga COVID-19.
Babu wata shaida da ta nuna cewa dabbobi za su iya yada cutar ga mutane, amma hukumomin Burtaniya sun ba da shawarar wanke hannu bayan sun taɓa dabbobi da kuma wuraren da mutane masu cutar suka taɓa.
Cutar coronavirus 2 mai saurin kamuwa da cutar numfashi (SARS-CoV-2) sabuwar cuta ce, da aka fara warewa daga mutane uku da ke fama da cutar huhu da ke da alaƙa da tarin cututtukan numfashi a Wuhan.
Dukkanin halayen sabon kwayar cutar SARS-CoV-2 sun yi kama da na coronaviruses masu alaƙa a cikin yanayinsu. A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke narkar da murfin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi imanin cewa ta zo daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar coronavirus tana da alaƙa da kwayoyin halitta zuwa nau'in Betacoronavirus, ƙaramin nau'in Sarbecovirus (tsarin B).
Yana da kamanni kashi 96 cikin ɗari, a matakin kwayoyin halitta, da sauran samfuran coronavirus daga jemage (BatCoV RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci na amino acid guda daya a wasu sassan tsarin kwayoyin halittar mutum tsakanin kwayar pangolin da na mutane.
Kwatanta dukkanin kwayoyin halitta, har zuwa yanzu, ya sami aƙalla kashi 92% na raba kayan kwayoyin halitta tsakanin pangolin coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da pangolins shine mai watsa shiri na tsakiya ba.
Ana iya gano kamuwa da cutar ta hanyar alamomi, amma tabbatacciyar tabbaci ita ce ta hanyar juyawa da kuma sake dawowa da ƙwayar polymerase (rRT-PCR) na ɓoyewar da ke da cutar ko ta hanyar CT.
Wani bincike da aka yi a Wuhan, wanda ya kwatanta rRT-PCR da CT ya nuna cewa CT ya fi hankali sosai, kodayake ba shi da ƙayyadaddun bayani, tare da yawancin siffofin hoton da suka dace da sauran ciwon huhu da hanyoyin cututtuka.
Tun daga watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "kada a yi amfani da CT don tantancewa ko a matsayin gwajin layin gaba don gano COVID-19".
WHO ta wallafa wasu ka'idojin gwajin RNA don SARS-CoV-2, na farko daga cikinsu an buga shi a ranar 17 ga Janairu.
Gwajin yana amfani da juyawa baya bayan amsawa da sarkar polymerase (rRT-PCR) a ainihin lokacin.
Ana iya yin gwajin a kan numfashi ko jini.
Sakamakon yana samuwa a cikin sa'o'i kadan zuwa kwanaki.
Yawancin lokaci ana yin wannan gwajin a cikin nasopharyngeal, kodayake ana amfani da shafawar makogwaro.
A ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan da ya nuna cewa ya isa ya zama daidai don yarda da amfani da shi gaba ɗaya.
Wani gwajin ƙwayar cuta wanda Cellex ta samar a Amurka an amince da shi don amfani da gaggawa kawai ta hanyar dakunan gwaje-gwaje masu izini.
Abubuwan da ke cikin hotuna na X-ray da CT na mutanen da ke da alamun sun hada da asymmetrical opacities a cikin gilashin gilashi da kuma rashin zubar da jini.
Ƙungiyar Radiology ta Italiya tana tattara bayanan duniya na kan layi na sakamakon hoto a cikin lokuta da aka tabbatar.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, hotuna ba tare da tabbatarwar PCR ba suna da iyakantaccen ƙayyadaddun gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da na PCR kuma ya nuna cewa ko da yake hoton bai dace da kamuwa da cuta ba, amma yana da sauri kuma yana da hankali, wanda ke nuna cewa yana da amfani a matsayin kayan aikin bincike a yankunan da ke fama da annoba.
An tsara hanyoyin sadarwa na kwakwalwa da ke da hankali don gano siffofin hotuna na cutar ta hanyar X-ray da CT.
Dabaru don hana yaduwar cutar sun haɗa da kiyaye tsabtar jiki gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci ko baki ba tare da wanke hannu ba, tari ko hancin kunne a kan takardar takarda da sanya wannan takardar kai tsaye a cikin kwandon shara.
Ana ba da shawarar duk wanda ya riga ya kamu da cutar ya sanya abin rufe fuska a fili.
Ana kuma ba da shawarar nisantar da kai don hana yaduwa. Gwamnatoci da yawa sun hana ko ba da shawarar balaguron da ba dole ba zuwa ko daga ƙasashe da yankunan da cutar ta shafa.
Amma cutar ta kai matakin yaduwar al'umma a wurare da dama a duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'ummomi kuma wasu membobin al'umma ba su san inda ko yadda suka kamu ba. Ana ba da shawarar ma'aikatan kiwon lafiya da ke kula da mutanen da za su iya kamuwa da cutar su yi amfani da ƙa'idodin kiyayewa, kiyayewa da kariya ta ido. Binciken tuntuɓar hanya ce mai mahimmanci ga hukumomin kiwon lafiya don ƙayyade tushen kamuwa da cuta da hana ci gaba da yaduwa.
Amfani da gwamnatoci ke yi da bayanan wurin da aka samo daga wayoyin salula don wannan dalili ya haifar da tambayoyin sirri, tare da Amnesty International da wasu kungiyoyi sama da 100 da suka ba da sanarwa suna kira da a kawo iyaka ga irin wannan sa ido.
An aiwatar da aikace-aikacen wayar hannu da yawa ko kuma aka ba da shawarar don amfani da son rai.
Masu amfani za su sami saƙo idan sun kasance kusa da wanda ya kamu da COVID-19. Wasu ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar sun bazu, kamar, goge hanci da kuma yin gargadi da kayan shafawa, wanda ya riga ya tabbatar da rashin tasiri.
Babu riga-kafin COVID-19, amma kungiyoyi da dama suna aiki don samar da ɗaya.
Ana bada shawarar wanke hannu don hana yaduwar cutar.
Hukumar CDC ta ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa a kai a kai na aƙalla daƙiƙa ashirin, musamman bayan sun je bayan gida mai tsabta ko kuma idan hannayensu sun ƙazantu sosai.
Wannan domin bayan jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke karya murfinta na kariya.
CDC ta kuma ba da shawarar yin amfani da tsabtace hannu na giya wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na giya, lokacin da sabulu da ruwa ba su da sauƙi.
Hukumar Lafiya ta Duniya ta ba da shawarar kada a taɓa idanu, hanci ko baki ba tare da wanke hannu ba.
Za'a iya tsabtace farfajiyoyi tare da mafita daban-daban (a cikin minti daya na fallasa maganin kashe ƙwayoyin cuta don farfajiyar bakin karfe), ciki har da ethanol 6271%, isopropyl alcohol 50100%, sodium hypochlorite 0,1%, hydrogen peroxide 0,5% da iodopovidone 0,27,5%.
Wasu magunguna kamar su benzalkonium chloride da chlorhexidine gluconate ba su da amfani sosai.
CDC ta ba da shawarar cewa idan aka yi zargin ko tabbatar da COVID-19 a wani wuri kamar ofis ko makarantar yara, duk wuraren kamar ofisoshi, dakunan wanka, wuraren da mutane ke amfani da su, kayan lantarki da aka raba kamar su kwamfutar hannu, allon taɓawa, mabuɗan rubutu, sarrafawa ta nesa da kuma akwatunan lantarki da marasa lafiya ke amfani da su ya kamata a kashe su.
Ƙungiyoyin kiwon lafiya sun ba da shawarar rufe baki da hanci da ƙafarka ko kuma da takardar ɗamara sa'ad da kake tari ko hancinsa, kuma ka zubar da duk wani ɗamara nan da nan.
Ana ba da shawarar rufe fuska na tiyata ga waɗanda za su iya kamuwa da cutar, saboda sanya abin rufe fuska na iya iyakance girma da nisa na motsawar ɗigon numfashi yayin magana, hancinsa ko tari.
Hukumar Lafiya ta Duniya ta wallafa wasu bayanai game da lokacin da kuma yadda za a saka abin rufe fuska.
A cewar Stephen Griffin, masanin kwayar cuta a Jami'ar Leeds, "Sanya abin rufe fuska na iya rage yawan mutanen da ke taba fuskokinsu, wanda shine daya daga cikin manyan hanyoyin kamuwa da cutar ba tare da tsabtace hannaye ba".
WHO ta ba da shawarar yin amfani da abin rufe fuska ta lafiyayyun mutane kawai lokacin da suke cikin haɗari, kamar masu kula da mutanen da ke da COVID-19, kodayake sun kuma yarda cewa yin amfani da abin rufe fuska na iya taimaka wa mutane kada su taɓa fuskokinsu.
A ƙasashe da dama, ana ƙarfafa yin amfani da abin rufe fuska ga jama'a.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na ba likita ba wanda aka yi da masana'anta. China ta ba da shawarar musamman yin amfani da abin rufe fuska na likita da za a iya amfani da su ta hanyar mutane masu lafiya gaba ɗaya, musamman lokacin da suke kusanci da wani mutum (kasancewa mita 1 ko ƙasa da haka).
A Hong Kong, ana ba da shawarar sanya abin rufe fuska lokacin amfani da jigilar jama'a ko kasancewa a wuraren da mutane suka cika.
Hukumomin kiwon lafiya a Thailand suna ƙarfafa mutane su yi abin rufe fuska na masana'anta a gida kuma su wanke su kowace rana.
A Jamhuriyar Czech da Slovakia, an hana fita waje ba tare da saka abin rufe fuska ko rufe hanci da baki ba.
A ranar 16 ga Maris, Vietnam ta bukaci kowa ya sanya abin rufe fuska yayin da yake fita a wuraren jama'a don kare kansa da wasu.
Gwamnatin Austria ta bukaci duk wanda ya shiga manyan kantuna ya sanya abin rufe fuska.
A Isra'ila, an nemi duk mazauna su sanya abin rufe fuska a fili.
Taiwan, wadda ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjoji a jiragen kasa da bas na tsakanin birane su sanya abin rufe fuska daga ranar 1 ga Afrilu.
A Panama, an tilasta amfani da abin rufe fuska a waje, kuma an ba da shawarar samar da abin rufe fuska a gida ga waɗanda ba za su iya ba.
An kuma yi amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa tsakanin jama'a (wanda kuma aka sani da nisantar jiki) ya ƙunshi ayyukan kula da kamuwa da cuta da nufin rage saurin yaduwar cutar, ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun hada da killace mutane, hana tafiya da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko cibiyoyin kasuwanci.
Za a iya amfani da hanyoyin nisantar da jama'a ta hanyar kasancewa a gida, rage tafiye-tafiye, kauce wa wuraren da mutane ke yawa, amfani da gaisuwa ba tare da tuntuɓar juna ba, da nisantar wasu.
A halin yanzu, gwamnatoci da yawa suna tilasta ko ba da shawarar nisantar da jama'a a yankunan da annobar ta shafa.
An rage yawan mutane da hukumomin gwamnatin Amurka da kungiyoyin kiwon lafiya suka ba da shawarar daga mutane 250 (idan ba a san cewa an samu yaduwar COVID-19 a wani yanki ba) zuwa mutane 50 sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane sama da biyu. Tsofaffi da waɗanda ke da cututtuka masu mahimmanci kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da kuma tsarin garkuwar jiki da aka raunana suna fuskantar haɗarin kamuwa da cututtuka da rikitarwa, kuma CDC ta shawarce su da su zauna a gida gwargwadon iko a wuraren annobar al'umma. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "nisanci" da "nisanci na zahiri", don bayyana cewa makasudin shine rage hulɗar jiki ta hanyar kiyaye alaƙar zamantakewa, ko dai a zahiri ko nesa.
Amfani da kalmar "nisanci" ya haifar da ma'anar cewa ana buƙatar keɓewar jama'a gaba ɗaya maimakon ƙarfafa hulɗa ta wasu hanyoyi. Wasu hukumomi sun buga jagororin kiwon lafiyar jima'i yayin annobar.
Waɗannan shawarwari sun haɗa da yin jima'i da wanda kuke zama tare da shi wanda ba shi da cutar ko alamun cutar.
An ba da shawarar keɓe kai a gida ga waɗanda aka gano suna da COVID-19 da waɗanda ake zargi da kamuwa da cutar.
Hukumomin kiwon lafiya sun ba da cikakkun bayanai game da keɓe kai yadda ya kamata. Gwamnatoci da yawa sun bukaci ko kuma sun ba da shawarar keɓe kai ga dukan mutanen da ke zaune a yankunan da cutar ta shafa.
An ba da umarnin keɓe kai mafi ƙarfi ga waɗanda ke cikin manyan ƙungiyoyin haɗari.
An shawarci mutanen da za su iya kasancewa a cikin haɗuwa da wasu da ke da COVID-19 da waɗanda suka yi tafiya kwanan nan zuwa ƙasa ko yanki tare da yaduwar yaduwar su yi keɓewa na kwanaki 14 daga lokacin da suka kasance a cikin haɗuwa.
Dabarun sarrafa barkewar cutar sune hanawa ko kawarwa da ragewa.
Ana gudanar da hana yaduwar cutar a farkon lokacin barkewar cutar kuma ana nufin ganowa da ware masu kamuwa da cutar, da gabatar da wasu matakan kula da kamuwa da cuta da alluran rigakafi don hana cutar yaduwa ga sauran jama'a.
Idan ba za a iya hana yaduwar cutar ba, za a fara aiki don rage ta. Matakan da ake dauka yanzu suna rage saurin yaduwar cutar da kuma rage illolinta ga tsarin kiwon lafiya da kuma jama'a.
Ana iya ɗaukar matakan hanawa da ragewa a lokaci guda, a hade.
Don kawar da cutar, ana bukatar a ɗauki matakan da za su rage yawan mutane da ke kamuwa da cutar zuwa ƙasa da ɗaya. Yin maganin cutar da ke sa mutum kamuwa da cuta yana nufin rage yawan mutane da ke kamuwa da cutar. Wannan shi ne abin da ake kira "ƙarancin cutar".
Hakan zai rage haɗarin cinkoson ayyukan kiwon lafiya, kuma hakan zai ba da ƙarin lokaci don a samu alluran rigakafi da kuma magani.
Abubuwan da ba magunguna ba da za su iya magance barkewar cutar sun haɗa da matakan kariya na mutum kamar tsabtace hannu, sanya abin rufe fuska da keɓe kai; matakan al'umma don nisantar da jiki kamar rufe makarantu da soke abubuwan da ke haifar da taron jama'a; shigar al'umma don ƙarfafa karɓa da shiga cikin waɗannan maganganun; da matakan muhalli kamar tsabtace wuraren tuntuɓar. An ɗauki ƙarin matakai masu ƙarfi don hana barkewar cutar a China lokacin da aka fahimci tsananin barkewar cutar. Misali, an keɓe birane gaba ɗaya kuma an sanya takunkumin balaguro.
Sauran ƙasashe sun ɗauki matakai dabam dabam don hana yaduwar cutar.
Alal misali, Koriya ta Kudu ta gabatar da tantancewar mutane da kuma keɓewar wurare, kuma gwamnati ta ba da gargaɗi game da motsi na mutanen da ke da cutar.
A Singapore, an ba masu kamuwa da cutar tallafin kuɗi lokacin da suka keɓe kansu kuma waɗanda ba su yi hakan ba an ɗora musu manyan tarar kuɗi.
A Taiwan, an kara samar da abin rufe fuska kuma an hukunta wadanda ke adana kayan aikin likita.Game da kwaikwayon da aka gudanar a Burtaniya da Amurka, an nuna cewa ragewa (rage saurin kamuwa da cutar ba tare da dakatar da yaduwar annobar ba) da kuma kawar da ita (watau sauya ci gaban annobar) suna da manyan kalubale.
Manufofin ragewa na iya rage yawan buƙatun kiwon lafiya da kashi biyu cikin uku kuma rage yawan mutuwar da rabi, amma hakan zai haifar da dubban daruruwan mutuwar, kuma a lokaci guda ya sa tsarin kiwon lafiya ya yi yawa.
Dakatar da cutar zai iya zama mafi kyawun zaɓi, amma dole ne a ci gaba da shi har sai cutar ta yi yawo a cikin ɗan adam ko har sai an sami allurar rigakafi, idan hakan ta faru a baya. In ba haka ba, watsawa zai sake faruwa da zarar an sassauta matakan.
Matakin da aka ɗauka na dogon lokaci don kawar da annobar yana kawo farashi na zamantakewa da tattalin arziki.
Babu wani magani da aka amince da shi na rigakafin cutar da ke da takamaiman cutar COVID-19, amma akwai ƙoƙarin haɓaka magunguna, wanda ya haɗa da gwajin magunguna na yanzu.
Yin amfani da magungunan sanyi da ba a rubuta wa likita ba, shan ruwa da yawa, da kuma hutawa za su iya taimaka maka ka rage alamun.
Dangane da tsananin cutar, ana iya buƙatar amfani da maganin oxygen, shigar da ruwa cikin jijiya ko taimakon numfashi.
Yin amfani da magungunan hana ɗaukar ciki zai iya sa yanayin ya yi muni.
Yawancin mahaɗan da aka amince da su a baya don magance wasu cututtukan ƙwayoyin cuta suna ƙarƙashin bincike don amfani da su don maganin COVID-19.
Hukumar Lafiya ta Duniya ta kuma bayyana cewa wasu magunguna "na gida da na gargajiya" na iya rage alamun cutar SARS-CoV-19.
WHO ta bayyana karuwar iya aiki da daidaita kulawar lafiya ga bukatun da COVID-19 ya kawo a matsayin muhimman matakan magance barkewar cutar.
Cibiyar Kula da Cututtuka ta Turai, ECDC, da ofishin WHO a Turai sun ba da jagorori ga asibitoci da cibiyoyin kula da lafiya na farko don tura albarkatun su a matakai da yawa, gami da mayar da hankali kan ayyukan dakin gwaje-gwaje don gwajin COVID-19, soke hanyoyin da ba dole ba da kuma warewa da keɓe marasa lafiya da suka gwada tabbatacce ga COVID-19, da haɓaka ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka adadin gadaje da masu ba da iska.
Akwai ra'ayoyi da yawa game da bayyanar yanayin farko (wanda ake kira mai haƙuri zero).
An fara samun mutum daya da cutar korona a ranar 1 ga watan Disamba na shekarar 2019 a birnin Wuhan na lardin Hubei na kasar Sin.
A cikin wata guda, yawan masu kamuwa da cutar coronavirus a yankin ya karu a hankali.
Wadannan lamuran sun kasance suna da alaƙa da kasuwar siyar da kayan abincin teku ta Huanan. Kasuwar kuma tana sayar da dabbobi masu rai, wanda hakan ya haifar da ka'idar cewa kwayar cutar ta fito ne daga ɗayan waɗannan dabbobin. A wasu kalmomin, an yi imanin cewa yana da asalin dabbobi. A ranar 26 ga Disamba, wani rukunin marasa lafiya ne Dr. Zhang Jixian ya lura da kula da su a Asibitin Lardin Hubei. Washegari, likitan ya sanar da Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Wuhan Jianghan.
A ranar 30 ga Disamba, wasu likitoci a babban asibitin Wuhan sun gargadi abokan aikin su game da "Covid-19 irin SARS".
Likitoci takwas daga cikin wadannan likitoci, ciki har da Li Wenliang, 'yan sanda sun tsawata musu saboda yada labaran karya.
Hukumar Lafiya ta Birnin Wuhan a ranar 31 ga Disamba ta ba da sanarwar ga jama'a kuma ta sanar da WHO.
An riga an bayar da rahoton isassun cututtukan ciwon huhu da ba a san asalin su ba ga hukumomin kiwon lafiya na Wuhan don gudanar da bincike a farkon watan Janairu. A farkon lokacin barkewar cutar, yawan masu cutar ya ninka sau biyu a kowace kwana bakwai da rabi, kusan.
A farkon da tsakiyar watan Janairun 2020, cutar ta yadu zuwa wasu lardunan China, wanda ya sauƙaƙe ta hanyar ƙaura ta Sabuwar Shekarar China da kuma kasancewar Wuhan cibiyar sufuri, ban da babban hanyar jirgin ƙasa.
A ranar 20 ga Janairu, kasar Sin ta ba da rahoton sabbin mutane 140 a rana ɗaya, ciki har da mutane biyu a Beijing da ɗaya a Shenzen.
Bayanai na baya-bayan nan sun nuna cewa mutane 6,174 sun riga sun sami alamun cutar har zuwa 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta zarce China da Italiya tare da yawan adadin mutanen da aka tabbatar a duniya. A ranar 9 ga Afrilu, 2020, an samu sama da mutane miliyan 1.61 a duk duniya; sama da mutane 97,000 sun mutu, kuma sama da 364,000 sun warke.
Kimanin ƙasashe da yankuna 200 sun riga sun sami aƙalla mutum ɗaya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da yawa da ke cikin Yarjejeniyar Schengen sun ƙuntata motsi da kuma kafa kulawar kan iyaka.
Sakamakon da ƙasashe suka bayar ya haɗa da matakan hana fita kamar keɓewa (wanda kuma ake kira umarnin killace gida, umarnin killace gida ko kullewa) da kuma dokar hana fita. A ranar 2 ga Afrilu, kusan mutane miliyan 300 (kusan kashi 90% na yawan jama'a) suna cikin wasu nau'o'in killacewa a Amurka, sama da mutane miliyan 50 suna cikin killacewa a Philippines, kusan mutane miliyan 59 suna cikin killacewa a Afirka ta Kudu, kuma mutane biliyan 1.3 suna cikin killacewa a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya sun riga sun kasance a ƙarƙashin wasu nau'ikan kulle-kulle, wanda ya karu zuwa mutane biliyan 2.6 bayan kwana biyu, kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An samu mutum na farko da ya kamu da cutar a Wuhan a ranar 1 ga Disamba, 2019. Wani rahoto da ba a tabbatar da shi ba ya nuna cewa an samu mutum na farko a ranar 17 ga Nuwamba.
Dokta Zhang Jixian ta lura da wasu marasa lafiya da ke fama da cutar huhu da ba a san dalilin da ya sa ba a ranar 26 ga Disamba. Asibitin ta ya sanar da Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Wuhan Jianghan a ranar 27 ga Disamba.
Gwajin kwayoyin halitta na farko a ranar 27 ga Disamba, 2019, akan samfuran da aka karɓa daga marasa lafiya sun nuna kasancewar coronavirus irin SARS.
Hukumar Kula da Lafiya ta Birnin Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a ranar.
A lokacin da aka samu wannan sanarwar, 'yan sanda sun gargadi likitocin Wuhan kan "fitar da jita-jita" game da barkewar cutar.
Hukumar lafiya ta kasar Sin ta fara da'awar cewa babu "tabbaci mai kyau" na yaduwar cutar tsakanin mutane.
A ƙarshen watan Janairu, gwamnatin China ta ƙaddamar da wani babban kamfen, wanda daga baya babban sakataren jam'iyyar kwaminis ta China Xi Jinping ya bayyana a matsayin "yaƙin mutane", don dakile yaduwar cutar.
A cikin abin da aka bayyana a matsayin "mafi girma keɓewa a tarihin ɗan adam", an sanar da dokar hana fita a ranar 23 ga Janairu don dakatar da tafiye-tafiye zuwa Wuhan, wanda aka faɗaɗa zuwa birane 15 a Hubei, yana shafar kusan mutane miliyan 57 gaba ɗaya.
An haramta amfani da motocin jama'a a birnin.
An soke bikin sabuwar shekara ta kasar Sin a ranar 25 ga watan Janairu a wasu wurare.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, Huoshenshan Hospital, wanda aka kammala cikin kwanaki 10.
An gina wani asibiti kuma, Leishenshan, don kula da ƙarin marasa lafiya.
Tare da sabbin asibitocin da aka gina, kasar Sin ta mayar da wasu wurare 14 na Wuhan zuwa asibitoci na wucin gadi, kamar cibiyoyin taro da filayen wasa. A ranar 26 ga Janairu, gwamnati ta fitar da karin matakan dakile barkewar COVID-19, gami da bayar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
Jami'o'i da makarantu a duk fadin kasar sun rufe.
Yankunan Hong Kong da Macao sun dauki matakai da dama musamman ga makarantu da jami'o'i.
An ɗauki matakai don aiki daga nesa a yankuna da yawa na ƙasar.
An sanya takunkumin hana tafiye-tafiye a cikin Hubei da wajensa.
An sauya hanyar sufuri ta jama'a, kuma an rufe gidajen tarihi a duk faɗin ƙasar Sin na ɗan lokaci.
An sanya dokar hana zirga-zirgar jama'a a birane da dama, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun shiga cikin wasu nau'ikan ƙuntatawa na fita. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana "shigo da" cutar daga wasu ƙasashe.
Alal misali, Beijing ta kafa dokar killace mutane na kwanaki 14 ga duk matafiya na duniya da suka zo birnin. A ranar 23 ga Maris, babban yankin China yana da mutum ɗaya ne kawai da ya kamu da cutar a cikin gida a cikin kwanaki biyar, a wannan yanayin, ta hanyar matafiyi da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin, Li Keqiang, ya ba da rahoton cewa an toshe yaduwar cututtukan watsawa na cikin gida kuma an sarrafa barkewar cutar a China.
A ranar, an sassauta takunkumin tafiye-tafiye a Hubei, sai dai Wuhan, watanni biyu bayan an sanya dokar kulle. Ministan Harkokin Wajen China ya sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigar mutane da ke da biza ko izinin zama daga ranar 28 ga Maris, ba tare da wani takamaiman bayani game da lokacin da za a kawo ƙarshen wannan manufar ba.
Duk wanda ke son shiga kasar Sin dole ne ya nemi biza a ofisoshin jakadancin kasar Sin ko ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta karfafawa kamfanoni da masana'antu gwiwa su sake budewa a ranar 30 ga watan Maris, ta hanyar ba da kayan tallafi na kudi ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki, ta fara da yin shiru na mintuna uku a duk fadin kasar a ranar 4 ga Afrilu da karfe 10 na safe, daidai da bikin Qingming. Duk da haka, gwamnatin tsakiya ta nemi iyalai su yi bukukuwan su ta yanar gizo, suna kiyaye nisantar jiki don hana sake barkewar COVID-19.
A ranar 20 ga Janairun 2020, an tabbatar da yaduwar COVID-19 daga China zuwa Koriya ta Kudu.
Hukumar kiwon lafiya ta kasar ta ba da rahoton wani babban ci gaba a cikin shari'o'in da aka tabbatar a ranar 20 ga Fabrairu, wanda galibi ana danganta shi ne ga wani taro a Daegu na wani sabon motsi na addini, wanda aka sani da Shincheonji Church of Jesus.
Ana zargin cewa masu ibada na Shincheonji da suka ziyarci Daegu daga Wuhan ne suka haifar da barkewar cutar.
A ranar 22 ga Fabrairu, daga cikin mabiya coci 9,336, 1,261, ko kusan kashi 13 cikin dari na su, sun ba da rahoton samun alamomi.
A ranar 28 ga Fabrairu, an ba da rahoton sama da mutane 2,000 da suka kamu da cutar, wanda ya kai 3,150 a ranar 29 ga Fabrairu.
An sanya dukkan sansanonin soji na Koriya ta Kudu cikin keɓewa bayan gwaje-gwaje sun tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma yi tasiri da sauya jadawalin jiragen sama. Koriya ta Kudu ta gabatar da abin da aka ɗauka mafi girma kuma mafi kyawun tsari a duniya dangane da tantance yawan mutane don cutar. Ƙasar ta kuma ware mutanen da ke da cutar kuma ta bi da kuma keɓe waɗanda suka taɓa saduwa da su.
Hanyoyin tantancewa sun haɗa da buƙatar rahoton mutum na alamun bayyanar cututtuka ga waɗanda suka zo daga balaguron ƙasa da ƙasa ta hanyar aikace-aikacen wayar hannu, gwajin kwayar cutar ta hanyar tuki, tare da sakamakon da ke samuwa a rana mai zuwa, ban da haɓaka ƙarfin gwaji, wanda ya ba da damar gwada mutane 20,000 kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin nasara wajen sarrafa barkewar cutar, kodayake ba ta sanya birane gaba ɗaya cikin keɓewa ba.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman tsige Moon bisa zargin rashin kulawar gwamnati da barkewar cutar, ko kuma suna yabon yadda ya amsa.
A ranar 23 ga watan Maris, an ba da rahoton cewa Koriya ta Kudu ta sami mafi ƙarancin adadin masu cutar a cikin makonni huɗu.
A ranar 29 ga Maris an sanar da cewa daga ranar 1 ga Afrilu duk sabbin masu shigowa daga kasashen waje dole ne su shiga keɓewa na makonni biyu.
Ta hanyar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta sami buƙatun taimako don gwajin cutar daga ƙasashe daban-daban 121.
Iran ta tabbatar da kamuwa da cutar SARS-CoV-2 a ranar 19 ga watan Fabrairu a Qom, inda, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu suka mutu a ranar.
Matakan farko da gwamnatin ta sanar sun hada da soke kide kide da sauran al'adu, wasanni, da kuma taron addini a ranakun Juma'a, rufe jami'o'i, cibiyoyin ilimi, da makarantu.
Iran ta samu Rials biliyan biyar don magance cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairun 2020 cewa ba shi da wani shiri game da wuraren da ke cikin keɓewa da cutar ta shafa, kuma za a sanya mutane a keɓewa kawai.
An sanar da tsare-tsaren iyakance tafiye-tafiye tsakanin biranen a watan Maris, kodayake zirga-zirgar ababen hawa tsakanin biranen kafin Sabuwar Shekarar Fasha Nowruz ta ci gaba.
Wuraren ibada na Shi'a a Qom sun kasance a bude ga mahajjata har zuwa 16 ga Maris, 2020.
A yayin da ake zargin cewa an rufe yaduwar cutar a Iran, sama da kasashe goma sun sake gano cututtukansu da suka shafi Iran a ranar 28 ga Fabrairu suna nuna cewa yaduwar cutar na iya zama mafi muni fiye da 388 da gwamnatin Iran ta ruwaito har zuwa wannan ranar.
An rufe majalisar dokokin Iran, tare da 23 daga cikin mambobi 290 da suka kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta yi kira ga hukumomin kurkuku na Iran da su saki masu kare hakkin dan adam da aka tsare saboda rashin amincewarsu da zaman lafiya ba tare da wata doka ba, da kuma sakin duk fursunonin da suka cancanci.
Hukumar ta ce akwai hadarin yaduwar cutar a cibiyoyin da aka rufe kamar cibiyoyin tsare mutane, wadanda kuma ke fama da rashin kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana ɗaya, mafi yawan mutane tun lokacin da annobar ta fara a ƙasar.
Akalla 'yan siyasa 12 da suka yi ritaya da jami'an gwamnati sun mutu sakamakon cutar har zuwa ranar 17 ga Maris.
Har zuwa 23 ga Maris, Iran tana da sabbin mutane 50 a kowace awa da kuma mutuwa guda a kowane minti goma sakamakon cutar Coronavirus.
A cewar wani wakilin Hukumar Lafiya ta Duniya, akwai adadin mutane da suka kamu da cutar a Iran fiye da sau biyar.
An ba da shawarar cewa takunkumin da Amurka ta sanya wa Iran na iya shafar ikon kuɗin ƙasar don amsa cutar kwayar cutar.
Babban Kwamishinan 'Yancin Dan Adam ya nemi a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar zuwa Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido' yan China biyu suka gwada ingancin SARS-CoV-2 a Rome.
Lamuran sun fara ƙaruwa cikin sauri, wanda ya sa gwamnatin Italiya ta dakatar da duk jirage zuwa da daga China kuma ta ayyana dokar ta baci.
An gano wasu mutane da ba su da alaƙa da cututtukan COVID-19 daga baya, farawa da tabbatar da shari'o'i 16 a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta sanar da dokar doka don hana barkewar cutar, gami da keɓe mutane sama da 50,000 daga gundumomi 11 daban-daban a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A yankunan da cutar ta bulla, an hana mutane shiga da fita.
An riga an yanke shawarar dakatar da ayyukan aiki da wasannin motsa jiki a waɗannan yankuna. "A ranar 4 ga Maris, gwamnatin Italiya ta nemi a rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar lokacin da Italiya ta kai mutuwar 100.
Duk manyan abubuwan wasanni, gami da wasannin kwallon kafa na Serie A, dole ne a gudanar da su a rufe har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da duk abubuwan wasanni gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya nemi rufe kusan dukkanin ayyukan kasuwanci, ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiya na Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta buga shawarwarin ɗabi'ar likita game da hanyoyin da za a iya amfani da su.
A ranar 19 ga Maris, Italiya ta wuce China a matsayin ƙasa da ta fi yawan mutanen da suka mutu sakamakon cutar Coronavirus a duniya bayan ta ba da rahoton mutuwar 3,405 da ke da nasaba da annobar.
A ranar 22 ga Maris, an ba da rahoton cewa Rasha ta aika da jiragen sama na soja tara tare da kayayyakin kiwon lafiya zuwa Italiya.
A ranar 5 ga Afrilu, akwai mutane 128,948 da aka tabbatar da cutar, mutane 15,887 da suka mutu, da kuma mutane 21,815 da aka warke a Italiya, kuma yawancin waɗannan sun faru ne a yankin Lombardy.
Wani rahoto daga CNN ya nuna cewa yawan tsofaffi a Italiya da rashin iya gwada duk wanda ya kamu da cutar har zuwa wannan lokacin na iya taimakawa wajen yawan mutuwar.
Amsar da Burtaniya ta bayar ga cutar ta fara fitowa a matsayin mafi laushi daga cikin ƙasashen da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane irin nisantar zamantakewa ko matakan keɓewa ga jama'arta ba.
A sakamakon haka, gwamnati ta fuskanci suka saboda sanannen rashin himma da kuma tsananin amsar da ta bayar ga matsalolin da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da wata sanarwa da ke ba da shawarar dakatar da duk balaguron da ba su da mahimmanci da kuma hulɗa da jama'a, yana ba da shawarar mutane su yi aiki daga gida gwargwadon iko kuma su guji wurare kamar mashaya, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa duk wuraren shakatawa kamar mashaya da dakunan motsa jiki ya kamata a rufe su da wuri-wuri, kuma ta yi alkawarin biyan kashi 80% na albashin ma'aikata har zuwa iyakar £ 2,500 a wata don kauce wa rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da matakan nisantar da jama'a, hana tarurruka da mutane fiye da biyu da kuma takaita tafiye-tafiye da ayyukan waje zuwa mafi ƙarancin da ake buƙata.
Ba kamar matakan da suka gabata ba, 'yan sanda sun ƙara tsaurara waɗannan ƙuntatawa ta hanyar ba da takunkumi da kuma tarwatsa taron jama'a.
An umarci mafi yawan kasuwancin da su rufe, sai dai wasu da aka ce "mahimmanci" ne, ciki har da manyan kantuna, kantin magani, bankuna, shagunan kayan aiki, tashoshin mai da kuma motocin mota.
A ranar 20 ga Janairu, an tabbatar da sanannen mutum na farko da ya kamu da COVID-19 a jihar Pacific Northwest na Washington a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa Hukumar Kula da Cutar Korona ta Fadar White House a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya, kuma ta sanya takunkumi kan shiga matafiya daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka  babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka  ta sanar da cewa sun samar da kayan gwajin kansu.
Duk da haka, Amurka ta yi jinkirin fara gwajin, wanda ya ɓoye ainihin yaduwar cutar a lokacin.
Gwajin ya kasance mai alamar kayan gwaji mara kyau da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya don kayan gwajin da ba na gwamnati ba (daga wuraren motsa jiki, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ƙuntatawa ga mutanen da za a gwada su har zuwa farkon Maris (ana buƙatar buƙatar likita daga baya).
Har zuwa ranar 27 ga Fabrairu, jaridar Washington Post ta ba da rahoton cewa an yi gwaji ƙasa da 4,000 a Amurka.
Har zuwa ranar 13 ga Maris, jaridar The Atlantic ta ba da rahoton cewa an yi gwaje-gwaje ƙasa da 14,000.
A ranar 22 ga Maris, Associated Press ta ba da rahoto: "Mutane da yawa da ke da alamun cutar kuma suna da buƙatar likita sun jira na sa'o'i ko kwanaki don yin gwaji". Bayan an ba da rahoton mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, wani mataki da wasu jihohi suka bi a takaice.
Makarantu a yankin Seattle sun soke karatu a ranar 3 ga Maris, kuma a ƙarshen mako na biyu na watan Maris, makarantu a duk faɗin ƙasar suna rufe. A ranar 6 ga Maris, 2020, ƙungiyar masana cututtukan cututtuka a Kwalejin Imperial ta London sun yi gargadi ga Amurka game da hasashen tasirin sabon coronavirus a ƙasar.
A wannan ranar, Shugaba Trump ya rattaba hannu kan Dokar Ƙarin Kuɗaɗen Shirye-shiryen Cutar Korona da Amsawa, wanda ya ba da dala biliyan 8.3 a cikin kuɗin gaggawa ga hukumomin tarayya don amsa cutar.
Kamfanoni sun hana ma'aikata tafiya, sun soke taron taro, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An soke abubuwan wasanni da yanayi. A ranar 11 ga Maris, Trump ya ba da sanarwar ƙuntatawa tafiye-tafiye ga yawancin Turai, ban da Burtaniya, na kwanaki 30, wanda ya fara aiki daga ranar 13 ga Maris.
Kashegari, ya faɗaɗa ƙuntatawa don ya haɗa da Burtaniya da Ireland.
A ranar 13 ga Maris, ya ayyana gaggawa ta ƙasa, wanda ya sa kudaden tarayya suka kasance don amsa rikicin.
Tun daga ranar 15 ga Maris, yawancin kasuwanni sun rufe ko rage sa'o'i a duk faɗin Amurka don ƙoƙarin rage yaduwar kwayar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a jihohi 50 da gundumar Columbia. A ranar 23 ga watan Maris, an ba da rahoton cewa birnin New York yana da mutane 10,700 da suka kamu da cutar Coronavirus, wanda ya fi yawan adadin mutanen da ke Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce nisantar da jama'a ta bayyana tana aiki, yayin da ƙididdigar ninki biyu na lokuta ta ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
Tun daga ranar 28 ga watan Maris, an tabbatar da mutane 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga Maris, Amurka ta ba da rahoton mutane da suka kamu da cutar Coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya. Tun daga ranar 8 ga Afrilu, an tabbatar da mutane 400,335 da cutar a Amurka, kuma mutane 12,841 sun mutu.
A cewar rahotannin kafofin watsa labarai, a ranar 30 ga Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita ƙa'idodin nisantar jama'a har zuwa 30 ga Afrilu.
A wannan ranar, jirgin ruwan asibiti mai ɗauke da gadaje 1,000 mai suna USNS Comfort ya sauka a birnin New York.
A ranar 3 ga Afrilu, Amurka ta sami adadin mutuwar mutum 884 daga cutar Coronavirus a cikin sa'o'i 24.
A jihar New York, mutane sun zarce 100,000 a ranar 3 ga Afrilu. An soki Fadar White House don rage girman barazanar da kuma sarrafa saƙon ta hanyar umarci jami'an kiwon lafiya da masana kimiyya da su daidaita wallafe-wallafen da ke da alaƙa da cutar da ofishin Mataimakin Shugaban Mike Pence.
Gabaɗaya amincewa da yadda Trump ya gudanar da rikicin ya kasance a tsakanin jam'iyyun.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayan masarufi, gami da kayan aikin likita daga China.
An yi amfani da nazarin yanayin tafiye-tafiyen jirgin sama don yin taswira da hasashen yanayin yaduwa kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Bisa ga bayanan 2018 na Ƙungiyar Jirgin Sama ta Duniya, Bangkok, Hong Kong, Tokyo da Taipei sun sami yawan matafiya da suka tashi daga Wuhan.
An kuma ba da rahoton cewa Dubai, Sydney da Melbourne sanannun wurare ne ga mutanen da suka zo daga Wuhan.
Bali an ba da rahoton cewa ita ce mafi ƙarancin iyawa a cikin shahararrun wurare 20 dangane da shiri, yayin da biranen da ke Ostiraliya aka ɗauka mafi iyawa. Ostiraliya ta ba da izinin Tsarin Amsar Gaggawa don Sabuwar Cutar Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ta bayyana cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19, kuma cewa Ostiraliya za ta jaddada kula da kan iyakoki da sadarwa a cikin amsar cutar.
A ranar 21 ga Maris, an ayyana gaggawa na lafiyar ɗan adam a Ostiraliya.
Saboda yadda ake kebe sufuri na jama'a a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasarsu da ma'aikatan diflomasiyya daga yankin, da farko ta hanyar jiragen sama da aka yi haya daga kasar da suka fito, tare da sakin hukumomin China.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand suna cikin na farko da suka fara shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta fitar da duk wani dan kasar da ya zo daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu ban da 'yan Poland hudu, da wani dan China da kuma wani dan Indiya.
'Yan kasar Poland, China da Indiya sun sauka a Poland, inda jirgin na Brazil ya tsaya kafin ya ci gaba da hanyarsa zuwa Brazil.
'Yan ƙasar Brazil da suka tafi Wuhan an killace su a wani sansanin soja kusa da Brasília.
A ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko, da 39 daga jirgin sama na biyu da gwamnatin Amurka ta yi hayar) daga Wuhan kuma aka tura su zuwa Tushen Sojan Sama na Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama tare da 'yan Kanada 185 daga Wuhan ya sauka a Tushen Sojojin Kanada na Trenton.
Hukumomin Ostiraliya sun kai 'yan ƙasa 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda daga baya aka sake amfani da shi azaman wurin keɓewa, inda suka zauna na kwanaki 14.
Jirgin sama na kwashe 'yan ƙasar New Zealand ya sauka a Auckland a ranar 5 ga Fabrairu; fasinjojinsa (gami da wasu daga Ostiraliya da Pacific) an killace su a wani sansanin jiragen ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta janye Amurkawa daga jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama tare da fasinjojin Kanada 129 da aka cire daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar ta daga Iran. A ranar 14 ga Maris jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta yi hayar ya dawo da' yan Afirka ta Kudu 112.
An gudanar da bincike na likita kafin jirgin ya tashi, kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun coronavirus don rage haɗarin.
Sai kawai 'yan Afirka ta Kudu da suka gwada ba su da lafiya.
Sakamakon gwajin ya saki dukkan 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal,' yan sanda da sojoji da ke cikin aikin jin kai waɗanda, a matsayin kariya, suka kasance a cikin kulawa da keɓewa na kwanaki 14 a Resort The Ranch.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen kasar Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin a Jami'o'in Amurka sun hada kai don taimakawa wajen aika da agaji ga bangarorin da cutar ta shafa a kasar Sin, tare da wata kungiya a yankin Greater Chicago da ta samu nasarar aika da abin rufe fuska N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar agajin jin kai ta Direct Relief, tare da hadin gwiwar FedEx, ta aika da abin rufe fuska 200,000 tare da sauran kayan kariya na mutum, gami da safar hannu da gashi, ta hanyar jigilar gaggawa ta iska zuwa Asibitin Union na Wuhan a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da kokarin magani tare da kare "mutanen da ke cikin haɗari a Afirka da Kudancin Asiya".
Interaksyon ta ruwaito cewa gwamnatin China ta ba da gudummawar masks 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 a matsayin tallafi ga kasar Sin.
Japan ta ba da takunkumi miliyan guda ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da sama da tan 13 na kayayyakin kiwon lafiya zuwa Wuhan, Malaysia ta sanar da bayar da hannayen riga na likita miliyan 18 ga China, Jamus ta ba da kayayyakin kiwon lafiya da yawa, ciki har da tufafin kariya 10,000, kuma Amurka ta ba da tan 17.8 na kayayyakin kiwon lafiya ga China kuma ta yi alkawarin ƙarin dala miliyan 100 a matsayin taimakon kuɗi ga ƙasashen da cutar ta shafa. Bayan da lamura a China suka daidaita, ƙasar ta ci gaba da aika taimako ga ƙasashe da dama da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da masana don taimakawa Italiya wajen kula da barkewar cutar Coronavirus.
Dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da kuma tufafi 60,000 zuwa Addis Ababa a Habasha don tarayyar Afirka ta rarraba.
Daga baya, ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin numfashi 5 zuwa Panama.
Ma ya kuma ba da kayan aikin likita ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da kayan gwaji da aka yi a China.
Alal misali, Spain ta karɓi kayan gwaji na Coronavirus 58,000 da aka yi da China da ƙimar daidaito na kashi 30 cikin ɗari, yayin da Netherlands ta mayar da abin rufe fuska 600,000 da ke da lahani.
Belgium ta tattara abin rufe fuska 100,000 da ba za a iya amfani da su ba, da ake zaton sun fito ne daga China, amma a zahiri sun fito ne daga Colombia.
A wani bangare kuma, an yi maraba da taimakon da kasar Sin ta bayar a sassan Latin Amurka da Afirka.
Hukumar lafiya ta duniya ta yaba wa kokarin da hukumomin kasar Sin ke yi na sarrafawa da kuma dakile annobar.
WHO ta lura da bambanci tsakanin barkewar SARS ta 2002-2004, inda aka zargi hukumomin China da yin watsi da bayanai da ke kawo cikas ga rigakafi da kokarin hanawa, da rikicin yanzu, inda gwamnatin tsakiya "ta ba da sabuntawa na yau da kullun don kauce wa firgici da ke gab da bikin sabuwar shekara ta wata".
A ranar 23 ga watan Janairu, a lokacin da manyan hukumomi suka yanke shawarar hana zirga-zirgar mutane daga Wuhan, wakilin WHO Gauden Galea ya lura cewa "ba lallai ba ne shawarar WHO ba ce" kuma "alamu ne masu mahimmanci na sadaukar da kai don dakile annobar a yankin da ta fi mayar da hankali". A ranar 30 ga Janairu, bayan tabbatar da yaduwar mutum zuwa mutum a wajen China da kuma karuwar adadin masu cutar a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiyar jama'a ta duniya (PHEIC), PHEIC na shida tun lokacin da aka fara amfani da matakin a lokacin annobar cutar zazzabin alade ta 2009.
Darakta Janar na WHO Tedros Adhanom ya ce an kira PHEIC saboda "hadarin yaduwar duniya, musamman a ƙasashe masu karamin kuɗi da matsakaitan kuɗi ba tare da ingantaccen tsarin kiwon lafiya ba.
Dangane da aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili da zai sa a ɗauki matakan da za su tsoma baki ba tare da buƙatar ba a cikin tafiye-tafiye na duniya da kasuwanci" kuma "WHO ba ta ba da shawarar iyakance kasuwanci da tafiya".
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 don tallafawa shirye-shiryen da ake yi a ƙasashe masu karamin kuɗi da matsakaitan kuɗi, tana mai cewa akwai gaggawa wajen taimaka wa waɗannan ƙasashe waɗanda "ba su da tsarin da za su iya gano mutanen da suka kamu da cutar, ko da kuwa ta taso".
Tedros ya yi jawabai daga baya yana cewa "mu masu ƙarfi ne kamar yadda rauninmu ya fi rauni" kuma ya nemi al'ummar duniya su "yi saka hannun jari yanzu ko kuma su biya daga baya". A ranar 11 ga Fabrairu, WHO a wani taron manema labarai ta kafa COVID-19 a matsayin sunan cutar.
A wannan rana, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya, António Guterres ya amince da samar da "ikon dukan tsarin Majalisar Dinkin Duniya a matsayin amsa".
An kunna Rukunin Gudanar da Rikicin Majalisar Dinkin Duniya a sakamakon haka, yana ba da damar daidaita dukkan martani na Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar "mai da hankali kan maganin kiwon lafiya yayin da sauran hukumomi za su iya shiga tare da kwarewarsu kan zamantakewar, tattalin arziki da ci gaban ci gaban da ke tattare da barkewar cutar".
A ranar 14 ga watan Fabrairu, an ba da izinin ƙungiyar WHO ta China don samar da ƙwararrun ƙwararrun ƙasashen duniya da WHO a ƙasar Sin don taimakawa wajen kula da gida da kuma tantance "tsananin cutar da yaduwar cutar" ta hanyar bita da tarurruka tare da manyan cibiyoyin matakin ƙasa da gudanar da ziyarar filin don tantance " tasirin ayyukan amsawa a lardin da ƙananan hukumomi, gami da birane da ƙauyuka". A ranar 25 ga Fabrairu, WHO ta ce "duniya ta kamata ta yi ƙarin shiri don yiwuwar cutar ta Coronavirus", ta bayyana cewa ko da yake ba da daɗewa ba za a fara cutar, ƙasashe ya kamata su fara "shirye-shiryen".
A sakamakon barkewar cutar a Iran, WHO ta tura wani rukunin aiki na hadin gwiwa don tantance lamarin. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a ɗaga kimanta barazanar Coronavirus a duniya daga "mai girma" zuwa "mai girma sosai", wanda shine matakin faɗakarwa da kimanta haɗari mafi girma.
Mike Ryan, darektan zartarwa na shirin gaggawa na kiwon lafiya, ya yi gargadi a cikin wata sanarwa cewa "Wannan sanarwa ce ta gaskiya ga kowace gwamnati a duniya: Ku farka.
Wannan kwayar cutar na iya zuwa kuma kuna buƙatar kasancewa a shirye", yana mai jaddada cewa matakan da suka dace na amsawa na iya taimaka wa duniya ta guji "mafi muni".
Ryan ya ci gaba da cewa bayanan da ake da su yanzu ba su ba jami'an kiwon lafiya izinin ayyana cutar a duniya ba, yana mai cewa irin wannan sanarwar na nufin "muna yarda da cewa kowane ɗan adam a duniya zai kamu da wannan kwayar cutar".
A ranar 11 ga watan Maris, WHO ta ayyana barkewar cutar Coronavirus a matsayin annoba.
Darakta Janar ya ce WHO tana da "tsananin damuwa game da yawan yaduwar cutar da kuma mummunan aiki, da kuma rashin aiki". WHO ta fuskanci suka da yawa saboda abin da aka gani a matsayin rashin kula da cutar, gami da jinkirin ayyana gaggawa ga lafiyar jama'a da kuma rarraba kwayar cutar a matsayin annoba.
Wannan ya hada da takardar neman shugaban hukumar lafiya ta duniya Tedros Adhanom ya ajiye aikinsa, wanda mutane dubu 733 suka sanya hannu a ranar 6 ga watan Afrilu.
A ranar 26 ga Maris, 2020, da dama daga cikin masana kare hakkin bil'adama na Majalisar Dinkin Duniya sun jaddada girmama haƙƙin kowane mutum a lokacin annobar COVID-19.
Ƙungiyar ta ce kowa yana da hakkin ya yi amfani da maganin da zai ceci ran mutane kuma gwamnati ce ke da hakkin yin hakan.
Kungiyar ta jaddada cewa rashin kudi ko tsarin kiwon lafiya bai kamata ya zama hujja ba don nuna bambanci ga wani rukuni.
Masana sun jaddada cewa kowane mutum yana da hakkin samun lafiya, gami da nakasassu, 'yan tsiraru, tsofaffi, masu tabin hankali, marasa gida, waɗanda ke rayuwa cikin matsanancin talauci, waɗanda ke cikin kurkuku, da kuma 'yan gudun hijira da sauran rukunin da ba a bayyana su ba waɗanda ke buƙatar taimakon gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin gwiwa da ci gaban tattalin arziki ta kaddamar da wani dandamali don samar da cikakken bayani a kan lokaci game da martani na siyasa a kasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya don magance tasirin kulle-kulle da ƙuntatawa na balaguro, cibiyar dijital ta haɗa da Mai Binciken Manufofin Ƙasa, wanda ke taimaka wa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen amsawar duniya ga ƙalubalen Coronavirus.
Gwamnatin China ta sha suka daga Amurka, da Ministan Ma'aikatar Burtaniya, Michael Gove, da dan shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro, saboda yadda ta gudanar da annobar, wacce ta fara a lardin Hubei na kasar Sin.
An kori wasu jami'an jam'iyyar kwaminis ta kasar Sin (CPC) a lardin saboda yadda suka tunkari kokarin killace mutane a yankin tsakiya na kasar Sin, a matsayin wata alama ta rashin jin dadin yadda jam'iyyar siyasa ta mayar da martani kan barkewar cutar a yankunan.
Wasu masu sharhi sun yi imanin cewa an yi wannan ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da barkewar cutar Coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian sun yi watsi da amincewa da cutar Coronavirus da ta fara a Wuhan, suna goyon bayan ka'idojin maƙarƙashiya game da COVID-19 da suka samo asali daga Amurka ko Italiya.
Gwamnatin Amurka ta Donald Trump ta kira Coronavirus da "Covid-19 na China" ko "Covid-19 na Wuhan" tana cewa takunkumin da China ta yi "ya kara cutar da ta zama annoba ta duniya", wanda wasu masu sukar suka yi watsi da shi a matsayin wariyar launin fata da kuma "hanyar da za a bi don kauce wa gazawar gwamnati wajen dakile cutar".
Jaridar Daily Beast ta samu daga wani jami'in gwamnatin Amurka wani cikakken tsarin sadarwa da ya samo asali daga Kwamitin Tsaro na Kasa, tare da wata dabara da aka ambata cewa "Dukkan wannan yana da alaƙa da China.
An shawarce mu da mu yi ƙoƙari mu samu waɗannan saƙonnin ta kowane hanya, har da taron manema labarai da kuma nunawa a talabijin. "Kasuwanni kamar Politico, Foreign Policy da Bloomberg sun nuna cewa ƙoƙarin da China ke yi na aika taimako ga ƙasashen da cutar ta shafa wani ɓangare ne na yaɗa labarai don samun tasiri a duniya.
Shugaban hukumar kula da harkokin wajen Tarayyar Turai Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa da ya hada da gwagwarmayar samun tasiri ta hanyar nuna ra'ayi da kuma 'siyasa mai karimci'.
Borrell ya kuma ce "China tana ta yada sakon cewa, sabanin Amurka, ita abokiyar zama ce mai dogaro da amana".
China ta kuma nemi Amurka ta dakatar da takunkumin da ta kakaba wa Syria, Venezuela da Iran, yayin da take aikawa da taimako ga wadannan kasashen.
An toshe kyautar Jack Ma na abin rufe fuska 100,000 ga Cuba ta takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amirka da karkatar da taimakon da ake ba wasu ƙasashe zuwa ƙasarsu.
Kuma an samu rahotannin jayayya game da abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da ƙari, Turkiyya ta kwace ɗaruruwan na'urorin busawa da aka yi niyyar zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin haɗin kai na Tarayyar Turai ga waɗanda cutar Coronavirus ta shafa a Italiya.
Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce "Kasar Sin ce kawai ta mayar da martani a bangare biyu.
Wannan ba alama ce mai kyau ba ta haɗin kan Turai".
A ranar 22 ga Maris, bayan kiran waya da Firayim Minista Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aika da likitocin soja, motocin kashe ƙwayoyin cuta na musamman, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi ƙaulin wani "manyan 'yan siyasa" da ba a ambata sunansu ba cewa kashi 80 cikin ɗari na kayayyakin da Rasha take kawowa "marasa amfani ne ko kuma ba su da amfani ga Italiya".
Majiyar ta zargi Rasha da fara wani "ƙaddamar da siyasa da diflomasiyya".
Shugaban yankin Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya, Luigi Di Maio sun yi watsi da rahotannin kafofin watsa labarai kuma sun nuna godiyarsu.
Rasha ta kuma tura jirgin sama dauke da kayayyakin kiwon lafiya zuwa Amurka.
Kakakin Kremlin Dmitry Peskov ya ce "a cikin bayar da taimako ga abokan aikinsa na Amurka, [Putin] ya ɗauka cewa lokacin da masana'antun Amurka na kayan aikin likita da kayan aiki ke cikin kyakkyawan yanayi, su ma za su yi aiki tare idan ya cancanta".
Aikin sojin NATO da aka shirya "Defender 2020" a Jamus, Poland da Baltic, mafi girman aikin soja na NATO tun bayan ƙarshen Cold War, za a ci gaba da ƙarami.
Babban sakatare na Kamfen na Yaki da Nukiliya, Kate Hudson, ya soki aikin Defender 2020: "A cikin rikicin kiwon lafiyar jama'a na yanzu, wannan yana sanya rayuwar ba kawai sojojin Amurka da na ƙasashen Turai da ke halarta ba, har ma da mutanen ƙasashen da suke aiki". Gwamnatin Iran ta yi fama da cutar sosai, tare da kusan mambobi goma sha biyu na majalisar da suka kamu da cutar, da kuma wasu 'yan siyasa goma sha biyar masu aiki ko tsoffin' yan siyasa.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ta jama'a ga shugabannin duniya, yana neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa na fuskantar matsaloli wajen magance barkewar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka kan Iran.
Masu nazarin siyasa sun yi hasashen cewa hakan na iya shafar damar da Donald Trump ke da ita na sake zaɓar shugaban kasa a zaɓen 2020.
Koriya ta Kudu ta soki kokarin da Japan ke yi na killace mutane bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a killace shi na makonni biyu a wuraren da gwamnati ta nada.
Da farko dai al'ummar Koriya ta Kudu sun rabu biyu game da yadda Shugaba Moon Jae-in ya amsa wannan rikici.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman tsige Moon saboda abin da suka kira rashin kula da annobar, ko kuma sun yaba da yadda ya amsa. Cutar ta ba da damar ƙasashe su zartar da dokokin gaggawa don amsawa.
Wasu masu sharhi sun nuna damuwa cewa hakan zai ba gwamnatoci damar ƙarfafa ikon su.
A Hungary, majalisa ta kada kuri'ar da ta ba Firayim Minista Viktor Orbán damar yin mulki ta hanyar doka har abada, dakatar da majalisa da kuma zabukan, da hukunta wadanda ake ganin sun yada labaran karya game da cutar da kuma yadda gwamnati ke kula da rikicin.
Cutar Coronavirus ta haifar da karancin kayayyaki da yawa, sakamakon karuwar amfani da kayan aiki a duniya don magance barkewar cutar, sayayya ta firgici, da katsewar aiki a masana'antu da kayan aiki.
Hukumar Abinci da Kula da Abinci ta Amurka ta ba da gargaɗi game da ƙarancin magunguna da kayan aikin likita saboda ƙaruwar amfani da katsewar mai ba da kaya.
Yawancin wurare sun kuma fuskanci taron cinikin firgici wanda ya haifar da ɗakunan ajiya marasa komai na kayan masarufi kamar abinci, takarda na bayan gida, ruwan kwalba, gami da ƙarancin kayayyaki.
Masana'antar fasaha musamman tana faɗakarwa game da jinkirin aika kayayyakin lantarki.
A cewar Darakta Janar na WHO Tedros Adhanom, bukatar kayan kariya ta mutum ta karu sau 100.
Wannan bukatar ta jawo farashin da ya ninka na al'ada sau ashirin kuma ta jawo jinkiri wajen samar da kayayyakin kiwon lafiya na watanni huɗu zuwa shida.
Wannan kuma ya haifar da karancin kayan kariya na mutum a duniya, tare da gargadin WHO cewa hakan zai sanya lafiyar ma'aikata cikin haɗari.
A Ostiraliya, annobar ta samar da wata sabuwar dama ga masu sayen Sinawa, da kuma sayar da kayayyakin Australiya a China.
Wannan aikin ya haifar da karancin abinci na jarirai a wasu manyan kantunan abinci kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yawan kamuwa da cutar COVID-19 a arewacin Italiya da yankin Wuhan, da kuma yawan buƙatun kayayyakin abinci, an ceci yankuna biyu daga ƙarancin abinci.
Matakan da China da Italiya suka dauka kan adana kayayyaki da cinikin kayayyaki da ba na doka ba sun yi nasara, ta yadda aka kauce wa tsananin karancin abinci da aka yi hasashen zai faru a Turai da kuma Arewacin Amirka.
Arewacin Italiya da ke da yawan amfanin gona ba ta samu raguwa sosai ba, amma farashin na iya ƙaruwa a cewar wakilan masana'antu.
An samu kantunan abinci marasa abinci na ɗan lokaci ne kawai, har ma a birnin Wuhan, kuma jami'an gwamnatin China sun saki kayan naman alade don tabbatar da wadataccen abinci ga jama'a.
Irin waɗannan dokokin suna cikin ƙasar Italiya kuma suna bukatar masu sayar da abinci su ajiye kayan abinci don irin wannan gaggawa.
An ji rauni ga tattalin arzikin duniya a China: a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin China ya sha wahala sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta ɗauka don rage yaduwar cutar, kuma tallace-tallace na tallace-tallace ya faɗi da kashi 20.5%.
Saboda babban tattalin arziki da cibiyar masana'antu ne na kasar Sin, an ga barkewar cutar a matsayin babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na sashen leken asirin jaridar The Economist ta yi hasashen cewa kasuwanni za su ci gaba da yin tashin hankali har sai an samu cikakken bayani kan sakamakon da za a samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arzikin annobar kan ci gaban duniya zai iya wuce barkewar SARS na 2002-2004.
Wani ƙwararre a Jami'ar Washington da ke St. Louis ya kimanta cewa hakan zai shafi sarkar samar da kayayyaki na duniya da ya kai dala biliyan 300 kuma zai iya wucewa na tsawon shekara biyu.
An ce kungiyar kasashen dake fitar da man fetur (OPEC) ta "karya" bayan da farashin man ya fadi kasa sakamakon karancin bukatar da kasar Sin ke yi.
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda ƙaruwar yawan masu kamuwa da COVID-19 a wajen babban yankin China.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar Coronavirus, wasu alamun kasuwancin Amurka da suka haɗa da NASDAQ-100, S&P 500, da Dow Jones masana'antar masana'antu sun nuna raguwar su mafi girma tun 2008, tare da Dow ya faɗi da maki 1,191, raguwar mafi girma a rana ɗaya tun rikicin kuɗi na 2007-08.
Sauran kasafi uku sun ƙare mako da raguwa sama da kashi 10.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta tabbatar da darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar darajar.
Hannun jari sun sake faɗuwa bisa damuwa game da cutar coronavirus, mafi girman faɗuwa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa ana iya samun koma bayan tattalin arziki.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa na jihohi da manyan bankuna.
Bankunan tsakiya suna amsawa da sauri fiye da yadda suka amsa wa matsalar kudi ta 2008.
Yawon shakatawa yana ɗaya daga cikin ɓangarorin da aka fi shafa saboda ƙuntatawa na balaguro, rufe wuraren jama'a gami da wuraren shakatawa, da shawarar gwamnatoci game da duk wani tafiya a duniya.
Sakamakon haka, yawancin kamfanonin jiragen sama sun soke zirga-zirgar su saboda karancin buƙata, gami da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin sama na Flybe na Burtaniya ya rushe.
Sakamakon da aka samu a masana'antar jirgin ruwa ya kasance mai girma sosai.
An rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Cutar ta zo daidai da Chunyun, babban lokacin tafiya da ke da alaƙa da hutun Sabuwar Shekarar Sinawa.
Gwamnatocin ƙasa da na yanki sun soke abubuwan da suka shafi taron jama'a da yawa, gami da bukukuwan Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu suna rufe shagunan su da wuraren yawon buɗe ido kamar Disneyland a Hong Kong da Shanghai.
Yawancin abubuwan da suka faru na Sabuwar Shekarar Lunar da wuraren yawon bude ido an rufe su don kauce wa taron jama'a, gami da Haramtaccen Birni a Beijing da al'adun gargajiya na haikalin.
A larduna 24, da kananan hukumomi da yankuna 31 na kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara zuwa ranar 10 ga watan Fabrairu, suna umurtar yawancin wuraren aiki da kada su sake buɗewa har zuwa wannan ranar.
Waɗannan yankuna sun kai kashi 80 cikin ɗari na GDP na ƙasar da kuma kashi 90 cikin ɗari na fitar da kayayyaki.
Hong Kong ta kara matakinta na mayar da martani ga cutar zuwa matakin da ya fi girma kuma ta ayyana gaggawa, ta rufe makarantu har zuwa watan Maris da kuma soke bikin Sabuwar Shekara. An shafi sashin sayar da kayayyaki a duniya, tare da rage lokutan shaguna ko rufewa na wucin gadi.
Ziyarar dillalai a Turai da Latin Amirka ta ragu da kashi 40 cikin ɗari.
Masu sayar da kayayyaki a Arewacin Amirka da Gabas ta Tsakiya sun ga raguwar kashi 50 zuwa 60 cikin ɗari.
Wannan kuma ya haifar da raguwar 33-43% a cikin zirga-zirgar ƙafa zuwa cibiyoyin kasuwanci a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin cin kasuwa a duniya sun ɗora ƙarin matakan kamar tsaftacewa, sanya na'urorin duba zafin jiki don bincika zafin jiki na masu siye, da soke abubuwan da suka faru. A cewar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, an kiyasta cewa koma bayan tattalin arziki da annobar ta haifar na iya barin tsakanin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda zai faru a cikin yanayin da babu annobar.
A watan Janairu da Fabrairu na 2020, a lokacin da annobar ta kai kololuwa a Wuhan, mutane kusan miliyan biyar a China sun rasa ayyukansu.
Yawancin ma'aikatan karkara miliyan 300 na China sun bar gida a lardunan cikin gida ko kuma an tsare su a lardin Hubei. A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar Coronavirus na iya kashe ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32%, a cewar kimantawar Babban Bankin Tarayya na St. Louis. Kulle a Indiya ya bar miliyoyin ma'aikatan Indiya masu ƙaura (waɗanda ake biyan su ta hanyar albashi na yau da kullun) ba tare da aiki ba. Binciken Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai na Kanada sun sami wasu nau'ikan rashin aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da ƙasar ta ɗauki kulle a tsakiyar Maris 2020.
A cikin mako na biyu na watan Maris, ma'aikata miliyan 4 na Faransa sun nemi taimakon rashin aikin yi, kuma ma'aikata miliyan 1 na Birtaniya sun nemi shirin bashi na kowa.
An yi amfani da tsarin biyan albashi na Jamus na aikin lokaci na ɗan lokaci a Faransa da Birtaniya.
Masana'antar wasan kwaikwayo da al'adun gargajiya sun sami mummunan tasiri ta hanyar cutar, yana shafar ayyukan ƙungiyoyi da mutane - duka ma'aikata da masu zaman kansu - a duk duniya.
Kungiyoyin al'adu da al'adu sun yi ƙoƙarin ci gaba da aikinsu (sau da yawa ana tallafawa jama'a) don samar da damar samun kayan al'adu ga al'umma, kiyaye lafiyar ma'aikatan su da jama'a, da kuma taimaka wa masu fasaha a duk lokacin da zai yiwu.
A watan Maris na 2020, a duk duniya da kuma a matakai daban-daban, an rufe gidajen tarihi, shagunan littattafai, wuraren wasan kwaikwayo, da sauran cibiyoyin al'adu har abada tare da soke ko jinkirta baje kolin su, abubuwan da suka faru da wasan kwaikwayon.
A sakamakon haka, an yi ƙoƙari sosai don samar da madadin sabis ta hanyar dandamali na dijital. Wani sakamako na kwanan nan da kuma saurin cutar shine soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewar jama'a kamar bukukuwa da kide kide da wake-wake, taron fasaha da al'amuran zamani.
Har ila yau, masana'antar fim sun yi sanyin gwiwa sa'ad da Vatican ta sanar da cewa an soke bukukuwan mako mai tsarki a Roma, da za a yi a mako na ƙarshe na lokacin azumin Kirista.
Yawancin majami'u sun ba da shawarar tsofaffi Kiristoci su zauna a gida maimakon halartar Mass a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, watsa shirye-shiryen kan layi ko talabijin yayin da wasu ke ba da sabis na gidan mota.
Da Ikklesiya ta Katolika ta Roma ta rufe majami'unsu da ɗakunan sujada kuma St. Peter's Square ba shi da Kiristoci masu bautar Kirista, sauran ƙungiyoyin addini sun soke ayyukan kuma sun iyakance taron jama'a a majami'u, masallatai, majami'u, haikalin da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma daga baya an rufe wuraren ibada, yayin da Saudiyya ta hana shiga mahajjata na kasashen waje da mazaunansu daga wuraren tsarki a Makka da Madina.
Cutar ta haifar da babbar katsewa a kalandar wasanni ta duniya tun bayan Yaƙin Duniya na Biyu.
Yawancin manyan abubuwan da suka faru an soke su ko kuma an jinkirta su, gami da gasar zakarun Turai ta 2019-2020, gasar Premier ta 2019-2020, kakar NBA ta 2019-2020, da kakar NHL ta 2019-20.[1]
Cutar ta tsoma baki tare da tsare-tsaren wasannin Olympics na bazara na 2020, wanda aka shirya fara a ƙarshen Yuli; Kwamitin Olympics na Duniya ya ba da sanarwar a ranar 24 ga Maris cewa za a "sake shirya taron zuwa wani lokaci bayan 2020, amma ba bayan bazara na 2021 ba".
Wannan ya sa yawancin 'yan wasa suka yi caca ta yanar gizo, tare da shafukan yanar gizo da yawa suna ba da rahoton ƙaruwa mai yawa a cikin sababbin rajistar su.
Ƙari ga haka, manyan gidajen wasan kwaikwayo kamar na Broadway sun soke dukan wasan kwaikwayon.
Wasu masu fasaha sun binciko hanyoyin da za su ci gaba da samarwa da kuma raba aikin su a kan intanet a matsayin madadin ga al'adun gargajiya na rayuwa, kamar wasan kwaikwayo na rayuwa ko ƙirƙirar "bikin" na kan layi don masu fasaha su gabatar da kansu, su raba da kuma yada aikin su.
A kan layi, ana yada labarai da yawa game da cutar coronavirus a cikin yanar gizo, yayin da mutane da yawa ke neman raha da nishaɗi a cikin rashin tabbas.
Tun barkewar COVID-19, an ga ƙaruwar nuna bambanci, ƙin baƙi da wariyar launin fata ga mutanen da ke da asalin ƙasar Sin ko Gabashin Asiya, da kuma mutanen da ke cikin yankunan da aka fi mayar da hankali a Turai, Amurka da sauran ƙasashe.
An lura da tsoro, rashin amincewa, da ƙiyayya a ƙasashe da yawa, musamman a Turai, gabashin Asiya, Arewacin Amirka, da yankin Asiya Pacific.
Sakamakon watan Fabrairu (lokacin da yawancin masu cutar ke cikin kasar Sin) ya nuna cewa akwai wasu kungiyoyi a duniya da ke nuna nuna wariyar launin fata game da mutanen China da suka cancanci kamuwa da cutar ko kuma za a hukunta su saboda abin da suka yi.
Wasu ƙasashe a Afirka sun kuma lura da ƙaruwar ƙiyayya da China.
Mutane da yawa a Wuhan da Hubei sun ba da rahoton nuna bambanci bisa asalin yankin.
Wannan ya samu goyon baya daga Sinawa, a kan layi da wajen layi, kuma an yi niyyar kai wa mutanen da ke yankunan da cutar ta shafa.
Bayan barkewar cutar a wasu ƙasashe, 'yan ƙasar Italiya, ƙasa ta farko a Turai da ta fara fuskantar mummunan barkewar COVID-19, suma za su iya fuskantar rashin amincewa da ƙiyayya. 'Yan ƙasa daga ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore da Koriya ta Kudu da farko sun sanya hannu kan takardun neman izinin hana Sinawa shiga ƙasashensu, a ƙoƙarin hana cutar.
A Japan, hashtag #ChineseDontComeToJapan ya shiga cikin abubuwan da ke faruwa a Twitter.
Jama'ar kasar Sin, da sauran mutanen Asiya a Burtaniya da Amurka, sun ba da rahoton karuwar cin mutuncin wariyar launin fata da kuma hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ya kira coronavirus "kwayar cutar China", kalmar da masu sukar suka dauka wariyar launin fata ce da kuma adawa da kasar Sin.
Masu zanga-zanga a Ukraine sun kai hari kan bas din da ke dauke da 'yan Ukraine da kasashen waje da aka kwashe daga Wuhan zuwa Novi Sanzhary.
Dalibai daga arewa maso gabashin Indiya, wanda ke iyaka da China, da ɗalibai a manyan biranen Indiya an ce sun sha wahala saboda cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal, Dilip Ghosh, ya ce Sinawa sun lalata yanayi kuma "wannan shine dalilin da yasa Allah ya juya musu baya".
Bayan haka, ofishin jakadancin China da ke Calcutta ya yi tir da maganganun, wanda ya kira shi "rashin gaskiya". A China, cutar ta kara da nuna kyamar baki da wariyar launin fata ga mutanen da ba Sinawa ba, tare da kiran baƙi "sharar waje" da kuma "ƙarar" manufa.
Jaridu da yawa da ke da damar shiga sun cire su daga wasu ko duk labaran da suka shafi cutar coronavirus.
Yawancin masu wallafa kimiyya sun samar da takardun kimiyya da suka shafi barkewar cutar a cikin budewa.
Wasu masana kimiyya sun zaɓi su raba binciken su da wuri-wuri a kan sabobin shirye-shiryen, kamar bioRxiv.
Cutar cututtuka mai tasowa  Cutar cututtuka daga cututtukan cututtuka masu tasowa, sau da yawa ba a taɓa gani ba game da yadda cutar ta ɓarke ko yadda ake watsawa
Duniya da cututtuka  Bayani kan duniya da kuma yaduwar cuta
Jerin cututtuka da annoba  Jerin yawan mutuwar cututtuka
Cinikin namun daji da cututtukan dabbobi  Hadarin kiwon lafiya da ke tattare da cinikin namun daji na waje
Gwajin gwaji don cutar coronavirus ta numfashi ta 2019 (COVID-19) da kuma cutar SARS - CoV-2 da ke hade sun haɗa da hanyoyin da ke gano kasancewar kwayar cutar da waɗanda ke gano ƙwayoyin cuta da aka samar don amsa kamuwa da cuta.
Ana tabbatar da kasancewar kwayar cutar a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne kawai don gano RNA na kwayar SARS-CoV-2.
Ana amfani dashi don tabbatar da cututtuka na kwanan nan ko masu aiki.
Ana iya amfani da ganowar ƙwayoyin cuta (sorology) don ganewar asali da kuma lura da yawan jama'a.
Gwaje-gwajen rigakafi suna nuna yawan mutanen da suka kamu da cutar, har da waɗanda alamun cutar ba su da tsanani sosai ko kuma waɗanda ba su da alamun cutar.
Za a iya ƙayyade ƙimar mutuwar cutar da matakin rigakafin garken a cikin yawan daga sakamakon wannan gwajin.
Saboda iyakancewar gwaji, a watan Maris na 2020, babu wata ƙasa da ke da tabbaci game da yaduwar cutar a cikin jama'arta.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma akwai bambance-bambance masu yawa a yawan gwajin da aka yi a ƙasashe.
Wannan bambancin na iya shafar yawan mutuwar mutane da aka samu, wanda zai iya zama mai yawa a wasu ƙasashe.
Ta amfani da ainihin lokacin juyawa na juyawa na polymerase chain reaction (rRT-PCR), ana iya yin gwajin akan samfurori na numfashi da aka samo ta hanyoyi daban-daban, ciki har da shafawa daga nasopharynx ko samfurin ƙura.
Sakamakon zai kasance cikin sa'o'i kadan ko cikin kwanaki biyu.
Gwajin RT-PCR da aka yi tare da shafawar farji yana da tabbaci ne kawai a makon farko na cutar.
Daga baya, kwayar cutar za ta iya ɓacewa a cikin makogwaro yayin da take ci gaba da yawaita a cikin huhu.
Don mutane masu kamuwa da cutar da aka gwada a mako na biyu, a madadin haka, ana iya cire kayan samfurin daga cikin ƙananan iska ta hanyar bututun tsotsa ko kuma ana iya amfani da kayan da aka fitar ta hanyar fitarwa (saki).
An haɓaka ɗayan gwajin PCR na farko a Charité, Berlin a cikin Janairu 2020 ta amfani da ainihin lokacin jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju
Ƙasar Ingila ta kuma ƙaddamar da gwaji a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya ƙaddamar da wani nau'in asibiti, kayan aikin gano SARS-CoV-2 na PCR (PowerCheck Coronavirus) a ranar 28 ga Janairu, 2020.
Yana neman kwayar halitta "E" da dukkan beta-coronavirus ke da ita, da kuma kwayar halitta ta RdRp, wacce ta dace da SARS-CoV-2. A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami amincewar gaggawa daga Hukumar Kula da Magunguna ta China don kayan aikin gano SARS-CoV-2 na PCR. A Amurka, Cibiyar Kula da Cututtuka da Cututtuka (CDC) tana rarraba sabbin kayan aikin bincikenta na Coronavirus (2019-nCoV) na RT-PCR na ainihi ga dakunan gwaje-gwajen kiwon lafiya ta hanyar Reagent Resource International.
Daya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin nau'ikan kayan gwajin ya haifar da gwaje-gwaje marasa kyau saboda abubuwan da ke cikin lalacewa, da kuma hana gwaji a CDC a Atlanta; wannan ya haifar da matsakaita ƙasa da samfuran 100 a kowace rana ana aiwatar da su cikin nasara a cikin watan Fabrairu 2020.
Gwaje-gwajen da ke amfani da abubuwa biyu ba a amince da su ba har zuwa 28 ga Fabrairu, 2020, kuma sai bayan haka ne aka ba da izinin dakunan gwaje-gwaje na gida da na jihar su fara gwaji.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin amfani da gaggawa.
Tun daga ranar 5 ga Maris, 2020, LabCorp ta sanar da samun gwajin COVID-19 na RT-PCR a duk ƙasar.
Quest Diagnostics ta kuma samar da gwajin COVID-19 a duk ƙasar daga 9 ga Maris, 2020.
Babu ƙuntatawa na yawa da aka sanar; dole ne a tattara da sarrafa samfuran daidai da bukatun CDC.
A Rasha, Cibiyar Nazarin Jihar kan Virology da Biotechnology, VECTOR ce ta haɓaka da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, Mayo Clinic ta ce ta haɓaka gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya gudanarwa cikin awanni 3.5 a cikin babban sikelin, don haka yana ba da damar inji ɗaya don aiwatar da gwaje-gwaje kusan 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin Amfani da Gaggawa (Amurka) ga Labs na Abbott don gwaji a cikin Abbott's m2000 system; FDA ta ba da izini ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta kuma sami US FDA don gwaji wanda ke ɗaukar kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar isothermal nucleic acid amplification maimakon PCR.
Tun da yake ba ya bukatar sake zagayowar zafin jiki, wannan hanyar tana iya ba da sakamako mai kyau cikin minti biyar kawai kuma sakamako mara kyau cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan injunan a Amurka kuma Abbott na fatan haɓaka samarwa don samar da gwaje-gwaje 50,000 a kowace rana. Ana haɓaka gwaji wanda ke amfani da kwayar cutar monoclonal kuma yana ɗaure ta musamman ga furotin nucleocapsid (furotin N) na sabon coronavirus a Taiwan, tare da tsammanin samar da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin saurin mura.
Wani bita na wallafe-wallafen a watan Maris na 2020 ya kammala cewa "hotunan kirji suna da ƙarancin kimantawa a farkon matakan, yayin da binciken CT na iya kasancewa tun kafin bayyanar cututtuka".
Hanyoyin da suka dace a CT sun haɗa da ƙananan ƙananan hanyoyi a cikin gilashin da ke da mahimmanci tare da rarraba baya, gefe da kuma asymmetrical.
Ƙarƙashin ƙwayar cuta, ƙuƙwalwar ƙwayar cuta, da kuma ƙarfafawa suna ci gaba yayin da cutar ta ci gaba.
Wani bincike da ya kwatanta PCR da CT a Wuhan a asalin cutar ta yanzu ya nuna cewa CT ya fi PCR hankali sosai, kodayake ba shi da takamaiman bayani, tare da yawancin fasalolin hotonta da suka dace da sauran ciwon huhu da hanyoyin cututtuka.
Tun daga watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "bai kamata a yi amfani da CT don tantancewa ko azaman gwajin farko don gano COVID-19 ba". Tun daga watan Maris na 2020, CDC ta ba da shawarar PCR don gwaji na farko.
Wani ɓangare na maganin rigakafi na kamuwa da cuta shine samar da ƙwayoyin cuta ciki har da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutane da suka fara kwanaki 7 ko jim kaɗan bayan bayyanar cututtuka, don ƙayyade rigakafi, da kuma lura da yawan jama'a. Ana iya yin gwaje-gwaje a cikin cibiyoyin bincike na tsakiya (CLT) ko ta hanyar gwaje-gwajen gwaje-gwaje na nesa (PoCT).
Tsarin sarrafa kansa mai inganci a yawancin dakunan gwaje-gwaje na asibiti zai iya yin waɗannan gwaje-gwajen, amma kasancewarsu zai dogara da yawan samar da kowane tsarin.
Don CLT, ana amfani da samfurin jini guda ɗaya, kodayake ana iya amfani da samfurori da yawa don bin tsarin rigakafi.
Don PoCT, ana yawan samun samfurin jini guda ɗaya ta hanyar bugun jini.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin tattarawa kafin gwaji. A ranar 26 ga Maris, 2020, FDA ta nuna ƙungiyoyi 29 waɗanda suka sanar da hukumar kamar yadda aka buƙata, kuma daga yanzu suna iya rarraba gwajin rigakafin su.
Tun daga 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai tare da izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, waɗanda za su iya gano ƙwayoyin IgG da IgA ga kwayar cutar a cikin samfuran jini.
Ana iya gwada ɗaruruwan samfurori a cikin awanni kaɗan kuma saboda haka ya fi saurin gwajin PCR na RNA na kwayar cuta.
Ana yawan gano ƙwayoyin cuta bayan kwanaki 14 bayan kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta yi la'akari da cewa babu ɗayan kayan gwajin ƙwayoyin cuta da aka saya da suka dace don amfani.
Hong Kong ta shirya tsarin da marasa lafiya masu zargi za su iya zama a gida, "sashen gaggawa zai ba da bututun samfurin ga mai haƙuri", dole ne su zubar da haushi a cikin bututun, su dawo da shi kuma su sami sakamako jim kaɗan bayan haka. NHS na Burtaniya ta sanar da cewa tana daidaita tsarin don gwada masu cutar a gida, wanda ke kawar da haɗarin mai haƙuri ya kamu da wasu idan sun je asibiti ko buƙatar kashe ambulan idan an yi amfani da su. A cikin gwajin tuki don COVID-19 a cikin masu cutar da ake zargi, ƙwararren masaniyar tattara samfuran suna ɗaukar matakan kariya.
Cibiyoyin tuki sun taimaka wa Koriya ta Kudu don yin wasu gwaje-gwaje masu sauri da kuma cikakke a cikin ƙasa.A Jamus, Ƙungiyar Likitocin Kula da Lafiya ta Ƙasa ta ce a ranar 2 ga Maris tana da damar yin gwaje-gwaje kusan 12,000 a kowace rana a asibiti, tare da 10,700 da aka gwada a makon da ya gabata.
Ana biyan kuɗin idan likita ya ba da umurnin yin gwajin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da ƙarfin gwaji 160,000 a mako.
Tun daga ranar 19 ga Maris, an yi gwajin mota a manyan birane da yawa.
Tun daga ranar 26 ga Maris, 2020, ba a san yawan gwajin da aka yi a Jamus ba, saboda gwajin da aka yi ne kawai aka rubuta.
Cibiyar bincike ta farko ta bayyana cewa tun daga mako na 12 na 2020 an gwada aƙalla samfura 483,295 har zuwa mako na 12 na 2020 kuma samfura 33,491 (6.9%) sun gwada tabbatacce ga SARS-CoV-2. A Isra'ila, masu bincike a asibitocin Technion da Rambam sun haɓaka da gwada hanyar gwada samfuran marasa lafiya 64 a lokaci guda, tattara samfuran da yin ƙarin gwaje-gwaje kawai idan samfurin da aka haɗa ya zama tabbatacce. A Wuhan, an buɗe dakin gwaje-gwaje na kayan aiki na 2000m2 don gano gaggawa da ake kira "Huo-Yan" (Cinese: 火眼, ko "Fire Eye" a Turanci) a ranar 5 ga Fabrairu, 2020 ta BGI, wanda zai iya sarrafa samfuran sama da 10,000 a kowace rana.
Tare da ginin da mai kafa BGI, Wang Jian ya kula da shi kuma ya ɗauki kwanaki 5, ƙirar ta nuna cewa ƙwayoyin cuta a Hubei za su kasance da kashi 47 cikin ɗari kuma kuɗin da ya dace don magance keɓewa zai ninka sau biyu idan wannan ƙarfin gwajin ba shi da damar shiga kan layi.
An bi sahun dakin gwaje-gwaje na Wuhan da sauri ta hanyar dakin gwaje-gwaje na Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, a jimillar birane 12 a duk faɗin China.
A ranar 4 ga Maris, 2020, jimlar yawan gwajin yau da kullun ya kai 50,000 a kowace rana. An ƙaddamar da samfuran buɗe tushen da Origami Assays ya fitar don iya gwada samfurori har zuwa 1,122 na marasa lafiya don COVID-19, ta amfani da gwaji 93 kawai. Waɗannan samfuran daidaitaccen za a iya gudanar da su a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar masu sarrafa robotic don ruwa ba.
A watan Maris, ƙarancin ko ƙarancin kayan aiki ya zama abin ƙyama ga gwaji mai yawa a Tarayyar Turai, Burtaniya da Amurka.
Wannan ya sa wasu marubuta suyi nazarin tsarin shirya samfurin wanda ya shafi dumama samfuran zuwa 98 °C (208 °F) na mintuna 5 don sakin kwayoyin halittar RNA don ƙarin gwaji.A ranar 31 ga Maris, an bayyana cewa UAE yanzu tana yin ƙarin gwaji a kowane mutum a cikin yawanta don Coronavirus fiye da sauran ƙasashe, kuma suna kan hanyar haɓaka matakin gwaji da isa ga yawancin jama'a.
Wannan ya faru ne ta hanyar haɗuwa da damar tuki, da kuma sayen dakin gwaje-gwaje don sarrafawa mai yawa daga Kungiyar 42 da BGI (wanda aka yi wahayi zuwa gare ta daga dakin gwaje-gwaje na gaggawa "Huo-Yan" a China).
An gina shi cikin kwanaki 14, dakin gwaje-gwajen yana iya yin dubun dubatan gwaje-gwaje na RT-PCR a kowace rana kuma shine na farko a duniya a wannan sikelin da ke aiki a wajen China.
An samar da hanyoyin gwaji daban-daban da suka shafi abubuwa daban-daban na kwayar halittar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta bi tsarin Jamus wajen yin kayayyakin da ake tura wa ƙasashen da ba su da kuɗi sosai.
An bayyana hanyar Jamus a ranar 17 ga Janairun 2020; yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta haɓaka ba ta samuwa ba har zuwa 28 ga Janairu, an sami jinkiri a cikin gwaje-gwajen da aka samar wa Amurka da China da Amurka sun fuskanci matsaloli game da amincin kayan gwajin a farkon barkewar cutar, ƙari kuma, waɗannan ƙasashe tare da Ostiraliya ba su iya samar da isassun kayan aikin don biyan buƙata da shawarwarin gwaji da ƙwararrun likitoci suka yi ba.
A akasin wannan, masana sun ce yawan shirye-shiryen gwajin da Koriya ta Kudu ta yi ya taimaka wajen rage yaduwar sabon coronavirus.
Ƙarfin gwaji, galibi a cikin dakunan gwaje-gwaje na kamfanoni masu zaman kansu, an kafa su tsawon shekaru da yawa ta gwamnatin Koriya ta Kudu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta nuna ƙarfafa shirye-shiryen gwaji a matsayin hanya mafi kyau don rage ci gaban cutar COVID-19. Babban buƙatar gwaji saboda yaduwar kwayar cutar ya haifar da jinkirin dubban daruruwan gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma samar da kayan kwalliya da kayan aikin sinadarai ya shafa.
A watan Maris na 2020, China ta ba da rahoton matsaloli tare da daidaito a cikin kayan gwajinta.
A Amurka, kayan gwajin da CDC ta haɓaka sun nuna "raunuka"; don haka gwamnati ta cire shingen da ke hana gwajin masu zaman kansu.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba zai iya zama sakamakon rashin nasarar tattara samfur ko kuma rashin amfani da kayan aiki.
Ministan Spain ya ce zai soke kayan aikin da suka samar da sakamakon da ba daidai ba kuma ya maye gurbin su da wani kayan gwaji daban wanda Shenzhen Bioeasy ya samar. 80% na kayan gwajin da Jamhuriyar Czech ta saya daga China sun samar da sakamakon da ba daidai ba. Slovakia ta sayi kayan gwaji miliyan 1.2 daga China da aka ɗauka ba daidai ba.
Firayim Minista Matovic ya ba da shawarar cewa za a zubar da su a cikin Danube. Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin Turkiyya da aka saya daga China suna da "babban kuskuren kuskure" kuma ba zai "yi amfani da su ba".
Gwajin, sannan keɓe waɗanda suka gwada tabbatacce da kuma lura da waɗanda waɗanda ke da SARS-CoV-2 sun haɗu da su, sun sami sakamako mai kyau.
Masu bincike a birnin Vò na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun yi gwaje-gwaje biyu na mutane kusan 3,400, a tsakanin kwanaki goma.
Kimanin rabin mutanen da suka kamu da cutar ba su da wata alama, kuma an killace duk waɗanda aka gano.
Da yake an hana mutane zuwa unguwar, hakan ya kawar da sababbin cututtuka.
Tare da sa ido sosai kan tuntuɓar mutane, ƙuntatawa na balaguro zuwa ƙasar, gwaji da keɓewa, annobar coronavirus a 2020 a Singapore ta ci gaba a hankali fiye da sauran ƙasashe masu tasowa, kuma ba tare da tsauraran matakai kamar rufe gidajen abinci da wuraren sayar da kayayyaki ba.
An soke abubuwa da yawa, kuma Singapore ta fara ba da shawara sosai ga mazauna su zauna a gida a ranar 28 ga Maris, amma an sake buɗe makarantu a lokacin da aka tsara bayan hutu a ranar 23 ga Maris.
Ƙasashe da yawa sun gudanar da annobar ta hanyar sa ido sosai kan waɗanda suka yi hulɗa da su, da ƙuntatawa kan balaguro zuwa ƙasar, gwaji da keɓewa, amma ba su yi hakan ba, kamar Iceland da Koriya ta Kudu.
Wani bincike ya nuna cewa ƙasashen da suka yi ƙarin gwaji, dangane da yawan mutanen da suka mutu, sun fi samun ƙananan mace-mace, wataƙila domin waɗannan ƙasashe sun fi iya gano waɗanda ba su da alamun cutar ko kuma ba su da alamun cutar.
WHO ta ba da shawarar cewa ƙasashe da ba su da ƙarfin gwaji kuma suna da dakunan gwaje-gwaje na ƙasa waɗanda ke da ƙarancin ƙwarewa a cikin COVID-19 su aika da samfuran su biyar na farko masu kyau da samfuran su goma na farko marasa kyau zuwa ɗayan dakunan gwaje-gwaje 16 na WHO don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amurka, ɗaya kuma a Ostiraliya.
A cikin teburin da ke ƙasa, shafi na "Abubuwan da suka nuna inganci a cikin kashi na gwaji" yana da tasiri ga manufofin gwaji na ƙasashe.
Kasar da ke gwada mutanen da ke asibiti kawai za ta sami kashi mafi girma na gwajin da ya dace fiye da ƙasa da ta gwada dukkan 'yan ƙasa, ko suna da alamomi ko a'a, sauran halaye daidai suke.
Wanke hannu (ko tsabtace hannu), wanda aka fi sani da tsabtace hannu, shine aikin wanke hannu don cire datti, mai, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
Wanke hannaye da sabulu a kai a kai a wasu "lokaci masu muhimmanci" a rana yana hana yaduwar cututtuka da yawa, kamar su zawo da kwalara, da ake yaduwa ta hanyar baki da ƙura.
Mutane kuma suna iya kamuwa da cututtukan numfashi kamar mura ko sanyi, misali idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hancinsu ko bakinsu (wato, mucous membranes).
Abubuwa biyar masu muhimmanci a rana da wanke hannu da sabulu ke da muhimmanci sun haɗa da: kafin da bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan bayan
Idan sabulu da ruwa ba su da yawa, za a iya wanke hannaye da toka.
Kafin, lokacin da kuma bayan ka shirya abinci.
Kafin ka kula da marar lafiya da kuma bayan ka kula da shi.
Bayan ka canja diapers ko kuma ka share bayan yaro ya yi amfani da bayan gida.
Bayan ka hura hanci, ka yi tari ko kuma ka yi fitsari.
Bayan ya taɓa dabba, abinci ko ƙura.
Tsabtace hannu na asibiti yana nufin ayyukan tsabtace jiki da suka shafi hanyoyin likita.
Wanke hannu kafin a ba da magani ko kulawar likita zai iya hana ko rage yaduwar cututtuka.
Babban manufar wanke hannu shine tsabtace hannaye daga ƙwayoyin cuta (ƙwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cuta) da sunadarai waɗanda zasu iya haifar da lahani ko cuta.
Wannan yana da muhimmanci musamman ga mutanen da suke kula da abinci ko kuma waɗanda suke aikin likita, amma kuma yana da muhimmanci ga jama'a.
Wanke hannu yana da fa'idodi da yawa ga lafiya, gami da rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan cututtukan gudawa; rage cututtukan numfashi;
kuma rage yawan mutuwar yara a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa yin wanke hannu sosai zai iya sa yara 'yan kasa da shekara biyar su yi girma sosai.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara daga zawo da cututtukan numfashi ta wajen canja halayen mutane kamar wanke hannaye da sabulu.
Wannan matakin zai iya rage mutuwar mutane kusan kashi hamsin.
Yin wanke hannu zai iya rage yawan zazzabin ciki da kashi ɗaya cikin uku, wanda ya yi daidai da samar da ruwa mai tsafta a wuraren da ake bukatarsa.
48% na raguwar cututtukan gudawa na iya kasancewa tare da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da tsada don hana gudawa da cututtukan numfashi mai saurin kamuwa da cuta (IRA), kamar yadda ake yi a gidaje, makarantu, da al'ummomi a duk duniya.
Ciwon huhu, babban ciwon huhu, shi ne sanadin mutuwa mafi yawa a cikin yara 'yan ƙasa da shekara biyar, yana kashe yara miliyan 1.8 a kowace shekara.
Ciwon amai da gudawa da kuma ciwon huhu suna kashe yara kusan miliyan 3.5 kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan yin wanka zai iya ceton rayuka fiye da allurar rigakafi ko kuma maganin likita, yana rage mutuwar masu zazzaɓin jini da kusan rabi kuma ya rage mutuwar masu kamuwa da cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana yawan haɗa wanke hannu da sauran ayyukan kiwon lafiya a matsayin ɓangare na shirye-shiryen ruwa, tsaftacewa da tsaftacewa (WASH).
Wanke hannu yana kuma kāre mu daga cutar da ake samu ta wurin taɓa jiki.
Wani mummunar sakamako na wanke hannu shine cewa wanke hannu sau da yawa na iya haifar da rauni a fata saboda bushewar fata.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu zai iya sa a yi fata da kuma fushin fata da ake kira eczema ko kuma cututtukan hannu, wanda ya fi yawa a tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin yawan wanke hannu a matsayin wata alama ta cuta ta obsessive-compulsive disorder (OCD).
Akwai muhimman lokuta guda biyar a rana da wanke hannu da sabulu ke da muhimmanci wajen rage yaduwar cututtuka ta hanyar bargo: bayan amfani da bayan gida (yin fitsari, bayan bayan gida), bayan share bayan yaro (canza diapers), kafin ciyar da yaro, kafin cin abinci da kafin/bayan shirya abinci ko sarrafa nama, kifi ko kaza.
Sauran yanayi da ya kamata a yi amfani da hanyoyin wanke hannu da suka dace don hana yaduwar cututtuka sun haɗa da kafin da kuma bayan kula da rauni ko rauni; bayan yin fitsari, tari ko hura hanci; bayan taɓa ƙurar dabbobi ko dabbobi; da kuma bayan taɓa shara.
A ƙasashe da yawa, ana wanke hannu da sabulu sosai.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa, a matsakaita, kashi 38.7% na iyalai suna da al'adar wanke hannu da sabulu. Wani binciken da aka yi a shekarar 2014 ya nuna cewa Saudiyya tana da mafi girman kashi 97 cikin dari; Amurka tana kusa da matsakaita da kashi 77 cikin dari; da kuma China tare da mafi karancin kashi 23 cikin dari. Yawancin hanyoyin da za a canza halayyar yanzu suna wanzu don kara karbuwa game da al'adar wanke hannu da sabulu a lokuta masu mahimmanci.
Shirin "Mafi Muhimman Ayyukan Kiwon Lafiya" da Ma'aikatar Ilimi ta Philippines ta aiwatar misali ne na wani babban aiki na inganta lafiyar yara da iliminsu.
Aikin kashe kwari sau biyu a shekara, tare da wanke hannaye da sabulu a kullum, da kuma goge hakora da fluoride a kullum, su ne ainihin abin da wannan shirin na ƙasa ya ƙunsa.
An kuma yi nasarar aiwatar da shi a Indonesia.
Ana ƙara cire ƙwayoyin cuta daga fata ta hanyar ƙara sabulu da kayan wanki zuwa ruwa.
Babban aikin sabulu da kayan wanki shine rage shinge ga bayani, da kuma kara narkewa.
Ruwa kaɗai ba ya sa fata ta yi tsafta domin kitse da furotin da ke cikin ƙazantar da ke cikin jiki ba sa narkewa cikin ruwa.
Amma, ana iya yin tsabtace ta da ruwa mai yawa.
Sabulu mai yaduwa, saboda yanayin sake amfani da shi, na iya riƙe ƙwayoyin cuta da suka tara daga amfani da su a baya.
Ƙananan nazarin da suka bincika ƙwayar cuta daga sabulu da ke cikin mashaya da aka ƙazantar sun kammala cewa ba za a iya yaduwa ba domin ana wanke ƙwayoyin cuta da kumfa.
Hukumar CDC ta sake cewa "sabulu mai ruwa tare da umarnin atomatik don sashin magani ya fi dacewa".
An yi amfani da sabulu na ƙwayoyin cuta sosai don ya taimaka wa mutane su san lafiyarsu.
Har zuwa yanzu, babu wata alama da ke nuna cewa amfani da maganin kashe ƙwari ko kuma maganin kashe ƙwari da aka ba da shawarar zai iya haifar da zaɓin ƙwayoyin cuta masu jurewa a cikin yanayi.
Duk da haka, sabulu na antibacterial yana dauke da magungunan antibacterial na yau da kullun, kamar triclosan, wanda ke da jerin kwayoyin cuta masu jurewa.
Saboda haka, ko da yake sabulu na ƙwayoyin cuta ba sa iya kawar da ƙwayoyin cuta, amma ƙwayoyin cuta ba su da tasiri sosai kamar yadda ake faɗa.
Baya ga masu amfani da fata da kuma masu kare fata, ƙwararrun ƙwayoyi na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai kula da pH, benzoic acid mai aiki da antimicrobial, da sauran kayan shafawa na fata (aloe vera, bitamin, menthol, tsire-tsire masu tsire-tsire).
Ruwan zafi da ke da kyau don wanke hannu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin cutar suna girma da sauri a zafin jiki (37 oC).
Amma, ruwan zafi da sabulu ya fi ruwan sanyi da sabulu kyau wajen kawar da mai da ke cikin jiki da ke riƙe ƙazanta da ƙwayoyin cuta.
Amma, akasin abin da mutane da yawa suke tsammani, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba ya rage ƙwayoyin cuta a hannayenmu.
Mai tsabtace hannu ko maganin kashe ƙwayoyin cuta shine wakili mai tsabtace hannu wanda ba ruwa ba.
A ƙarshen shekarun 1990s da farkon karni na 21, masu tsabtace hannu na yau da kullun marasa ruwa da ke da tushen barasa (wanda aka fi sani da kayan tsabtace hannu na giya, kayan tsabtace hannu na antiseptic, ko tsabtace hannu) sun fara samun karbuwa.
Yawancin su ana yin su ne da isopropyl ko ethanol da aka yi da wani wakili mai kauri, kamar carbomer (polymer ko acrylic acid), a cikin gel, ko mai laushi, kamar glycerin, a cikin ruwa, ko a cikin kumfa don sauƙaƙe amfani da rage tasirin bushewar barasa.
Ƙarin hydrogen peroxide yana sa hannuwanmu su yi aiki sosai kuma masu tsabtace hannu da ke ɗauke da kashi 60 zuwa 95 cikin ɗari na giya suna kashe ƙwayoyin cuta sosai.
Masu tsabtace jiki na barasa suna kashe kwayoyin cuta, kwayoyin cuta masu jurewa (MRSA da REV), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinoviruses, vaccia, mura da hepatitis) da fungi.
Masu tsabtace hannu da ke dauke da kashi 70% na barasa suna kashe kashi 99.97% (ragewa ta 3.5 log, kwatankwacin ragewa ta decibel 35) na kwayoyin cuta a hannaye, da dakika 30 bayan amfani da su da kuma kashi 99.99% zuwa 99.999% (ragewa ta 4 zuwa 5 log) na kwayoyin cuta a hannaye minti 1 bayan amfani da su. Masu tsabtace hannu sun fi tasiri akan kwayoyin cuta kuma basu da tasiri akan wasu ƙwayoyin cuta.
Masu tsabtace hannu da ke da barasa ba su da tasiri sosai a kan kwayar cutar norovirus (ko Norwalk), wadda ita ce sanadin cututtukan gastroenteritis. Ana iya amfani da maganin kashe ƙwayoyin cuta ko kuma masu tsabtace hannu da ke da barasa don su shafe ko kuma su rufe hannayen biyu.
Bayan haka, a shafa baya da dabino tsakanin yatsunsu da kuma ƙarshen su na kimanin dakika 30 har sai ruwan, kumfa ko gel ya bushe.
Cibiyar Kula da Cututtuka da Cututtuka ta ba da shawarar wanke hannuwanku da kayan tsabtace hannu, musamman idan hannayenku suna da datti.
Ana amfani da waɗannan magungunan da yawa saboda sauƙin amfani da saurin kashe ƙwayoyin cuta; duk da haka, bai kamata su maye gurbin wanke hannu da kyau ba, sai dai idan sabulu da ruwa ba su da yawa.
Amfani da kayan tsabtace hannu na giya sau da yawa na iya haifar da bushewar fata sai dai idan an ƙara emollients da/ko moisturizers na fata a cikin tsari.
Za a iya rage ko kawar da sakamakon bushewar barasa ta hanyar ƙara glycerin da/ko wasu emollients zuwa tsari.
A cikin gwaji na asibiti, masu tsabtace hannu na barasa da ke dauke da emollients sun haifar da ƙarancin damuwa da bushewa a fata fiye da sabulu ko kayan wanke cututtuka.
Maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ƙarancin haɗarin cutar cututtukan fata ya zama mai ban sha'awa idan aka kwatanta da wanke hannu da sabulu da ruwa.
Duk da yadda suke da amfani, magungunan da ba su da ruwa ba sa wanke hannuwanku daga ƙwayoyin halitta, amma suna kashe su ne kawai.
Wannan shi ne dalilin da ya sa masu tsabtace hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtuka da yawa, domin har yanzu cututtukan suna cikin hannuwanku.
Amfani da kayan wanke hannu ba tare da barasa ba ya dogara da abubuwa da kuma tsari, kuma a tarihi ya kasance ƙasa da barasa da kuma tsabtace hannu.
A kwanan nan, an gano cewa magungunan da ke amfani da benzalkonium chloride suna da ci gaba da aiki na antimicrobial bayan aikace-aikacen, ba kamar barasa ba, wanda aka nuna cewa yana da tasiri sosai bayan sake amfani, mai yiwuwa saboda karuwar mummunan sakamako a fata.
Mutane da yawa a cikin ƙananan al'ummomi ba za su iya sayen sabulu ba, maimakon haka suna amfani da toka ko ƙasa.
Ƙura ko ƙasa za su iya yin aiki fiye da ruwa mai tsabta, amma ba za su iya yin aiki sosai kamar sabulu ba.
Abin damuwa shi ne, idan ƙasa ko toka ta ƙazantu da ƙwayoyin cuta, za a iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, toka tana kuma aikin kashe ƙwayoyin cuta, domin idan ta taɓa ruwa, tana zama ruwan gishiri.
Hukumar Lafiya ta Duniya ta ce ana iya amfani da toka da yashi a madadin sabulu idan babu sabulu.
Hanyar wanke hannu daidai da Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar don hana yaduwar cututtuka ta haɗa da waɗannan matakan:
Wanke hannuwanku da ruwan sanyi ko ruwan zafi.
Ana ba da shawarar ruwan da ke gudana tun da yake za a iya gurɓata wuraren wanka, kuma zafin ruwan ba shi da muhimmanci.
Rub da hannayenka, shafa su da sabulu mai yawa, ciki har da bayan hannayenka, tsakanin yatsunsu da ƙarƙashin ƙusoshinka.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna yawan wanke hannayensu sosai idan ana amfani da sabulu maimakon ruwa mai tsabta.
Rub don akalla 20 seconds.
Yin shafawa yana sa a riƙa gogewa, kuma hakan yana taimaka wa mutum ya kawar da ƙwayoyin cuta daga fatarsa.
Ku wanke sosai da ruwan da ke gudana.
Wankewa a cikin kwandon ruwa zai iya sake gurɓata hannayenka.
Ka bushe shi da tawul mai bushe ko kuma ka bar shi ya bushe a waje.
Hannun da suke da rigar suna iya sake kamuwa da cutar, amma wuraren da ake yawan manta da su su ne babban yatsu, wuyan hannu, tsakanin yatsunsu da kuma ƙarƙashin ƙusa.
Ƙunƙarar da aka yi da ƙusa da kuma ƙyalle da aka yi da ƙusa suna iya ɗauke da ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da ruwan shafa don kiyaye hannayenka; bushewar fata na iya haifar da raunuka a fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Zaɓuɓɓuka masu rahusa da yawa za a iya yi don sauƙaƙe wanke hannu inda babu ruwan da ke gudana da sabulu, misali, zubar da ruwa daga galan ko ruwan da ke da ramuka masu dacewa da kuma / ko amfani da toka idan ya cancanta a ƙasashe masu tasowa. A cikin yanayi tare da iyakance samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai mafita don adana ruwa kamar "mai jujjuyawar ruwa" da sauran zaɓuɓɓuka masu arha.
Faucet ɗin da aka yi da kansa fasaha ce mai sauƙi da ke amfani da kwalba da aka rataye a kan igiya, da kuma matattarar da ƙafafun ke motsawa don zubar da ruwa kaɗan a hannayenka da kuma sabulu.
Drying hannu yadda ya kamata wani muhimmin bangare ne na aikin tsabtace hannu, amma akwai muhawara game da yadda ya fi dacewa don bushewa a cikin dakunan wanka na jama'a.
Bincike da yawa ya nuna cewa takardar tawul tana da tsabta fiye da na'urar busar hannu da ake samu a ɗakunan wanka da yawa.
A shekara ta 2008, Jami'ar Westminster, London ta gudanar da bincike kuma masana'antar takarda ta tallafawa, Tissue Symposium na Turai, don kwatanta matakan tsabtace jiki da takarda takarda, bushewar hannu mai zafi da na zamani na iska.
Bayan wankewa da bushe hannuwanku da na'urar bushewa mai zafi, yawan kwayoyin sun karu da kashi 194 cikin dari a cikin dabino kusa da yatsunsu da kuma kashi 254 cikin dari a sauran dabino.
Drying da na'urar busar iska ya haifar da karuwar yawan kwayoyin cuta, a matsakaita, da kashi 42 cikin dari a yankin dabino kusa da yatsunsu da kuma kimanin kashi 15 cikin dari a sauran dabino.
Bayan wankewa da bushe hannuwanku da takardar tawul, yawan kwayoyin sun ragu, a matsakaita, har zuwa kashi 76% a yankin dabino kusa da yatsunsu kuma har zuwa kashi 77% a sauran dabino. Masu binciken sun kuma gudanar da gwaje-gwaje don tantance ko akwai yiwuwar gurɓatawar giciye tsakanin sauran masu amfani da yanayin gidan wanka sakamakon kowane nau'in bushewa.
Jirgin iska mai iska, wanda ke fitar da iska daga cikin na'urar a cikin saurin gudu na 180 m/s (650 km/h; 400 mph), ya sami nasarar fitar da ƙwayoyin cuta daga hannaye da na'urar da ke iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin da ke nesa da mita 2.
Amfani da na'urar busar hannu da iska mai zafi yana yada ƙwayoyin cuta har zuwa mita 0.25 daga na'urar busar.
Takaddun takarda ba su nuna yaduwar ƙwayoyin cuta ba. A cikin binciken da TÜV Produkt da Umwelt suka gudanar a shekara ta 2005, an kimanta hanyoyi daban-daban na bushe hannu.
Wadannan canje-canje a cikin ƙididdigar ƙwayoyin cuta bayan bushe hannu sun lura:
Akwai masu yin na'urorin busar hannu da yawa, kuma an kwatanta na'urorin busar hannu da na'urar busar da takarda.
Wanke hannu da tawul din hannu mai tsabtace hannu shine madadin rashin sabulu da ruwa yayin tafiya.
Masu tsabtace hannu na barasa dole ne su ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
Wanke hannu na asibiti ya zama tilas ne tun bayan likitan Hungary Ignaz Semmelweis ya gano ingancinsa (a 1846) wajen hana cututtuka a cikin asibiti.
Akwai na'urorin lantarki da ke ba da amsa don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa yawan kamuwa da cutar ya ragu da amfani da shi.
Wanke hannu na asibiti ya zama na aƙalla dakika 15, ta amfani da sabulu da ruwa ko gel mai yawa don sabulu da shafa dukkan sassan hannu.
Dole ne a shafa hannayenka a lokaci guda da yatsunsu.
Idan akwai wasu abubuwa a ƙarƙashin ƙusa, za a iya amfani da goga don cire su.
Tun da ƙwayoyin cuta za su iya kasancewa cikin ruwa a hannayenku, yana da muhimmanci ku wanke hannuwanku sosai kuma ku bushe su da tawul mai tsabta.
Bayan bushewa, dole ne a yi amfani da takarda don rufe famfo (da kuma bude kofa idan ya cancanta).
Hakan zai hana hannayenku sake kamuwa da wannan cutar.
Manufar wanke hannu a cikin yanayin kiwon lafiya shine cire ƙwayoyin cuta ("kwayoyin cuta") da hana su yaduwa.
Jaridar New England Journal of Medicine ta ba da rahoton cewa rashin wanke hannu ya ci gaba da zama abin ƙyama a yawancin wuraren kiwon lafiya, da yawa cikin likitoci da ma'aikatan jinya da suke mantawa da wanke hannayensu kafin su taɓa marasa lafiya, suna ba da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu ayyuka masu sauƙi za su iya rage yawan cututtukan jini da ke tattare da kateter da kashi 66 cikin ɗari. Ƙungiyar Lafiya ta Duniya ta wallafa wata takarda da ta nuna yadda ake wanke hannu da kuma shafawa a wuraren kiwon lafiya.
Ana kuma iya samun shawarwari game da tsarin tsabtace hannu na ƙungiyar a wannan rukunin yanar gizon don tsokaci.
An yi bita mai amfani da Whitby et al.
Na'urorin kasuwanci na iya auna da kuma tabbatar da tsabtace hannu, idan ana buƙatar tabbatar da daidaito na doka.
Hukumar Lafiya ta Duniya ta bayyana "Lokaci biyar" don wanke hannu:
bayan an yi amfani da ruwa na jiki/jinin
kafin aikin ascetic, kuma
Bayan kulawar mai haƙuri, ƙara sinadarai masu kashe ƙwayoyin cuta a sabulu (sabulu "magunguna" ko "antimicrobial") yana ba da aikin kashewa ga mai wanke hannu.
Irin wannan aikin kashewa na iya zama mai kyau kafin yin tiyata ko a cikin yanayin da kwayoyin da ke jure wa maganin rigakafi suka fi rinjaye. Don "tsabtace" hannayenka don aikin tiyata kana buƙatar samun famfo wanda za a iya buɗewa da rufewa ba tare da taɓa shi da hannunka ba, wasu maganin kashe ƙwayoyin cuta na chlorhexidine ko iodine, tawul ɗin da aka tsabtace don bushe hannayenka bayan wankewa, da kuma goga mai tsabta don tsabtacewa da sauran kayan aikin da aka tsabtace don tsabtace ƙarƙashin kusoshi.
Dole ne a cire duk kayan ado.
Wannan aikin yana buƙatar wanke hannu da makamai har zuwa gwiwoyi, yawanci na minti 2-6.
Ba a buƙatar tsaftacewa mai tsawo (10 minti).
Lokacin wankewa, ruwa daga makamai ba zai shiga hannayenku ba.
Bayan an gama wanke hannu, sai a goge hannayen da tawul mai tsabta kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, zai fi kyau a wanke hannu ko kuma a yi amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan kula da marar lafiya.
Don kula da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wanke hannu da sabulu na yau da kullum ya ninka yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Duk da haka, sabulu da ruwa sun fi inganci fiye da masu tsabtace hannu na barasa don rage cutar mura A, H1N1, da kuma Clostridium difficile a hannaye. Matsaloli don ƙara tsabtace hannu a wuraren asibiti na iya haɗawa da wayar da kan ma'aikata game da wanke hannu, ƙara yawan masu tsabtace hannu na barasa, da kuma gargadi na magana da rubuce-rubuce ga ma'aikata.
Ana bukatar ƙarin bincike game da yadda za a magance matsalar a wurare dabam dabam.
A ƙasashe masu tasowa, ana ɗaukan wanke hannu da sabulu a matsayin muhimmin abu da zai sa mutum ya kasance da koshin lafiya da kuma abinci mai gina jiki.
Amma rashin ingantaccen ruwa, sabulu ko kayan wanke hannu a gidajen mutane, makarantu da wuraren aiki ya sa samun wanke hannu a duniya ya zama ƙalubale.
Alal misali, a yawancin yankunan karkara na Afirka, famfunan wanke hannu kusa da duk wani gidan wanka na jama'a ko na masu zaman kansu ba su da yawa, duk da cewa akwai wasu hanyoyin da za a iya gina wuraren wanke hannu.
Amma, ƙananan yawan wanke hannu na iya zama sakamakon al'ada maimakon rashin sabulu da ruwa.
Ƙarfafawa da kuma ba da shawara game da wanke hannu da sabulu na iya rinjayar yanke shawara na siyasa, haifar da wayar da kan jama'a game da fa'idodin wanke hannu da kuma haifar da canjin halayyar jama'a na dogon lokaci.
Don wannan ya yi aiki yadda ya kamata, ana bukatar sa ido da kuma kimantawa.
Wani bincike na nazari na nazarin bincike 70 ya gano cewa hanyoyin da ke cikin al'umma suna da tasiri wajen kara wanke hannu a ƙasashe masu karamin kuɗi da matsakaitan kuɗi, yayin da kamfen ɗin tallan zamantakewar ba su da tasiri sosai. Misali don inganta wanke hannu a makarantu shine "Hanyar Tauraruwa Uku" ta UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi da araha don tabbatar da ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran buƙatun tsabta.
Idan aka kai matakin mafi ƙanƙanci, za a iya sa makarantun su tashi daga tauraruwa ɗaya zuwa tauraruwa uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen ɗin talla don wanke hannu da aka gudanar da nufin rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a wanda ke ƙoƙarin kawo canjin al'ada. Sakamakon annobar coronavirus ta 2019-2020, UNICEF ta sanar da karɓar emoji don wanke hannu.
Wasu nazarin da aka yi sun yi la'akari da jimlar kuɗin da ake samu daga wanke hannu a ƙasashe masu tasowa dangane da ƙimar DALY.
Amma, bincike ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin samar da ruwa da tsaftacewa.
Muhimmancin wanke hannu ga lafiyar ɗan adam  musamman ga mutanen da ke cikin mawuyacin hali kamar uwaye da suka haihu ko sojoji da aka ji rauni a asibitoci  an fara gane su a tsakiyar karni na 19 ta hanyar masu gabatar da tsabtace hannu biyu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria, da Florence Nightingale, Ingilishi "mai kafa aikin jinya na zamani".
A lokacin, mutane har ila suna ganin cewa ƙwayoyin cuta suna zuwa ne daga ƙamshi mai ƙyama da ake kira miasmas.
A cikin shekarun 1980, ɓarkewar cututtuka da ke zuwa daga abinci da kuma cututtuka da ke tattare da kula da lafiya sun sa Cibiyar Kula da Cututtuka da Cututtuka ta Amirka ta ƙara ƙarfafa tsabtace hannu a matsayin hanya mai muhimmanci na hana yaduwar cututtuka.
Cutar mura ta alade a shekarar 2009 da annobar COVID-19 a shekarar 2020 sun haifar da karuwar wayewa a ƙasashe da yawa game da mahimmancin wanke hannu da sabulu don kare kanku daga irin waɗannan cututtukan cututtuka.
Alal misali, an rataye allon tallace-tallace da ke ɗauke da "dabaru na wanke hannu yadda ya kamata" kusa da wuraren wanke hannu a wuraren wanka na jama'a da kuma wuraren wanka na gine-ginen ofis da kuma filayen jirgin sama a Jamus.
Furcin nan "wanke hannuwanku" yana nufin cewa ba ku son ku ɗauki hakkinku ko kuma ku amince da wani abu.
Wannan ya samo asali ne daga nassi na Littafi Mai-Tsarki a cikin Matta inda Pontius Bilatus ya wanke hannayensa daga yanke shawarar gicciye Yesu Almasihu, amma ya zama jumla mafi amfani a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari na share wani tabo na tunanin, yana wakiltar lamirinta na laifi game da laifukan da ta aikata kuma ta sa mijinta ya aikata.
An kuma gano cewa mutane bayan sun tuna ko sun shaida ayyukan da ba su dace ba, suna yawan wanke hannayensu fiye da wasu, kuma suna ba da fifiko ga kayan wanke hannu.
Ƙari ga haka, waɗanda za su iya wanke hannayensu bayan sun ga wannan ba sa yin wasu ayyuka na "tsabtacewa" kamar aikin sa kai.
Addinai suna ba da umarnin wanke hannu don dalilai na tsabta da alama. Wanke hannu na alama, ta amfani da ruwa amma ba sabulu ba, don wanke hannuwansa wani ɓangare ne na al'adar wanke hannu da ke cikin addinai da yawa, gami da Baha'i, Hindu, tevilah da netilat yadayim a Yahudanci, wanka a cikin Kiristanci, da wankewa a cikin Islama. Addinai kuma suna nuna wanke hannuwan tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun yarda da wanke hannu bayan amfani da bayan gida.
Kuma addinin Hindu, Buddha, Sikh, da Islama sun yarda da wanke hannu kafin da kuma bayan cin abinci.
Kulawa da haɗari a wurin aiki don COVID-19
Kula da haɗarin aiki don COVID-19 shine aikace-aikacen hanyoyin kiwon lafiya da aminci na aiki don kula da haɗari don rigakafin cutar coronavirus ta 2019 (COVID-19).
Kula da haɗarin da ya dace a wurin aiki ya dogara da wurin aiki da aikin da kansa, bisa la'akari da haɗarin tushen kamuwa da cutar, tsananin cutar a cikin al'umma, da kuma abubuwan haɗarin ma'aikata na mutum waɗanda za su iya zama masu saurin kamuwa da COVID-19.
A cewar Ma'aikatar Lafiya da Tsaro ta Aiki (OSHA), ayyuka da ke da haɗarin haɗari mafi ƙaranci suna da ƙarancin hulɗa da jama'a da sauran abokan aiki, wanda ake ba da shawarar matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, kiyaye alamar numfashi da tsaftacewa da tsabtace yanayin aiki.
Ayyukan da ke da haɗarin haɗari sun haɗa da waɗanda ke buƙatar hulɗa kai tsaye ko sau da yawa tare da mutanen da ba a san ko suna da cutar COVID-19 ba ko kuma ana zargin suna da cutar amma suna iya kamuwa da cutar saboda yaduwar al'umma ko kuma tafiya zuwa ƙasashen waje.
Wannan ya hada da ma'aikata da ke hulɗa da jama'a kamar a makarantu, wuraren aiki masu yawan jama'a, da kuma manyan kasuwanni.
Kula da haɗari ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta na asali sun haɗa da iska mai iska tare da amfani da matattarar iska mai inganci, suturar kariya da samar da kayan kariya na mutum idan an tabbatar da mutum da COVID-19.
OSHA ta yi la'akari da ma'aikatan kiwon lafiya da ma'aikatan gidan gawa da ke fuskantar haɗarin haɗari ga mutanen da ke da COVID-19 ko kuma waɗanda ake zargi da cutar, wanda ke ƙara haɗarin haɗari zuwa mafi girma idan ma'aikata suka yi aiki a kan mutanen da ke da COVID-19 ko kuma waɗanda ake zargi da cutar da kuma tattara ko sarrafa samfurin waɗannan mutanen.
Kulawa da haɗari masu dacewa ga waɗannan ma'aikata sun haɗa da kulawar injiniya kamar ɗakunan iska na matsa lamba mara kyau da kayan aikin kariya na mutum wanda ya dace da aikin da aka yi.
Cutar COVID-19 na iya haifar da sakamako da yawa a wurin aiki.
Ma'aikata suna iya yin watsi da aikin domin suna rashin lafiya, suna kula da wasu, ko kuma suna tsoron kamuwa da cutar.
Hanyoyin kasuwanci na iya canzawa, duka dangane da abin da ake buƙata da kuma hanyoyin da za a saya waɗannan kayayyaki (kamar yin sayayya a waje da lokacin aiki ko ta hanyar bayarwa ko sabis na drive-thru).
A ƙarshe, ana iya dakatar da aika kayayyaki daga yankunan da COVID-19 ta shafa sosai. Ana iya amfani da shirin aiki da shiri don kamuwa da cuta don jagorantar ayyukan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da wurare da ayyuka daban-daban, gami da tushen haɗari, abubuwan haɗari da ke faruwa a gida da cikin al'umma, da abubuwan haɗari na ma'aikata na mutum kamar tsofaffi ko yanayin rashin lafiya.
Sun kuma bayyana matakan da ake bukata don magance waɗannan haɗarin, da kuma shirye-shiryen gaggawa don yanayin da zai iya tasowa sakamakon annobar.
Shirye-shiryen aiki da shirye-shiryen cututtuka na iya zama batun shawarwari na ƙasa ko na yanki.
Manufofin aikin annoba sun hada da rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da cututtukan kiwon lafiya, ci gaba da ayyukan kasuwanci da rage tasirin tasirin tasirin wasu a cikin sarkar samarwa.
Matsayin cutar a cikin al'ummar da kamfanin yake, yana shafar ayyukan da ake yi.
Tsarin kula da haɗari tsari ne da aka yi amfani da shi sosai a cikin lafiyar aiki da aminci don haɗa abubuwan kula da haɗari ta hanyar tasiri.
Lokacin da ba za a iya kawar da haɗarin COVID-19 ba, iko mafi inganci shine sarrafa injiniya, sannan sarrafawa na gudanarwa, kuma a ƙarshe kayan kariya na mutum.
Kulawa na injiniya ya ƙunshi ware ma'aikata daga haɗarin da ke tattare da aiki ba tare da la'akari da halayyar ma'aikaci ba, kuma yana iya zama mafita mafi arha don aiwatarwa.
Kulawar injiniya canje-canje ne a cikin manufofin aiki ko hanyoyin aiki waɗanda ke buƙatar aikin ma'aikaci ko mai aiki.
Kayan kariya na mutum (PPE) ana ganin ba shi da tasiri kamar sarrafa aikin injiniya da gudanarwa, amma zai iya taimakawa wajen hana wasu kamuwa.
Duk nau'ikan PPE dole ne a zaɓa bisa haɗarin ma'aikaci, daidaita su yadda ya kamata (misali masu numfashi), amfani da su yadda ya kamata kuma a ci gaba, bincika su a kai a kai, kiyaye su da maye gurbinsu kamar yadda ya cancanta, kuma a cire su, tsaftace su da adana su ko kuma su zubar da su yadda ya kamata don hana gurɓata.
A cewar Ma'aikatar Lafiya da Tsaro ta Aiki ta Amirka (OSHA), ayyuka da ke da haɗarin haɗari suna da iyakantaccen haɗuwa da jama'a da kuma abokan aiki.
Matakan farko na rigakafin kamuwa da cuta da aka ba da shawarar ga duk wuraren aiki sun haɗa da wanke hannaye akai-akai da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya da kuma amfani da lakabin numfashi, gami da rufe hancin da tari, shirya kwanon rufi da kwandon shara, shirya don aiki ta waya ko sauye sauye idan ya cancanta, hana amfani da kayan aiki da kayan aiki na wasu ma'aikata da kuma kiyaye tsaftacewa da tsabtace yanayin aiki.
Gano da kuma ware mutanen da ke da cutar da wuri muhimmin mataki ne wajen kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa ma'aikata da ke nuna alamun cututtukan numfashi na yau da kullun su zauna a gida har sai sun daina zazzabi, alamun zazzabi, ko wasu alamun aƙalla awanni 24 ba tare da amfani da magungunan rage zazzabi ko sauƙaƙe wasu alamun ba, kuma suna ba da shawarar cewa manufofin hutu na rashin lafiya su kasance masu sassauƙa, ba ma'aikata damar zama a gida don kula da mara lafiya a cikin iyali, kuma su san waɗannan manufofin.
A cewar OSHA, ayyukan da ke da haɗarin haɗari sun haɗa da waɗanda ke buƙatar hulɗa sau da yawa ko kai tsaye na ƙafa 6 (1.8 m) tare da mutanen da ba a san ko sun tabbatar da ko ana zargin suna da COVID-19 ba, amma suna iya kamuwa da SARS-CoV-2 saboda yaduwar al'umma a yanzu a wurin aikin, ko kuma saboda mutumin yana da tarihin kwanan nan na tafiya zuwa ƙasashen waje, a cikin ƙasa mai yawan yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikata waɗanda ke hulɗa da jama'a gaba ɗaya kamar a makarantu, wuraren aiki masu yawan jama'a, da wasu shagunan sayar da kaya masu yawan tallace-tallace. Gudanar da aikin injiniya ga wannan rukunin da kuma don rukunin haɗari mafi girma sun haɗa da shigar da matattarar iska mai inganci, ƙara iska, shigar da shingayen jiki kamar su filayen tsabtace filastik masu haske da kuma shigar da taga-drive-thru don hidimar abokan ciniki. Gudanar da gudanarwa ga wannan rukunin da kuma rukunin haɗari mafi girma sun haɗa da ƙarfafa ma'aikata su zauna a gida, maye gurbin tarurrukan fuska da fuska da sadarwar kan layi, kafa saiti masu tsayi, hana zirga-zirgar balaguro waɗanda ba su da mahimmanci ga wuraren da ke cikin haɗarin cutar COVID-19, haɓaka shirye-shiryen sadarwa, gami da samar da dandalin ba da amsa ga abokan ciniki, samar da gargaɗi game da amfani da kayan aiki da kayan aiki na yau da kullun, amfani da kayan aiki na yau da kullun, amfani da kayan aiki, wanke hannu, da sauran hanyoyin da ake buƙata, da kuma samar da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki da ke buƙatar haɗari, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki da kayan aiki da ke buƙatar aiki, da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki da kayan aiki da kayan aiki, da kuma samar da kayan aiki, da kayan aiki, da kayan aiki da kayan aiki da kayan aiki, da kuma samar da kayan aiki da kayan aiki, da kayan aiki da kayan aiki, da kayan aiki da ke da kayan aiki, da kayan aiki, da kayan aiki da kayan aiki da ke da ke da kayan aiki, da kayan aiki, da kayan
Ma'aikata da ke cikin wannan rukunin haɗari ba sa bukatar na'urar numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da ware mutumin da ke rashin lafiya daga sauran mutane a nesa da ƙafa 6, tare da sanya wani ma'aikacin jirgin don yi wa mutumin da ke rashin lafiya hidima da ba shi abin rufe fuska, ko kuma a nemi mutumin da ke rashin lafiya ya rufe baki da hanci da zane yayin tari ko hancinsa.
Ma'aikatan jirgin za su sa safar hannu ta likita lokacin da suke hidimar wani matafiyi mara lafiya ko kuma suna taɓa ruwa na jiki ko kuma wuraren da za su iya zama masu gurɓataccen abu kuma wataƙila ƙarin kayan kariya na mutum idan mai haƙuri yana da zazzabi, tari mai ɗorewa ko wahalar numfashi.
Ya kamata a zubar da safar hannu da sauran abubuwa masu yarwa a cikin jaka don ɓarnar haɗarin halittu, kuma ya kamata a tsabtace da kuma kashe ƙwayoyin cuta a bayan haka. Don jigilar kasuwanci, gami da jiragen ruwa na jirgin ruwa da sauran jiragen ruwa masu fasinja, kulawar haɗari sun haɗa da jinkirta tafiya ta fasinjojin da ke rashin lafiya, keɓe kai da sanar da cibiyar likitancin jirgin nan da nan idan wani ya sami zazzabi ko wasu alamomi yayin tafiya.
A mafi kyau, ana bukatar kulawar likita a cikin ɗakin da aka ware mutum. Ga makarantu da cibiyoyin kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsaftacewa da kashe ƙwayoyin cuta idan mutum mai cutar ya kasance a cikin ginin, ba tare da la'akari da yadda cutar ta yadu a cikin al'umma ba.
Lokacin da akwai ƙananan zuwa matsakaiciyar yaduwar al'umma, ana iya aiwatar da dabarun nisantar zamantakewa, kamar soke tafiye-tafiye zuwa filin wasa, taro, da sauran manyan tarurruka kamar darussan motsa jiki ko waƙoƙi, ko cin abinci a cikin kantin abinci, ƙara sarari tsakanin teburin, tsauraran lokutan isowa da tashi, iyakance baƙi marasa mahimmanci, da amfani da keɓaɓɓen wurin kula da lafiya don yara masu alamun mura.
Idan akwai yaduwar cutar a cikin al'umma, ban da dabarun nisantar da jama'a, ana iya yin la'akari da doguwar barin makaranta. Ga jami'an tilasta yin doka da ke yin ayyukan yau da kullun, CDC ta ɗauki haɗarin lafiyar kai tsaye da ƙarancin.
Ana ba da shawarar cewa jami'an da suka yi hulɗa da mutanen da ake zargi da COVID-19 ko kuma waɗanda ke da cutar su bi ƙa'idodin da likitocin gaggawa ke bi, gami da amfani da kayan kariya na mutum.
Idan kai tsaye ya faru yayin kamawa, ma'aikata su tsabtace da kuma kashe ƙwayoyin cuta a belinsu da sauran kayan haɗi kafin sake amfani da su ta hanyar amfani da fesawa ko zane mai tsabtace gida kuma bi tsarin aiki na yau da kullun don riƙewa da zubar da PPE da aka yi amfani da shi da kuma riƙewa da wanke tufafi.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da ma'aikatan gidan gawa a matsayin masu haɗari mai haɗari ko mai haɗari.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da masu ba da magani, kula da lafiya, ma'aikatan dakin gwaje-gwaje da masu jigilar lafiya, waɗanda ke fuskantar marasa lafiya da aka tabbatar ko ana zargin suna da COVID-19.
Hadarin kamuwa da cutar ya zama mai girma idan ma'aikata suna yin aikin samar da iska a kan marasa lafiya da aka tabbatar ko ake zargi da COVID-19, ko kuma tattara ko sarrafa samfuran waɗannan marasa lafiyar.
Hanyoyin samar da aerosol sun hada da intubation, hanyoyin hana tari, bronchoscopy, wasu hanyoyin da gwaje-gwaje na hakori ko kuma tattara samfurori.
Ayyuka a cikin ɗakunan ajiya masu haɗari sun haɗa da ma'aikatan da ke cikin shirya gawawwakin mutanen da ke da tabbacin COVID-19 ko ana zargin cutar a lokacin mutuwarsu; haɗarin haɗari ya zama mai girma idan sun yi autopsy. Ƙarin sarrafa injiniya ga waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don marasa lafiya da aka tabbatar da COVID-19 ko ana zargin cutar, gami da lokacin da ake aiwatar da hanyoyin samar da aerosol.
Ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙwarƙwarƙwarƙwarƙwarƙwar ƙwar ƙwarƙwarƙwar ƙwarƙwar ƙwar ƙwarƙwarƙwar ƙwar ƙwarƙwarƙwar ƙwarƙwarƙwarƙwar ƙwar ƙwarƙwarƙ
Za a yi amfani da samfurin tare da matakin 3 na biosafety.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa marasa lafiya da ke shiga asibiti su kasance a cikin yankuna biyu daban-daban na jira dangane da ko suna da cutar COVID-19. Baya ga sauran PPE, OSHA ta ba da shawarar masu aikin numfashi don masu aiki a nisan ƙafa 6 daga marasa lafiya da aka tabbatar ko ake zargin suna da cutar SARS-CoV-2, da kuma masu aikin samar da aerosol.
A cikin Amurka, NIOSH-wanda aka amince da N95 masu tace ƙwayoyin cuta na fuska ko masu ɗaukar iska masu inganci ya kamata a yi amfani da su a cikin mahallin cikakken tsari da rubutaccen tsarin kariya na numfashi wanda ya haɗa da gwajin dacewa, horo da gwajin likita.
Sauran nau'ikan kayan numfashi na iya ba da kariya da haɓaka jin daɗin ma'aikaci. WHO ba ta ba da shawarar yin amfani da riguna ba, saboda COVID-19 cuta ce ta numfashi, kuma ba a watsa ta ta ruwa na jiki ba numfashi ba.
Hukumar Lafiya ta Duniya ta ba da shawarar kawai a sanya abin rufe fuska na tiyata ga ma'aikatan tantancewa a wurin shiga.
Ga masu aikin da ke karɓar samfurori na numfashi, kula ko jigilar marasa lafiya da COVID-19 ba tare da hanyoyin samar da iska ba, WHO ta ba da shawarar rufe fuska, tabarau masu kariya ko kariya ta fuska, rigar tiyata da safar hannu.
Idan an yi aikin samar da aerosol, za a maye gurbin abin rufe fuska da N95 ko FFP2 respirator.
Saboda wadatar PPE a duniya ba ta isa ba, WHO ta ba da shawarar rage buƙatar PPE ta hanyar telemedicine, shinge na zahiri kamar windows mai haske, ba da damar waɗanda ke da hannu cikin kula da marasa lafiya kai tsaye su shiga ɗaki tare da mai haƙuri da COVID-19, ta amfani da PPE kawai da ake buƙata don takamaiman aikin, ci gaba da amfani da injin numfashi ɗaya ba tare da cire shi ba yayin kula da marasa lafiya da yawa tare da ganewar asali ɗaya, saka idanu da daidaita sarkar samar da PPE, da hana amfani da abin rufe fuska ga mutane marasa alamomi.
DE: Katherine Maher, Shugaba na Gidauniyar Wikimedia
GA: Duk ma'aikatan Gidauniyar Wikimedia
TAMBAYA: [Covid-19] Rage matsalolin da kuma shirya don nan gaba
DATA/Lokaci: 14 ga Maris, 2020, 00:24 UTC
LISSACIN: CC0: Babu wani haƙƙin mallaka
Mun sami kanmu a cikin yanayi na musamman a wannan watan.
Cutar COVID-19 wani abu ne da ke nuna mana yadda mutane suke da alaƙa da juna da kuma yadda muke da alhakin juna.
Kalubalen da suke fuskanta ba su da misali, amma mun san cewa ayyukanmu mafi kyau suna tafiya tare da jinƙai na duniya, haɗin kai da kuma gina al'umma, waɗanda sune tushen wannan ƙungiyar.
Abokan hulɗa da kuma damuwa da muka gani tsakanin abokan aikinmu ta hanyar imel, kira da tattaunawa, tabbaci ne mai ban mamaki na mutane masu ban mamaki waɗanda muke da gatan aiki tare da su.
Ina farin ciki sosai da kuma alfahari da ku abokan aikina.
A makon da ya gabata, wani ya nuna mini godiyarsa don aikin da muka yi.
Wannan mutumin ya tunatar da ni yadda yake da muhimmanci ga duniya ta sami damar shiga Wikipedia a yanzu, da kuma yadda alama ce mai ƙarfi cewa wannan muhimmin kayan aiki ya ci gaba da kasancewa a kan layi kuma yana samuwa ga kowa.
Aikinku ne ya sa hakan ya yiwu domin kuna ci gaba da aiki, kuna biyan abokan aikinmu, kuma kuna kiyaye al'ummominmu.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa fiye da kowane lokaci.
Wannan lokaci ne da ba kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri sosai a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da za ku taka, za mu yi wasu canje-canje masu muhimmanci a yadda muke aiki tare, daga mako mai zuwa.
Daidaita Ayyukanmu da Kuma Jadawalinmu
Kamar yadda Robyn ta ambata a baya, ƙungiyar C ta haɗu a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan taron, mun tattauna abin da muke ganin ya dace da yanayin da muke ciki da kuma yadda za mu ci gaba da kasancewa da ƙungiyar a wannan lokacin.
Muna son mu kawar da damuwarmu kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar ka tafi na ɗan lokaci, ba matsala.
Ga dukkan ma'aikata, masu ba da sabis da ma'aikatan kwangila:
Aikinmu na yau da kullum zai zama awa hudu, ko kuma awa 20 a mako, sai dai idan an ba da umarni.
Idan za ka iya yin aiki a lokacin da ya dace, za ka iya taimaka mana.
Amma, duniya ba ta da tabbas yanzu, kuma ko kana bukatar kula da ƙaunatattunka, sayen abinci, ko zuwa asibiti, lafiyarka ita ce kan gaba.
Ba ma saka idanu a kan jadawalin aikinku.
Idan kana rashin lafiya, kada ka yi aiki.
Ba ma bukatar mu faɗi wannan dokar, amma mun tsai da shawara cewa za mu faɗi ta.
Ba a bukatar takardar shaidar ko hutu da ake biya, sai dai ka gaya wa manajanka ya taimaka wa ma'aikatanka su duba jadawalin da kuma lokacin aiki don su tabbata cewa an yi aiki a kan muhimman wuraren aiki.
(Idan an gano cewa kana da COVID-19, ka sanar da Bryan daga sashen koyarwa da takaddun shaida don sashensa su taimaka maka kuma su tabbatar da cewa an kula da yanayinka yadda ya kamata daga gudanarwa).
Ma'aikatan da suke aiki a kan sa'a za su sami cikakken albashi.
Mun riga mun faɗi haka, kuma muna yin alkawarin cika alkawarinmu ga masu aikinmu da ma'aikatanmu waɗanda suke aiki a kan sa'a.
Kowa zai sami albashinsa bisa tsarin aikinsa na yau da kullum a yanayi na yau da kullum.
Ana biya ku albashi ko kuna rashin lafiya ko kuma ba ku iya aiki.
Idan kana son yin aiki, za mu goyi bayanka sosai.
Mutane da yawa suna ganin aiki hanya ce ta kawar da damuwa saboda yanayin duniya.
Aikin da muke yi zai iya kawo albarka sosai, musamman a irin wannan lokacin.
Ka tuna cewa lafiyarka ta fi muhimmanci.
Abin da kawai muke roƙonku ku yi shi ne ku sanar da manajanku don mu san abin da za mu yi tsammani kuma mu taimaka muku yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Akwai wasu ayyuka da ya kamata mu ci gaba da yi.
Sites Reliability Engineering, HR, Reliability & Security, da kuma Fundraising (da sauransu) ƙungiyoyi suna yin ayyuka masu mahimmanci waɗanda zasu iya buƙatar ƙarin tallafi.
Za mu fara aiki tare da dukkan sassanmu don tantance manufofinmu na yanzu da kuma mayar da hankalinmu don tallafawa abin da ke da muhimmanci ga aikinmu.
Akwai ayyuka da yawa da za a yi a madadinmu, kuma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan muka rage gudu yanzu, hakan ba zai ɓata mana rai ba a nan gaba.
Ba mu da niyyar "yin aiki sau biyu don dawo da lokacin da aka rasa" bayan annobar ta ƙare.
Ba za a bukaci ka yi aiki na tsawon lokaci don ka cika jadawalin da ba za ka iya cim ma ba yanzu.
Mun yarda cewa yanayi ya canza, kuma za mu yi aiki don kafa sabbin manufofi da lokacin ƙarshe, kamar yadda ya dace.
Menene zai faru da Shirin Shekara-shekara?
Don daidaitawa da sabon yanayinmu da tsammanin awoyi da aka yi aiki a kowace rana, muna da niyyar daidaita jadawalin isar da shirinmu na shekara-shekara na 2020-2021.
Muna son mu ba da shawarar tsawaita shirinmu na 2019-2020, wanda zai ba da ƙarin lokaci don kasafin kuɗi, kuma ya ba ma'aikata fifiko kan aikin da ya dace, kula da kansu da kula da ƙaunatattun su, yayin da muke ba da damar waɗanda suke buƙatar ko suke son yin aiki a cikin sa'o'i kaɗan a cikin makonni masu zuwa.
Ƙaddamar da jadawalin yana rage yawan aikin tsarawa da kuma matsin lamba a cikin dukan ƙungiyar.
Za mu gabatar da shawarwarinmu ga hukumar a mako mai zuwa kuma za mu sanar da wakilanmu da ma'aikatanmu game da matakan da za mu ɗauka nan ba da daɗewa ba.
Muna godiya ga ƙungiyar Shirye-shiryen shekara-shekara don jagorancin wannan tsari.
Matsayi, bayyanar da tsabtace ofishin
A makon da ya gabata, mun sami labarin cewa ɗaya daga cikin abokan aikinmu a San Francisco na iya kamuwa da cutar COVID-19.
Saboda haka, don mu kāre kanmu, mun tura ma'aikatan tsabtace gida don su tsabtace dukan wuraren da ke ofishinmu a San Francisco.
Sun yi amfani da maganin rigakafin ƙwayoyin cuta na musamman don asibitoci don su kashe ƙwayoyin cuta a dukan wurare da kuma harabar gidan da kuma dukan lif da ke kaiwa bene.
Ginin yana amfani da tsarin kula da kansa ta hanyar amfani da kayayyakin da ke da lafiya ga masu halarta.
Mun yi farin ciki cewa an shirya ofishin sosai don lokacin da muka dawo.
Ofishinmu a Washington yana cikin WeWork, wanda ya raba mana da kuma ma'aikatansa na Washington tsarin aikin COVID-19.
A makon da ya gabata ne ofishinmu da ke Washington ya koma wurin da ba kowa ke aiki ba, daidai da yadda muka saba yi a San Francisco.
Kamar yadda wasu abokan aikinmu a New York suka sani, muna kuma tattaunawa game da hayar ofishi a Brooklyn.
Ana ci gaba da tattaunawar, amma za a iya jinkirta hakan.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu da suka daɗe suna aiki a nesa sun san cewa hakan zai iya zama gyara, kuma za su so su ba da wasu shawarwari:
Ku rage tsawon taron zuwa awa ɗaya ko biyu.
Idan ana bukatar a yi taro na tsawon lokaci, ka yi la'akari da raba su cikin kwanaki da yawa.
Ku tsara taron, ku tsara yadda za ku yi taron, kuma ku aika da littattafan da za ku karanta a gaba.
Yi amfani da bidiyo a matsayin abin da ka zaɓa, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da kuma haɗawa a ainihin lokacin.
Ku yi amfani da shugaban da zai taimaka muku ku yi taro, da wanda zai riƙa lura da tambayoyin da kuke yi a cikin hira da kuma waɗanda kuke halarta, da kuma wanda zai taimaka muku ku rubuta abin da kuka rubuta.
Idan kana bukatar lasifika masu kyau, ka aika wa masu ba da taimako ta imel.
Ku yi amfani da kuɗin da kuka samu don ku sayi abinci.
Shiga cikin tashar #remoties don tattaunawa da abokan aikinku game da aiki mai nisa
Ƙungiyar ayyukan HR tana bincike kan jagororin ergonomics a cikin mahallin yanar gizo don taimakawa haɓaka aiki mai nisa a Gidauniyar.
A makon da ya gabata, mun nemi duk masu karɓar tallafi na al'umma da su soke abubuwan da Wikimedia ke tallafawa jama'a, kamar su marathon editing, har sai WHO ta ayyana ƙarshen annobar.
Mun sanar da ku cewa mun fahimci cewa buƙatarmu ta sokewa da sauran ƙuntatawa na iya hana ku kammala ayyukan tallafin da kuka yarda da su, kuma ba wanda za a hukunta don tsawaitawa ko canza burin ku.
A mako mai zuwa, za mu ci gaba da ƙarin jagororin kan Wikimania da sauran taron yanki da na al'umma.
Babban motsin zuciyar jama'ar duniya kamar yana bakin ciki ne game da shinge, amma kuma yana da sauƙi tare da tsabta da ikon ci gaba da mai da hankali kan al'ummomin su, Wikimedia da sauran yanayi.
Ƙungiyar albarkatun sadarwa suna aiki kan ƙirƙirar shafi a Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasirin kuma karɓar sakonninmu zuwa gare su.
Ci gaba da samun bayanai kan al'amuran da suka shafi COVID-19
Za mu aika muku da gayyatar zuwa kalandarku na ranar Alhamis mai zuwa da karfe 14:00 UTC/ 07:00 PT don taron musamman tare da ma'aikata.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku da kuma ba da lokaci don haɗawa da juna.
Muna cikin wannan tare kuma za mu taimaka da duk abin da ake bukata.
A halin yanzu, za ku iya ci gaba da samun bayanin wannan imel da duk wasu bayanan da suka shafi COVID-19 a cikin wiki na kamfanin.
Ƙungiyar kula da sadarwa za ta sabunta waɗannan shafuka da dukan bayanai a wuri guda.
Muna kuma aiki don ci gaba da sadarwa tare da ma'aikatan da ke zaune a ƙasashen da ke fama da cutar.
Idan kana da wata tambaya game da tafiya, abubuwan da suka faru, babban aiki, ko game da ƙalubalen ɗaukar hoto, ko wani abu da za ka iya buƙatar taimako da shi, ka tabbata ka sanar da shi kuma ka yi aiki tare da ƙungiyar sadarwar.
Muna nan don taimakawa wajen samar da tallafi da hadin kai kamar yadda ake bukata.
Idan kana da wata matsala ta sirri ko kuma mai tsanani, aika imel zuwa Bryan Judan, Darakta na Ayyukan HR na Duniya.
Babu wani cikin waɗannan canje-canjen da za a ɗauka cewa mun yi watsi da aikinmu da kuma hakkokinmu.
Amma, sun nuna cewa a yanzu, aikinmu da kuma wajibai za su iya bukatar gyara a hanyar da ba mu taɓa yi ba.
Waɗannan su ne matakan da muke ganin ya kamata mu ɗauka don tallafawa a yanzu, don mu ci gaba da aiki, muna ba wa ƙungiyarmu tallafin da take buƙata kuma muna ba duniya sabis ɗin da ta dogara da shi.
Aikin da muka tsara zai kasance a gabanmu sa'ad da lokacin ya yi.
A yanzu, lokaci ya yi da za mu tallafa wa juna kuma mu ba da lokaci don aiki mai muhimmanci da za a yi a makonni masu zuwa, kuma wataƙila watanni masu zuwa.
Muna bukatar ku duka don wannan ya faru, don haka muna bukatar ku duka ku kula da kanku da danginku don ku kasance cikin mafi kyawun yanayinku lokacin da ya zama dole.
Ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, ƙungiyar albarkatun sadarwa (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Angiotensin mai canza enzyme nau'in 2 (ECA2) enzyme ne wanda aka haɗa a farfajiyar waje (ƙwayoyin sel) na ƙwayoyin huhu, jijiyoyi, zuciya, koda, da hanji.
ECA2 yana kawar da aikin enzyme mai canzawa na angiotensin (ACE) ta hanyar rage adadin angiotensin II da haɓaka Ang (1-7), yana mai da shi magani mai ban sha'awa don magance cututtukan zuciya. ECA2 kuma yana aiki azaman hanyar shiga cikin sel don wasu coronaviruses.
An kira ɗan adam na enzyme sau da yawa a matsayin hECA2.
Angiotensin mai canza enzyme nau'in 2 shine zinc-mai ƙunshe da enzyme wanda ke kan farfajiyar ƙwayoyin endothelial da sauran ƙwayoyin.
ECA2 yana dauke da wani yanki na N-terminal M2 peptidase da kuma wani yanki na C-terminal wanda ke dauke da amino acid da colectin a cikin tsarin koda.
ECA2 shine nau'in membrane mai wucewa guda ɗaya, tare da yankin aikin enzymatic wanda aka nuna akan farfajiyar sel a cikin huhu da sauran kyallen takarda.
Ana raba yankin ECA2 daga yankin transmembrane ta wani enzyme da ake kira sheddase, kuma ana sakin furotin mai narkewa cikin jini kuma a ƙarshe a cikin fitsari.
ECA2 yana cikin gabobin da yawa: ECA2 yana haɗuwa da ƙwayoyin salula na manyan ƙwayoyin alveolar huhu na nau'in II, ƙananan ƙwayoyin hanji, ƙwayoyin jini da ƙwayoyin jini da ƙwayoyin tsoka a cikin yawancin gabobin.
Ana kuma samun bayanin mRNA na ECA2 a cikin kwakwalwar kwakwalwa, jikin striatum, hypothalamus, da kwakwalwar kwakwalwa.
Babban aikin ECA2 shine ya zama mai daidaitawa ga ECA.
ASA yana raba nau'in angiotensin I zuwa nau'in angiotensin II wanda ke haifar da ƙarancin jijiyoyin jini.
ECA2 kuma yana rarraba amino acid carboxymethyl phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana haɓaka a cikin angiotensin mai fadada jini (1-7), (H-Asp-Arg-Val-Tyr-Ile-Gist-Pro-OH).
ECA2 kuma yana rarraba wasu peptides da yawa, gami da [des-Arg9]- bradicinine, apelin, neurotensin, dinorphine A, da ghrelin.
ECA2 kuma yana daidaita jigilar jigilar amino acid mai tsaka tsaki SLC6A19 kuma an haɗa shi da cutar Hartnup.
A matsayin furotin mai watsawa, ECA2 yana aiki a matsayin babban wurin shiga cikin sel don wasu coronaviruses, gami da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, ɗaurewar furotin S1 na SARS-CoV da SARS-CoV2 zuwa yankin enzyme na ECA2 a farfajiyar tantanin halitta yana haifar da endocytosis da sauyawar kwayar cutar da enzyme zuwa endosomes a cikin sel.
Wannan tsarin shigarwa kuma yana buƙatar shirya furotin S ta mai masaukin serine-protease TMPRSS2, wanda hana shi yana ƙarƙashin bincike a matsayin magani mai yuwuwa. Wannan ya sa wasu suka yi tunanin cewa rage matakan ECA2 a cikin sel na iya taimakawa wajen yaƙar kamuwa da cuta.
Duk da haka, ƙungiyoyi da hukumomin da ke kula da sana'a da yawa sun ba da shawarar ci gaba da tsarin hanawa na ACE da kuma maganin ARB.
Wani bita da aka yi a ranar 11 ga watan Yulin 2012 ya gano cewa "amfani da masu hana CTE yana da alaƙa da raguwar haɗarin cutar huhu da kashi 34% idan aka kwatanta da na sarrafawa".
Bugu da ƙari, "an rage haɗarin ciwon huhu a cikin marasa lafiya da ke shan ACE inhibitors waɗanda ke da haɗarin kamuwa da ciwon huhu, musamman waɗanda ke fama da bugun jini da kuma ciwon zuciya.
Amfani da ACE inhibitors kuma an haɗa shi da rage mutuwar da ke da alaƙa da cutar huhu, kodayake sakamakon bai da ƙarfi kamar na haɗarin cutar huhu gaba ɗaya".
Ana tsammanin mutum mai kwakwalwa na ECA2 (rhACE2) wani sabon magani ne don raunin huhu mai tsanani, kuma ya bayyana don inganta haemodynamics na huhu da oxygen saturation a cikin aladu tare da lipopolysaccharide-induced acute respiratory distress syndrome.
Rabin rabin rai na rhACE2 a cikin mutane shine kimanin sa'o'i 10 kuma farawa na aiki shine mintuna 30 bayan lokaci na sakamako (tsawon) na sa'o'i 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ba su da haƙuri ga masu hana tsarin renin-angiotensin na gargajiya (RAS inhibitors) ko kuma a cikin cututtukan da ke cikin jini na angiotensin II.
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu don taimakawa saka idanu don amsa cutar coronavirus ta 2019-2020, ma'ana, aiwatar da gano mutane ("masu lamba") waɗanda ƙila sun taɓa yin hulɗa da mutane masu kamuwa da cutar.
An samar da aikace-aikace da yawa ko kuma aka gabatar da su, tare da goyon bayan gwamnati a wasu yankuna da kuma hukunce-hukuncen.
An samar da wasu tsarin don ƙirƙirar aikace-aikacen sa ido kan lamba.
An kawo batutuwan sirri, musamman game da tsarin da ke bin diddigin wurin da masu amfani da manhajar suke.
Sauran hanyoyin da ba su da matsala sun haɗa da amfani da siginar Bluetooth don yin rajistar kusanci da mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar tare cewa za su haɗa aikin don tallafawa irin waɗannan aikace-aikacen da ke da tushen Bluetooth kai tsaye zuwa tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin tare da Alipay sun aiwatar da wata manhaja da ke baiwa 'yan kasa damar duba ko sun taba saduwa da wanda ke dauke da COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin. A Singapore, ana amfani da wata manhaja da ake kira TraceTogether.
An samar da manhajar ne ta hanyar kungiyar IT ta gida, an saki ta a matsayin buɗaɗɗen tushe kuma za a ba da ita ga gwamnati. Arewacin Macedonia ta ƙaddamar da "StopKorona!", aikace-aikacen da ke da tushen Bluetooth don bin diddigin kamuwa da mutanen da ke da cutar da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka kirkiro manhajar.
Tun daga ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen gano lamba yana cikin matakai na ci gaba, kuma zai kasance a shirye don rarrabawa a cikin makonni. An tsara irin wannan aikace-aikacen don Ireland, da Faransa ("StopCovid").
Australia da New Zealand suna shirin yin amfani da aikace-aikacen da suka danganci aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha tana son aiwatar da aikace-aikacen ƙuntatawa na ƙasa don marasa lafiya da aka gano da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba su fita daga gida.
Ross Anderson, farfesa a fannin injiniya na tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu amfani da tsarin aikace-aikacen, ciki har da kuskuren ƙarya da kuma yiwuwar rashin tasiri idan karɓar aikace-aikacen ya iyakance ga ƙananan ɓangare na yawan jama'a.
Dangane da damuwa game da yaduwar aikace-aikacen "coronavirus" na karya ko cutarwa, Apple ya kafa iyaka ga nau'ikan ƙungiyoyi waɗanda za su iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, ta iyakance su ga "hukuma" ko kuma ƙungiyoyi masu mutunci.
Google da Amazon sun kafa irin wannan dokar.
Masu ba da shawara game da sirrin sirri sun nuna damuwarsu game da tasirin sa ido kan mutane da yawa ta amfani da aikace-aikacen coronavirus, musamman game da ko za a rushe kayan aikin sa ido da aka gina don magance cutar coronavirus da zarar barazanar ta wuce.
Amnesty International da kuma wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a kawo iyaka ga irin wannan sa ido.
Kungiyoyin sun bayyana sharudda takwas ga ayyukan gwamnati:
Dole ne a sanya ido a kan 'doka, dole ne kuma daidai gwargwado';
tsawaitawa na sa ido da kuma sa ido ya kamata ya ƙunshi sharuddan dakatarwa;
amfani da bayanan ya kamata a iyakance don dalilai na COVID-19;
Tsaro da rashin bayanan sirri ya kamata a kare su kuma a gabatar da su a matsayin masu kariya bisa ga shaida;
Ya kamata a hana nuna bambanci da kuma nuna wariya ta hanyar leken asirin dijital.
Duk wani musayar bayanai tare da wasu kamfanoni dole ne a tsara shi a cikin doka;
Ya kamata a samar da kariya daga cin zarafi da kuma hakkin 'yan kasa na amsawa ga cin zarafi.
Za a bukaci sa hannun dukkan 'masu ruwa da tsaki' da suka dace, ciki har da masana kiwon lafiya da kungiyoyin da ba su da wata manufa.
Shirin da Google/Apple suka gabatar yana nufin magance matsalar sa ido ta hanyar cire injin sa ido daga tsarin aikin na'urar su lokacin da ba a buƙatarsa.
Wasu ƙasashe sun yi amfani da hanyar sadarwar wuri maimakon aikace-aikace, kawar da buƙatar sauke aikace-aikacen da kuma ikon kauce wa tracking.
A Isra'ila, an amince da bin hanyar sadarwa.
Hanyoyin sadarwa da ke da damar yin amfani da bayanan wuri na asali suna da matsala masu mahimmanci na sirri.
Duk da haka, ba duk tsarin da ke da uwar garke na tsakiya ba ne ya kamata ya sami damar yin amfani da bayanan wurin mutum; an tsara wasu tsarin tsare sirri don amfani da uwar garke na tsakiya don sadarwa kawai (duba sashin da ke ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba na aikace-aikace ba don aiwatar da bin diddigin lamba.
Maimakon amfani da wata manhaja ta musamman, tsarin ya tattara bayanan sa ido daga tushe daban-daban, gami da bayanan sa ido na na'urorin hannu da bayanan ma'amala na katin, ya haɗa su don samar da faɗakarwa ta hanyar saƙonnin rubutu ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu son tuntuɓar, gwamnati ta kuma ba da bayanan wurin a bayyane, wanda aka ba da izinin saboda canje-canje masu yawa a cikin dokokin sirrin bayanai bayan barkewar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo.
Har zuwa 6 ga Afrilu 2020 ba a bayyana cikakken bayani ba.
Binciken tuntuɓar da ke kiyaye sirrin sirri wata ma'ana ce da aka bayyana, tare da mahimmin ilimin kimiyya wanda ya koma aƙalla 2013. Tun daga 7 ga Afrilu 2020, sama da ƙungiyoyin masana goma sha biyu suna aiki kan hanyoyin da ke mutunta sirrin sirri, tare da amfani da Bluetooth Low Energy (BLE) don yin rajistar kusanci da mai amfani da wasu na'urorin hannu.
Duk da haka, PEPP-PT aiki ne na haɗin gwiwa wanda ya ƙunshi hanyoyin tsakiya da na rarraba, kuma ba yarjejeniya ɗaya ba.
A cikin waɗannan ladabi, bayanan sirri ba su fita daga na'urar ba, kuma duk wani haɗuwa da aka yi a cikin na'urar.
Ƙungiyar Sirri a MIT Media Lab ta haɓaka Safe Paths, dandamali don amfani da fasahohin kiyaye sirrin yayin tattarawa da amfani da bayanan wuri ko ƙetare hanya don bin hanyar yaduwar COVID-19.
An gina shi ne bisa bincike daga littafin fasaha "Aps Play Dirty: Tsayawa Sirrin Mutum a cikin Cutar" wanda aka fitar a watan Maris na 2020. Wani irin wannan ƙoƙari shine Enigma MPC's SafeTrace Platform, wani kamfani wanda ke haɓaka fasahar sirri kuma asali an kafa shi a MIT Media Lab.
SafeTrace yana amfani da fasahar kayan aiki mai aminci don bawa masu amfani damar raba bayanan wuri da lafiyar mutum tare da sauran masu amfani da masu kula da su ba tare da yin sulhu kan sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyin da suka haɗu a kusa da ainihin hanyar guda ɗaya da kuma yawancin ladabi masu yawa sun kafa Ƙungiyar TCN ta Duniya, da nufin rage rarrabuwa, da kuma ba da damar haɗin gwiwar duniya na faɗakarwa da aikace-aikacen sa ido, babban mahimmin al'amari na cimma karɓar karɓa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa yarjejeniyar BlueTrace, wacce aka yi amfani da ita ta hanyar aikace-aikacen hukuma, ta zama tushen buɗewa.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na Android da iOS, sun ba da sanarwar wani shiri don bin diddigin lamba, inda suka yi iƙirarin cewa za su kiyaye sirrinku, dangane da haɗin fasahar Bluetooth Low Energy da ɓoyewa don kiyaye sirrinku.
Sun kuma wallafa takamaiman fasahohin da aka yi amfani da su a cikin tsarin.
A cewar Apple da Google, tsarin yana ba da gudummawa a matakai uku:
samar da kayan aiki don bawa gwamnati damar ƙirƙirar aikace-aikacen gano coronavirus na hukuma yayin kiyaye sirrin
Haɗa wannan fasalin kai tsaye cikin iOS da Android; Google da Apple suna shirin magance matsalolin sa ido na yau da kullun da aka ɗauka ta hanyar fara rarraba tsarin ta hanyar sabunta tsarin aiki, kuma daga baya cire shi ta hanyar da ta dace da zarar barazanar ta ƙare.
Sake sanya magunguna (wanda aka fi sani da sake gabatar da magunguna, sake fasalin, sake rarrabawa ko maye gurbin magani) shine sake gabatar da magani da aka amince da shi don magance yanayin likita ko cuta daban da wanda aka tsara shi da farko.
Wannan shine ɗayan layin binciken kimiyya da ake ɗauka yanzu don haɓaka lafiya da ingantaccen magani don COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka ƙarin jini da allurar rigakafi don COVID-19. SARS-CoV-2 yana da ƙwayoyin cuta 66 masu magani, kowannensu yana da wuraren ɗaurewa da yawa.
Binciken waɗannan wuraren haɗin yana ba da kyakkyawan tsari don haɓaka ingantaccen maganin rigakafin ƙwayar cuta akan sunadarai na COVID-19.
Daga cikin mahimman sunadarai masu mahimmanci na SARS-CoV-2 sune papain-like protease, RNA-dependent RNA polymerase, helicase, S-protein, da ADP ribophosphatease.
Hussein A. A., et al., sun yi nazarin wasu mahaɗan ɗan takara waɗanda daga baya suka inganta kuma suka bincika don kamanceceniyar tsarin su da magungunan da aka amince da su don hanzarta haɓaka magani mai ƙarfi akan SARS-CoV-2 a cikin binciken su na farko don ba da shawarar don ƙirar gwajin asibiti.
Chloroquine magani ne na zazzabin cizon sauro wanda kuma ake amfani da shi wajen magance wasu cututtuka na jikin mutum.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine da ke da alaƙa za su kasance cikin magunguna huɗu da ake nazari a matsayin ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin chloroquine da hydroxychloroquine na jihar New York zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate ta hanyar Izinin Amfani da Gaggawa (AUE).
Ba a amince da maganin ta hanyar gwajin gwaji na FDA ba kuma an ba da izini ta hanyar AUE kawai azaman gwaji don amfani da gaggawa a cikin marasa lafiya da ke asibiti waɗanda ba za su iya karɓar magani a cikin gwajin asibiti ba.
CDC ta ce "ba a riga an kafa amfani, sashi ko tsawon lokacin amfani da hydroxychloroquine don rigakafi ko maganin kamuwa da cutar SARS-CoV-2" ba.
Likitoci sun ce suna amfani da maganin ne sa'ad da "ba su da wani zaɓi".
A Istanbul, wata ƙungiyar bincike ta Turkiya tana gudanar da ƙaramin bincike game da amfani da chloroquine a hade tare da zinc, bitamin A, bitamin C, da bitamin D.
Ana gudanar da manyan bincike a jami'ar Duke da Oxford.
Makarantar Likitancin Langone ta NYU tana gudanar da gwaji kan aminci da ingancin amfani da hydroxychloroquine don hana cutar.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun ce sun nuna favipiravir ya kasance "mai tasiri sosai".
A Shenzhen, marasa lafiya 35 sun gwada mummunan cikin kwanaki 4 a matsakaita, yayin da tsawon lokacin cutar a cikin marasa lafiya 45 da ba su karɓi shi ba ya kai kwanaki 11.
A wani bincike da aka yi a Wuhan da ya shafi marasa lafiya 240 da ke fama da cutar huhu, an ba rabin su favipiravir, rabin kuma umifenovir.
Hukumar kula da magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke akwai don tallafawa maganin ta yi kadan kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don adana shi kuma ta yi amfani da sojojin don isar da shi zuwa asibitocin jami'a, inda za a yi amfani da shi don kula da marasa lafiya da COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya yi wa gwamnatin Trump bayani game da sayan maganin, wanda zai iya zama da illa ga masu fama da cutar idan cutar ta kara yawa.
Amfani da shi bazai da lafiya ga mata masu ciki ko mata masu ƙoƙarin yin ciki.
Wani binciken lopinavir/ritonavir (Kaletra), haɗuwa da maganin antiviral lopinavir da ritonavir, ya kammala cewa " babu fa'ida da aka gani. "
An tsara magungunan ne don hana kwayar cutar HIV ta hanyar ɗaure ta da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magunguna don nemo wani fili da zai ɗaure da protease na SARS-CoV-2. Akwai suka a cikin ƙungiyar kimiyya game da tura albarkatu don sake samar da magunguna da aka haɓaka musamman don HIV/AIDS.
WHO ta haɗa lopinavir/ritonavir a cikin gwajin Solidarity na duniya.
Gilead Sciences ne ya kirkiro da kuma bunkasa remdesivir a matsayin magani ga cutar Ebola da kamuwa da cutar Marburg. Gilead Sciences ta gano cewa remdesivir yana da aikin rigakafin cutar a cikin vitro akan phylum, pneumo, paramyxovirus da coronavirus.
Wata matsala da magani na rigakafin ƙwayoyin cuta ita ce ƙwayoyin cuta da suka samo asali daga maye gurbi, wanda zai iya haifar da kamuwa da cuta ko kuma cutar.
Wasu nazarin farko na gwaji sun nuna cewa remdesivir na iya samun babban shinge na kwayoyin cuta don juriya. Akwai gwaji da yawa na asibiti da ke gudana, gami da biyu da Asibitocin Jami'ar Cleveland ke gudanarwa, ɗaya ga mutanen da ke da matsakaiciyar cuta da ɗaya ga waɗanda ke da cutar mai tsanani.
Akwai gwaji uku na asibiti na bitamin C na cikin jini da ke faruwa ga marasa lafiya da ke cikin asibiti da masu fama da cutar COVID-19: biyu daga cikinsu suna da iko da placebo (a China da Kanada), yayin da ɗayan ba shi da ƙungiyar sarrafawa (Italiya).
Jihar New York ta fara gwajin azithromycin, maganin rigakafi, a ranar 24 ga Maris, 2020.
Cibiyar Kiwon Lafiya ta Duniya da Magunguna ta Kasa ta Japan (NCGM) na shirin gwajin asibiti na kamfanin Teijin na Alvesco (ciclesonide), wanda shine corticosteroid na asma wanda ba a iya sha ba.
Wani gwaji na kashi na biyu na wani nau'in enzyme mai canza angiotensin 2 yana gudana tare da marasa lafiya 200, waɗanda za a tattara daga cikin manyan marasa lafiya da ke asibiti a Denmark, Jamus da Austria don tantance tasirin maganin.
A halin yanzu, masu bincike a Cibiyar Zuciya ta Kanada suna binciken rawar colchicine wajen rage rikicewar huhu da kumburi a cikin marasa lafiya da ke da alamun COVID-19 masu laushi.
Binciken, da ake kira COLCORONA, yana ɗaukan manya 6,000 da suka haura shekara 40, waɗanda aka gano suna da COVID-19 kuma suna da alamun rashin lafiya, waɗanda ba su bukaci a kwantar da su a asibiti ba.
Ba a haɗa mata masu ciki ba, masu shayarwa, ko waɗanda ba su yi amfani da maganin hana haihuwa.
Ana gwada wasu magunguna masu hana jini a ƙasar Italiya.
Ana amfani da ƙananan kwayoyin heparin a cikin maganin marasa lafiya, wanda ya sa Hukumar Magunguna ta Italiya ta buga jagororin amfani.
Wani bincike da aka yi a cibiyoyi da yawa, wanda ya shafi marasa lafiya 300, yana nazarin amfani da enoxaparin sodium a cikin rigakafi da kuma maganin maganin cutar. An sanar da binciken a ranar 14 ga Afrilu a Italiya.
Saboda SARS-CoV-2 kwayar cuta ce, hankalin masana kimiyya ya kasance mai yawa don sake amfani da magungunan rigakafin ƙwayoyin cuta da aka amince da su da kuma haɓaka don magance ɓarkewar cutar da ta gabata kamar MERS, SARS da cutar West Nile.
Ribavirin: an ba da shawarar ribavirin don maganin COVID-19, bisa ga fitowar 7 na jagororin China
Umifenovir: an ba da shawarar umifenovir don maganin COVID-19, bisa ga fitowar 7 na jagororin China.
Wasu magungunan rigakafi an gano su da ikon samun sabon amfani don kula da marasa lafiya da COVID-19:
Tocilizumab (mai karɓar IL-6): an amince da shi a China.
Akwai kuma gwaji a Italiya da China. Duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19 allurar rigakafi ce ta cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu riga-kafi da aka kammala gwajinsa, akwai ƙoƙarin da ake yi don samar da shi.
A ƙarshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin allurar rigakafin SARS-CoV-2, kwayar cutar da ke haifar da cutar, za ta kasance a cikin ƙasa da watanni 18.
An yi gwajin farko na shan allurar rigakafi biyar a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
An sami yaduwar cutar a cikin 2020, wanda ya haifar da saka hannun jari da ayyukan bincike masu yawa don haɓaka allurar rigakafi.
Kungiyoyi da yawa suna amfani da kwayoyin halittar da aka buga don haɓaka yiwuwar alluran rigakafin SARS-CoV-2.
Ƙungiyar Innovation Coalition for Epidemic Preparedness, CEPI, ta bayyana a watan Afrilu cewa bukatun don samar da allurar rigakafi shine sauri, iya samarwa, ci gaba mai yawa da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton dandamali 10 na fasahohi daban-daban da ake bincike da haɓaka a farkon 2020 don ƙirƙirar allurar rigakafin COVID-19.
Manufofin manyan dandamali waɗanda suka ci gaba zuwa karatun I na aminci sun haɗa da:
nucleic acid (DNA ko RNA) (mai tasowa a mataki na I kuma mai neman allurar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (mai haɓaka mataki na I kuma mai neman allurar rigakafi: CanSino Biologics, mai ɗaukar hoto na adenovirus type 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, jimillar masu neman allurar rigakafi 115 suna cikin matakan farko na ci gaba, tare da 78 daga cikinsu an tabbatar da su a matsayin ayyukan aiki (79, a cewar Cibiyar Milken).
Gwajin lokaci na I-II yana gudanar da gwajin farko na aminci da rigakafi. Yawanci ana sarrafa shi ne, ana sarrafa shi da placebo, kuma yana da yawa, yayin da yake ƙayyade mafi daidaito da tasiri.
Gwaje-gwaje na mataki na uku yawanci sun haɗa da ƙarin mahalarta a cikin ƙungiyar kulawa. Suna gwada ingancin allurar rigakafin don hana cutar, yayin da suke lura da mummunan sakamako a cikin mafi kyawun sashi.
Daga cikin allurar rigakafi 79 da ke cikin ci gaba (wanda aka tabbatar a farkon Afrilu 2020), 74 ba su riga sun gwada a cikin mutane ba (suna cikin binciken preclinical).
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar allurar rigakafi tare da matattarar kwayoyin halitta, wanda zai canza kwayoyin halitta na ƙwayoyin cuta don motsa amsawar rigakafi.
A ranar 24 ga Janairun 2020, a Kanada, Cibiyar Alurar riga kafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan, ta sanar da fara aikin a kan allurar rigakafi, da nufin gwaji a cikin mutane a 2021.
An sanar da ayyukan samar da allurar rigakafi a Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020, da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, Kamfanonin Magunguna na Janssen, wanda Hanneke Schuitemaker ke jagoranta, sun sanar da fara aikin su don haɓaka allurar rigakafi.
Kamfanin Janssen yana samar da allurar rigakafi ta baka tare da abokin aikinsa Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar.
A ranar 8 ga Fabrairu, 2020, OncoGen a Romania ya buga takarda game da samar da allurar rigakafi tare da fasahar da ta yi kama da wacce ake amfani da ita don maganin rigakafin neoantigen.
A ranar 25 ga Maris shugaban cibiyar bincike ya sanar da cewa sun kammala hada allurar rigakafin kuma suna fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani kamfanin Generex, NuGenerex Immnuno-Oncology, ya sanar da cewa suna fara aikin allurar rigakafi don ƙirƙirar allurar rigakafin peptide li-Key akan COVID-19.
Sun so su samar da rigakafin da za a iya gwadawa a kan mutane "a cikin kwanaki 90 masu zuwa".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Sojojin Amurka ta Bincike da Ci gaban Kiwon Lafiya a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, duka a yammacin Maryland, sun sanar da cewa suna aiki a kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta haɗu da Novavax Inc.
a cikin ci gaba da kuma samar da allurar rigakafi.
Abokan hulɗar sun sanar da shirye-shiryen gwajin farko da gwaji na farko a watan Yulin 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki da mutane 11 kuma ko da a cikin saurin gudu, zai ɗauki aƙalla tsakanin shekara ɗaya da rabi da shekaru biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar kere-kere a birnin Quebec, ya ba da rahoton ci gaban wani abu mai kama da kwayar cutar Coronavirus a ƙarƙashin tallafin kuɗi daga Cibiyoyin Binciken Kiwon Lafiya na Kanada.
Ana gudanar da bincike kan allurar rigakafin a dakin gwaje-gwaje, tare da gwajin ɗan adam da aka shirya a watan Yuli ko Agusta 2020.
A farkon wannan makon, The Guardian ta bayyana cewa Shugaban Amurka Donald Trump ya ba CureVac "manyan kuɗi don samun damar yin allurar rigakafin Covid-19" a kan ƙin yarda da gwamnatin Jamus.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA tare.
BNT162, wani allurar rigakafi mai amfani da mRNA, a halin yanzu yana cikin gwajin farko, tare da gwajin asibiti da ake sa ran farawa a watan Afrilu na 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin fasahar kere-kere na Italiya ya sanar da cewa zai sami sakamakon gwajin farko a watan Afrilu na 2020 kuma za a iya fitar da takarar allurar rigakafinsa ta ƙarshe don gwajin ɗan adam a kaka.
A Faransa, a ranar 19 ga Maris, 2020, Ƙungiyar Innovation a Shirye-shiryen Cutar (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar bincike don allurar COVID-19 da ta haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kawo jimlar saka hannun jari na CEPI a cikin haɓaka allurar COVID-19 zuwa dala miliyan 29.
Sauran abokan zuba jari na CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na 'yan takara shida daban-daban na allurar.
Masu bincike a Kwalejin Imperial da ke Landan sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar rigakafin RNA mai haɓaka kanta don COVID-19.
An samar da rigakafin a cikin kwanaki 14 da samun jeri daga China.
A ƙarshen watan Maris, gwamnatin Kanada ta sanar da dala miliyan 275 na C$ a cikin tallafi don ayyukan bincike 96 kan maganin COVID-19, gami da wasu takarar allurar rigakafi a kamfanonin Kanada da jami'o'i kamar Medicago da kuma yunivarsitin Saskatchewan.
A kusan lokaci guda, gwamnatin Kanada ta sanar da dala miliyan 192 na C$ musamman don haɓaka allurar rigakafin COVID-19, tare da shirye-shiryen kafa "bankin allurar rigakafi" na ƙasa na sabbin alluran rigakafi da yawa waɗanda za a iya amfani da su idan wasu ɓarkewar cutar Coronavirus suka faru.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh Medical School sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar COVID-19 a cikin beraye, suna cewa "MNA ta ba da alluran rigakafin SARS-CoV-2 S1 subunit waɗanda suka haifar da ƙarfin antibody-takamaiman martani ga antigen [a cikin beraye] waɗanda a bayyane suke sun fara makonni 2 bayan allurar rigakafi".
A Kanada a ranar 16 ga Afrilu, 2020, Jami'ar Waterloo School of Pharmacy ta sanar da samar da takarar rigakafin DNA kamar yiwuwar fesa hanci.
Ta amfani da kwayoyin cuta, za a tsara DNA don yin kwafi a cikin kwayar cutar ɗan adam don samar da ƙwayoyin cuta marasa lahani kamar ƙwayoyin cuta, waɗanda za su iya ƙarfafa tsarin garkuwar jiki don samar da ƙwayoyin cuta akan kwayar SARS-CoV-2.
A watan Maris na 2020, gwamnati, masana'antu da jami'o'i uku na Amurka sun haɗa albarkatu don samun damar kwamfutocin IBM, haɗe da girgije na Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako iri-iri, wanda ake kira sakamako mara ƙayyadaddun.
Hakan yana nufin cewa suna iya kawo amfani ban da cutar da suke hanawa.
Wani gwaji na gaba a Australia yana neman a yi rajistar ma'aikatan kiwon lafiya 4,170.
Ana iya samun alluran rigakafi da ba su da lafiya ko tasiri.
Binciken farko don kimanta ingancin allurar ta amfani da samfuran dabbobi na musamman don COVID-19, kamar linzamin kwamfuta mai kwayar halitta ta ACE2, sauran dabbobin gwaji, da kuma manyan dabbobi ba na mutum ba, ya nuna buƙatar matakan kiyaye lafiyar rayuwa na 3 don sarrafa ƙwayoyin cuta masu rai, da haɗin gwiwar ƙasa da ƙasa don tabbatar da daidaitaccen hanyoyin aminci.
An riga an gwada alluran rigakafin SARS da MERS a kan dabbobi da ba mutane ba.
A shekarar 2020, babu magani ko allurar rigakafin cutar SARS da aka tabbatar da inganci da lafiya a jikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da haɓaka sabbin alluran rigakafi da magunguna don magance SARS sun kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya.
Lokacin da MERS ya zama ruwan dare, an yi imanin cewa binciken SARS na yanzu zai iya samar da samfurin da zai iya taimakawa wajen samar da alluran rigakafi da maganin cutar MERS-CoV.
Tun daga watan Maris na 2020, akwai rigakafin MERS (wanda ya dogara da DNA) wanda ya kammala karatun mutum na farko, da wasu uku a ci gaba, dukansu alluran rigakafi ne na kwayar cuta, biyu tare da vector adenoviral (ChAdOx1-MERS, BVRS-GamVac), da kuma MVA (MVA-MERS-S).
Shafukan sada zumunta sun inganta ka'idar makirci da ke cewa an san kwayar cutar da ke bayan COVID-19 kuma an riga an samu allurar rigakafi.
Takaddun shaida da aka ambata a cikin kafofin watsa labarun da yawa suna nuna takaddun shaida na asali don jerin kwayoyin halitta da alluran rigakafi don sauran ƙwayoyin cuta na Coronavirus kamar SARS Coronavirus.
Cutar Betacoronavirus 2019 (COVID-19) cuta ce mai saurin kamuwa da cuta da ke haifar da mummunan cututtukan numfashi na Coronavirus 2 (SARS-CoV-2).
Alamun cututtuka na yau da kullum sun haɗa da zazzabi, tari, da wahalar numfashi.
Sauran alamun cututtuka na iya haɗawa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin jin ƙanshi, da ciwon ciki.
Lokacin da aka nunawa har zuwa farkon bayyanar cututtuka shine kimanin kwanaki 5, amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin mutane suna nuna alamun rashin lafiya, wasu suna ci gaba zuwa ciwon huhu da kuma ciwon gabobin jiki.
A ranar 17 ga Afrilu, 2020, an samu sama da mutane miliyan 2.24 da suka kamu da cutar a ƙasashe 210 da yankuna, kuma mutane fiye da 153,000 sun mutu.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar tsakanin mutane musamman ta hanyar tuntuɓar kai tsaye, galibi ta hanyar ɗigon ruwa da aka yi ta tari, hancinsa ko magana.
Ko da yake ana fitar da waɗannan ɗigon ruwa sa'ad da mutum ya numfasa, yawanci suna sauka a ƙasa ko kuma su kasance a kan ƙasa maimakon su zama masu saurin kamuwa da cuta.
Mutane za su iya kamuwa da cutar ta wurin taɓa abubuwa da ke da cutar kuma su taɓa idanunsu, hancinsu ko bakinsu.
Kwayar cutar na iya rayuwa a kan farfajiya har tsawon sa'o'i 72.
Yana da mafi yaduwa a cikin kwanaki 3 na farko bayan bayyanar cututtuka, kodayake yaduwa na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Ana ba da shawarar sanya abin rufe fuska ga mutanen da ake zargi da cutar da kuma masu kula da su.
Shawarwarin yin amfani da abin rufe fuska ga jama'a gabaɗaya sun bambanta, inda wasu hukumomi ke ba da shawarar kada a yi amfani da shi, wasu suna ba da shawarar amfani da shi, wasu kuma suna buƙatar amfani da shi.
A halin yanzu babu rigakafi ko maganin rigakafin cutar COVID-19.
An samu yaduwar cutar a cikin yawancin ƙasashe a duk yankuna shida na WHO.
Wadanda ke dauke da kwayar cutar ba za su iya nuna alamun cutar ba ko kuma su nuna alamun cutar kamar mura, tari, gajiya da kuma numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsin lamba, rikicewa, wahalar farkawa, fuska ko lebe mai launin shuɗi.
Ba a yawan ganin alamun cutar sama kamar yin fitsari, hanci mai gudana ko ciwon makogwaro.
Alamomin cututtukan hanji kamar tashin zuciya, amai da gudawa an lura da su a cikin kashi daban-daban.
Wasu mutane a China sun fara nuna ƙuntatawa a kirji da kuma bugun zuciya.
A wasu, cutar za ta iya kai wa ga ciwon huhu, gazawar gabobin jiki da yawa, har ma da mutuwa.
Wannan shi ne lokacin da ake kira lokacin ƙwanƙwasawa.
Lokacin ɓoyewa don COVID-19 yawanci kwanaki shida ne, amma zai iya bambanta daga kwana biyu zuwa 14.
Kashi 97.5 cikin ɗari na mutanen da suka kamu da cutar za su kamu da cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba dukan waɗanda suka kamu da cutar ba ne za su kamu da cutar.
Ba a san ainihin aikin da waɗannan marasa alamun ke yi ba a cikin watsawa; duk da haka, shaidar farko ta nuna cewa suna iya taimakawa wajen yaduwar cutar.
Adadin mutanen da ke dauke da cutar da ba su nuna alamun cutar ba a halin yanzu ba a sani ba kuma ana nazarin su, kuma Cibiyoyin Kula da Cututtuka na Koriya (KCDC) sun ba da rahoton cewa kashi 20 cikin ɗari na duk waɗanda aka tabbatar da cutar ba su nuna alamun cutar ba yayin da suke asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada marasa alamun cutar a cikin adadin cututtukansu na yau da kullun a ranar 1 ga Afrilu; daga cikin kamuwa da cutar 166 a wannan ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Ƙura da kuma leɓen ruwa suna ɗauke da ƙwayoyin cuta masu yawa.
Yin magana da ƙarfi yana sa ruwa ya yi yawa fiye da magana da ta fi ƙarfin jiki.
Wani bincike da aka yi a ƙasar Singafo ya nuna cewa yin tari ba tare da rufe baki ba zai iya sa ruwa ya yi zurfi fiye da kafa 15 (mita 4.5).
Kodayake ba a yawan daukar kwayar cutar ta iska, Cibiyar Kimiyya ta Kasa ta ba da shawarar cewa watsawa ta hanyar bioaerosol na iya yiwuwa kuma masu ɗaukar iska da aka sanya a cikin hanyoyin wucewa a waje da ɗakunan mutane suna da samfuran tabbatacce don RNA na kwayar cutar.
Wasu hanyoyin jinya, kamar intubation da CPR, suna iya haifar da ɓoyayyen numfashi wanda za a yi amfani da shi kuma saboda haka za a iya watsa shi ta iska.
Ko da yake akwai damuwa cewa ana iya yada shi ta hanyar ƙazanta, ana ganin cewa haɗarin yana da ƙanƙanci. Kwayar cutar tana da saurin yaduwa lokacin da mutane ke da alamomi. Kodayake yana yiwuwa a sami watsawa kafin bayyanar cututtuka, haɗarin yana da ƙanƙanci.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar ke yaduwa ba, amma yawanci mutum ɗaya ko biyu ne ke kamuwa da cutar. Kwayar cutar tana rayuwa na sa'o'i ko kwanaki a kan abubuwa.
Musamman, an gano cewa kwayar cutar tana iya ganowa har tsawon kwana ɗaya a cikin kwali, har zuwa kwana uku a cikin filastik (polypropylene) da bakin karfe (AISI 304) kuma har zuwa awanni huɗu a cikin jan ƙarfe 99%.
Amma hakan ya dangana ga yanayin zafi da kuma zafi.
Sabulu da kuma kayan wanki suna da amfani idan aka yi amfani da su yadda ya kamata. Sabulu yana lalata ƙwayar ƙwayar cuta ta ƙwayar cuta, yana kashe ta kuma yana kawar da ita daga fata da kuma wasu wurare.
Wasu magunguna, kamar su benzalkonium chloride da chlorhexidine glyconate (wani maganin kashe ƙwayoyin cuta na tiyata), ba su da tasiri sosai.
A cikin marasa lafiya biyar daga cikin shida, samfurin farko ya nuna mafi girman nauyin kwayar cutar, yayin da mai haƙuri na shida ya nuna mafi girman nauyin kwayar cutar a rana ta biyu da aka gwada.
Cutar coronavirus mai saurin kamuwa da cutar numfashi mai tsanani 2 (SARS-CoV-2) wata sabuwar cutar coronavirus ce ta cututtukan numfashi mai saurin kamuwa da cuta wacce aka fara ganowa a cikin mutane uku da ke da cutar huhu da ke da alaƙa da rukunin cututtukan cututtukan numfashi a Wuhan.
Dukkanin halayen sabon kwayar SARS-CoV-2 suna faruwa a cikin yanayi, a cikin coronaviruses masu alaƙa.
A waje da jikin mutum, kwayar cutar tana mutuwa idan ta taɓa sabulu na gida, wanda ke lalata layin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Cutar COVID-19 ta fi shafar huhu saboda kwayar cutar tana shiga cikin ƙwayoyin halitta ta hanyar enzyme mai canza angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar nau'in II na huhu.
Kwayar cutar tana amfani da glycoprotein na musamman da ake kira "spicular" (peplomer) don haɗa kansa da ACE2 kuma ya shiga cikin tantanin halitta.
An lura da rauni na zuciya a cikin kashi 12 cikin ɗari na mutanen da ke da cutar da aka kwantar a asibiti a Wuhan, China, kuma ya fi yawa a cikin mummunan cuta.
Yawan cututtukan zuciya yana da yawa saboda amsawar kumburi da kuma rikicewar tsarin garkuwar jiki yayin ci gaban cutar, amma lalacewar myocardial mai tsanani na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna da ma'ana sosai a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An sami babban adadin jini (31%) da jini (25%) a cikin marasa lafiya na ICU tare da kamuwa da COVID-19 kuma yana iya kasancewa da alaƙa da mummunan hangen nesa.
Kodayake SARS-CoV-2 yana da ƙwayoyin ƙwayoyin cuta na numfashi waɗanda ke bayyana ACE2, marasa lafiya da ke da COVID-19 mai tsanani suna nuna alamun cutar kumburi.
Musamman, an nuna cewa kwayoyin T na cututtukan da ke ɓoye GM-CSF suna da alaƙa da ɗaukar IL-6 mai ɓoye ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Hakanan an ba da rahoton infiltrates na lymphocyte a kan necropsy.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwaji don cutar.
Tsarin gwaji na yau da kullum shine polymerase chain reaction ta hanyar ainihin lokacin juyawa (rRT-PCR).
Ana yin gwajin ne a kan samfurori na numfashi da aka samo ta hanyar swab na nasopharyngeal, duk da haka ana iya amfani da swab na hanci ko samfurin sanyi.
Sakamakon zai kasance a cikin sa'o'i kadan zuwa kwana biyu.
Ana iya yin amfani da gwajin jini, amma ana bukatar a ɗauki jini biyu da suka bambanta da mako biyu kuma sakamakon ba shi da amfani nan da nan.
Masana kimiyya na kasar Sin sun iya ware wani kwayar cutar coronavirus da kuma buga jerin kwayoyin halittar ta don dakunan gwaje-gwaje a duk duniya su iya samar da gwaje-gwaje na polymerase chain reaction (PCR) don gano kamuwa da cutar.
Tun daga ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafi (wanda zai iya gano cututtukan da ke aiki da kuma ko mutum ya kamu da cutar a baya) amma ba a yi amfani da su sosai ba.
Kwarewar da Sinawa suka yi da gwajin ya nuna cewa sun fi daidaito da kashi 60 zuwa 70 cikin ɗari.
Hukumar kula da magunguna ta Amurka ta amince da gwajin dakin gwaje-gwaje na farko a ranar 21 ga Maris, 2020, don amfani a ƙarshen wannan watan. Jagororin bincike da Asibitin Zhongnan na Jami'ar Wuhan ya fitar sun ba da shawarar hanyoyin gano cututtuka bisa ga kayan aikin asibiti da haɗarin annoba.
Rashin tabarau mai yawa na filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen fila
Dominance na subpleural, mosaic paving (ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Akwai bayanai kaɗan game da lalacewar microscopic da ilimin lissafi na COVID-19.
Babban binciken cututtuka a lokacin autopsies sune:
Macroscopy: pleurisy, pericarditis, ƙarfafawa na huhu da ƙwayoyin huhu
Za'a iya lura da nau'ikan nau'ikan cutar sankarar ƙwayar cuta guda huɗu:
ƙananan ciwon huhu: huhu na huhu, hyperplasia na ciwon huhu, babban ciwon huhu, ƙwayoyin cuta tare da shiga cikin lymphocyte da kuma samar da kwayoyin halitta masu yawa
ciwon huhu mai tsanani: lalacewar alveolar (DAD) tare da ɓarna na alveolar.
DAD yana haifar da ciwon rashin jin daɗi na numfashi (ARDS) da kuma rashin ƙarfi.
ƙwayar cuta mai ɗauke da ƙwayar cuta: tsari na exudate a cikin cavities alveolar da kuma interstitial pulmonary fibrosis
Jini: yaduwar jini (CID); amsawar leukoerythroblastic
Matakan kariya don rage damar kamuwa da cutar sun haɗa da kasancewa a gida, guje wa wuraren da mutane da yawa suke, wanke hannuwanku sau da yawa da sabulu da ruwa na aƙalla dakika 20, yin tsabtace numfashi da kyau, da kuma guje wa taɓa idanu, hanci da baki da hannayen da ba a wanke ba.
Hukumar CDC ta ba da shawarar rufe baki da hanci da zane-zane lokacin da kake tari ko hancinka, da kuma rufe bakinka da gefen ciki na gwiwar hannu idan ba a samu zane ba.
Ana ƙarfafa tsabtace hannu bayan tari ko hancin.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, a wani ɓangare don iyakance yaduwar ta mutane marasa alamomi. Dabarun nisantar zamantakewa suna nufin rage hulɗar mutane masu kamuwa da cuta da manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, ƙuntata balaguro da soke manyan taron jama'a.
Ka'idojin nisantawa sun kuma haɗa da cewa mutane su kasance aƙalla mita 1.8 (6 ƙafa) nesa da juna.
Babu wani magani mai tasiri da aka sani don hana COVID-19. Tun da ba za a fitar da allurar rigakafi ba kafin 2021, babban mahimmin abu don sarrafa COVID-19 shine ƙoƙarin rage ƙimar annobar, wanda kuma aka sani da "lanƙwasawa".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa na aƙalla dakika 20, musamman bayan sun je gidan wanka ko lokacin da hannayensu suka ƙazantu sosai, kafin cin abinci da kuma bayan sun hura hanci, tari ko hancin.
Ya kuma ba da shawarar yin amfani da maganin kashe ƙwayoyin cuta na hannu da ke da giya da kashi 60 cikin ɗari na giya, amma kawai lokacin da sabulu da ruwa ba su da sauƙi.
A cikin waɗannan maganganun, aikin antimicrobial yana faruwa ta hanyar ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don ya taimaka wajen kawar da ƙwayoyin cuta a cikin barasa; ba "wani abu ne mai aiki don asphyxia na hannu ba".
Glycerol an kara shi a matsayin mai laushi.
Ana kula da mutane ta hanyar kula da lafiya, wanda zai iya haɗawa da maganin ruwa, taimakon oxygen da kuma taimakon sauran gabobin da suka kamu.
Hukumar CDC ta bada shawarar cewa mutanen da ake zargi da kamuwa da cutar su sanya abin rufe fuska mai sauki.
An yi amfani da maganin oxygenation na membrane (ECMO) don magance matsalar rashin numfashi, amma har yanzu ana nazarin amfaninta.
Ana ba da shawarar tsabtace jiki da salon rayuwa da abinci mai kyau don inganta rigakafi.
Magungunan tallafi na iya zama da amfani ga mutanen da ke da alamun rashin lafiya da kuma farkon kamuwa da cutar. Hukumar Lafiya ta Duniya da Hukumar Lafiya ta Kasa ta China sun ba da shawarwari game da kula da mutanen da ke asibiti da COVID-19.
Likitoci masu kula da ciwon huhu da masu kula da ciwon huhu a Amirka sun haɗa shawarwarin magani daga hukumomi dabam dabam a cikin wani shafi mai suna IBCC.
Har zuwa Afrilu 2020, babu takamaiman magani don COVID-19.
Don alamun, wasu likitoci sun ba da shawarar yin amfani da paracetamol (acetaminophen) maimakon ibuprofen a matsayin farkon layin.
Dole ne a ɗauki matakan kariya don rage haɗarin yaduwar kwayar cutar, musamman a cikin yanayin kiwon lafiya lokacin da ake aiwatar da hanyoyin da zasu iya haifar da aerosols, kamar intubation da numfashi na hannu.
Ga ma'aikatan kiwon lafiya da ke kula da mutanen da ke da COVID-19, CDC ta ba da shawarar sanya mutumin a cikin ɗakunan da ke keɓewa daga cututtukan da ke yaduwa ta iska (SIIA) ban da ɗaukar matakan kariya na yau da kullun, kariya ta tuntuɓar mutane, da kariya ta iska. CDC ta taƙaita jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Ana ba da shawarar kayan aiki kamar: bargon PPE, kayan numfashi ko abin rufe fuska, kariya ta ido da safar hannu. Idan akwai, ya fi kyau a yi amfani da kayan numfashi maimakon abin rufe fuska.
An amince da kayan numfashi na N95 don masana'antu, amma FDA ta ba da izinin amfani da masks a ƙarƙashin Izinin Amfani da Gaggawa (Amurka).
An tsara su don karewa daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da ingancinsu akan takamaiman wakili na halitta don amfani da ba a bayyana ba.
Idan ba a sami abin rufe fuska ba, CDC ta ba da shawarar amfani da abin rufe fuska ko kuma a ƙarshe, abin rufe fuska na gida.
Yawancin masu cutar COVID-19 ba su da tsanani sosai don buƙatar iska mai ƙarfi ko madadin, amma kashi ɗaya na masu cutar suna da tsanani.
Ana nazarin irin taimakon numfashi ga mutanen da ke fama da rashin numfashi da ke da alaƙa da COVID-19 ga mutane a asibitoci, tare da wasu shaidu cewa ana iya kauce wa intubation tare da babban ƙwanƙwasawar hanci ko matsin lamba mai kyau a cikin hanyoyin iska a matakai biyu.
Ko dai waɗannan biyun suna kawo amfanin mutane da ke rashin lafiya mai tsanani ba a sani ba.
Wasu likitoci sun fi son yin amfani da iska mai mahimmanci lokacin da yake samuwa saboda wannan fasaha yana iyakance yadda ƙwayoyin aerosol ke yadawa, idan aka kwatanta da ƙuƙwalwar ƙirar ƙirar ƙirar ƙirar ƙira.
Kasashe masu tasowa da yawa ba su da isassun gadajen asibiti a kowane mutum, wanda ke iyakance ikon tsarin kiwon lafiya don magance hauhawar kwatsam na yawan masu cutar COVID-19 masu tsanani da ke buƙatar asibiti.
Wani bincike da aka yi a ƙasar Sin ya nuna cewa kashi biyar cikin ɗari suna cikin cibiyar kula da marasa lafiya, kashi biyu cikin ɗari suna bukatar taimakon iska, kuma kashi ɗaya cikin ɗari sun mutu.
A China, kusan kashi 30 cikin dari na mutanen da ke asibiti da COVID-19 an kai su ICU.
Yin iska ta inji yana da rikitarwa yayin da cutar ta COVID-19 ta haifar da ciwon numfashi mai tsanani (ARDS) kuma samun iskar oxygen yana da wahala.
Masu ba da iska waɗanda ke da yanayin sarrafa matsin lamba da babban matakin PEEP ana buƙatar su don haɓaka isar da iskar oxygen yayin rage haɗarin rauni na huhu da ciwon huhu da ke tattare da iska.
Babban matakin PEEP bazai samuwa a cikin tsofaffin masu busawa ba.
Bincike don yiwuwar magani ya fara a watan Janairun 2020 kuma ana yin gwaji na asibiti tare da magungunan antiviral da yawa.
Remdesivir yana da alamar ci gaba.
Ko da yake sababbin magunguna na iya ɗaukar lokaci har zuwa 2021 kafin a samar da su, da yawa daga cikin magungunan da aka gwada an riga an amince da su don wasu amfani ko kuma suna cikin matakai na gwaji.
Za a iya gwada maganin rigakafin cutar a kan mutane da ke da cututtuka dabam dabam.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa masu sa kai su shiga gwajin inganci da amincin magunguna masu yuwuwa. Hukumar ta FDA ta ba da izini na ɗan lokaci don amfani da jini na mutane masu warkewa a matsayin magani a lokuta da rayuwar mutum ke cikin haɗari.
Har yanzu ba a gudanar da binciken asibiti da ya dace don nuna amincinsa da ingancinsa akan cutar ba.
A watan Fabrairun 2020, China ta ƙaddamar da wata manhajar wayar hannu don magance barkewar cutar.
Ana buƙatar masu amfani su bayar da sunayensu da lambar ID.
Aikace-aikacen yana iya gano "kusa da kusanci" ta amfani da bayanan sa ido kuma don haka haɗarin kamuwa da cuta.
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan an gano wata barazana, ba wai kawai ana ba da shawarar keɓewa ba ne kawai, amma kuma ana faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da nazarin manyan bayanai na bayanan wayar hannu, fasahar gane fuska, bin diddigin wayar hannu da hankali na wucin gadi don bin mutanen da ke da cutar da mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba hukumomin tsaro izinin bin diddigin bayanan wayar salula na mutanen da ake zargin suna da cutar coronavirus.
An dauki matakin ne don tsaurara keɓewa da kare mutanen da za su iya tuntuɓar 'yan ƙasa da suka kamu da cutar.
A watan Maris na 2020, Deutsche Telekom ta raba bayanan wurin wayar tarho tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don bincike da hana yaduwar kwayar cutar.
Rasha ta yi amfani da fasahar gane fuska don gano waɗanda ba su cika ƙa'idodin keɓewa ba.
Kwamishinan kiwon lafiya na yankin Italiya, Giulio Gallera, ya ce kamfanonin wayar salula sun gaya masa cewa "kashi 40 cikin ɗari na mutane suna ci gaba da yin hakan".
Gwamnatin Jamus ta gudanar da wata ganawar fasahar kwamfuta na tsawon sa'o'i 48 a karshen mako tare da masu halarta fiye da 42,000.
Bugu da ƙari, shugaban Estonia, Kersti Kaljulaid, ya yi kira ga duniya don samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane za su iya fuskantar matsaloli a keɓewa, ƙuntatawa na tafiya, cututtukan magani ko tsoron kamuwa da cutar kanta.
BBC ta yi ƙaulin Rory O'Connor, wanda ya ce: "Ƙaruwar ware kai, kaɗaici, damuwa game da lafiya, damuwa, da kuma matsalar tattalin arziki suna da kyau sosai wajen ɓata lafiyar mutane da kuma lafiyarsu".
Cutar za ta iya zama mai sauƙi, ba tare da alamomi kaɗan ba, kamar sauran cututtukan numfashi na sama kamar sanyi.
Masu ciwo mai sauƙi sukan warke cikin mako biyu, amma waɗanda suke da ciwo mai tsanani ko kuma mai tsanani suna iya yin mako uku zuwa shida kafin su warke.
Mata masu ciki na iya samun haɗarin kamuwa da cutar COVID-19 mai tsanani kamar yadda aka samu daga wasu ƙwayoyin cuta masu kama da SARS da MERS, amma babu bayanai game da COVID-19. A wasu mutane, COVID-19 na iya shafar huhu, yana haifar da ciwon huhu.
A cikin waɗanda suka fi fama da cutar, COVID-19 na iya ci gaba cikin sauri zuwa ciwon ciwon numfashi na manya (ARDS), yana haifar da rashin numfashi, harin septic ko gazawar gabobin jiki da yawa.
Matsaloli da ke tattare da COVID-19 sun haɗa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An bayyana cututtukan zubar jini, musamman ƙaruwar lokacin prothrombin, a cikin kashi 6% na waɗanda aka kwantar a asibiti tare da COVID-19, yayin da aka ga rashin aikin koda a cikin kashi 4% na wannan rukunin.
Kimanin kashi 20-30 cikin ɗari na mutanen da ke da COVID-19 suna da ƙwayoyin enzymes na hanta (transaminases).
Bisa ga wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa kwanaki goma ne, tare da asibiti biyar.
Koyaya, marasa lafiya da aka sauya zuwa ICU suna da matsakaicin kwanaki bakwai tsakanin asibiti da mutuwa.
A cikin binciken da aka yi da wasu mutane, matsakaicin lokacin bayyanar cututtuka na farko har zuwa mutuwa ya kasance kwanaki 14, tare da jimlar kwanaki shida zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta yi, maza sun mutu da kashi 2.8 cikin dari, yayin da mata suka mutu da kashi 1.7 cikin dari.
Binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An lura da canje-canjen kwayar cutar ta cututtukan huhu.
Hoton da aka yi masa ya nuna cewa yana da ciwon huhu.
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Kiwon Lafiyar Kasa ta kasar Sin ta ruwaito, an gano lalacewar zuciya saboda yawan matakan troponin ko kuma tsayawar zuciya.
A cewar bayanan watan Maris na Amurka, kashi 89 cikin ɗari na waɗanda aka kwantar da su a asibiti suna da cututtuka na gaba. Samun albarkatun likita da abubuwan da ke tattare da tattalin arziki na yanki na iya shafar mutuwar.
Ƙididdigar mutuwar ta hanyar cutar ta bambanta saboda waɗannan bambance-bambance na yanki, amma kuma saboda matsalolin hanyoyin.
Rashin bayar da rahoto game da ƙananan lokuta na iya haifar da yawan mutuwar da aka ƙididdige.
Amma, mutuwar da aka yi a baya zai iya nuna cewa ba a san yawan mutanen da suke mutuwa a yau ba.
Masu shan sigari sun fi sau 1.4 samun alamun COVID-19 mai tsanani kuma kusan sau 2.4 sun fi buƙatar kulawa mai tsanani ko mutuwa, idan aka kwatanta da waɗanda ba masu shan sigari ba. An nuna damuwa game da tasirin cutar na dogon lokaci.
Hukumar asibiti ta Hong Kong ta gano raguwar kashi 20 zuwa 30 cikin dari na karfin huhu a wasu mutane da suka warke daga cutar, kuma gwajin huhu ya nuna lalacewar gawar.
Hakan zai iya sa mutum ya soma ciwon ciwon daji bayan ya warke.
Har zuwa watan Maris na 2020, ba a san ko kamuwa da cutar da ta gabata za ta ba da kariya mai inganci da daɗewa ga mutanen da suka warke daga cutar ba.
Ana ganin rigakafi mai yiwuwa ne, bisa ga halayyar sauran coronavirus, amma an ba da rahoton lokuta inda murmurewa daga COVID-19 ya biyo bayan gwajin tabbatacce don coronavirus a wani lokaci na gaba.
Ana ganin cewa waɗannan cututtukan sun fi muni idan sun ci gaba da kamuwa da cuta fiye da sake kamuwa da cuta.
Ana ganin kwayar cutar ta halitta ce kuma ta samo asali ne daga dabbobi, ta hanyar kamuwa da cutar ta hanyar wuce gona da iri.
Ba a san ainihin asalin ba, amma, daga watan Disamba na 2019, yaduwar kamuwa da cuta ya kusan zama gaba ɗaya ta hanyar watsawa daga mutum zuwa mutum.
Wani bincike da aka yi kan mutane 41 da suka kamu da cutar COVID-19 da aka wallafa a watan Janairun 2020 a jaridar The Lancet ya nuna cewa ranar farko da alamun cutar suka fara bayyana ita ce ranar 1 ga Disamba, 2019.
A cikin wallafe-wallafen WHO, an ba da labarin farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da matakai da yawa don auna yawan mutuwa.
Waɗannan lambobin sun bambanta ta yanki da lokaci kuma suna da tasiri ta yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da ya gabata tun farkon barkewar cutar da kuma halayen jama'a kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambobin gaggawa na CID-10 U07.1 don mutuwar da aka tabbatar a cikin dakin gwaje-gwaje na kamuwa da cutar SARS-CoV-2 da U07.2 don mutuwar COVID-19 tare da ganewar asali ko annoba, ba tare da kamuwa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje ba.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran ma'aunin sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da ke kamuwa da cuta (wanda aka gano da wanda ba a gano ba) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyakance lokaci kuma suna bin takamaiman mutane daga lokacin kamuwa da cutar har zuwa lokacin warwarewar lamarin.
Ko da yake ba dukan mutanen da suka kamu da cutar ba ne suke samun rigakafi, amma idan akwai rigakafi, za su iya nuna adadin mutanen da suka kamu da cutar.
A tsakiyar barkewar cutar a Italiya, Castiglione d'Adda, ƙaramin gari mai yawan mutane 4,600, 80 (1.7%) sun mutu.
A Gangelt, an yada cutar ta hanyar bukukuwan Carnival kuma ta bazu tsakanin matasa, wanda ya haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 za a iya yin rajistar ta ba.
Ƙari ga haka, ba a matsa wa tsarin kiwon lafiya na ƙasar Jamus ba.
A Netherlands, kusan kashi 3 cikin ɗari na iya samun rigakafi, kamar yadda aka gano a cikin masu ba da jini.
69 (0.004% na yawan jama'a) sun sami mutuwar COVID-19 da aka tabbatar.
Tasirin annobar da kuma yawan mutuwar ta ya bambanta ga maza da mata.
Mutuwa ta fi girma a cikin maza a cikin binciken da aka yi a China da Italiya.
Matsayin haɗari mafi girma ga maza yana cikin shekaru 50, inda bambancin tsakanin maza da mata ke kusan shekaru 90.
A ƙasar Sin, mace-macen ta kai kashi 2.8 cikin ɗari ga maza da kuma kashi 1.7 cikin ɗari ga mata.
Ba a san ainihin dalilin da ya sa ake da bambanci tsakanin jinsi ba, amma wasu abubuwa na halitta da kuma halayyar mutane ne.
Bambancin tsarin rigakafi ta jinsi, ƙananan yawan shan taba mace da kuma ci gaban maza na cututtuka kamar hawan jini a ƙaramin shekaru fiye da mata na iya taimakawa wajen mutuwar maza.
A Turai, kashi 57 cikin ɗari na mutanen da suka kamu da cutar maza ne, kuma kashi 72 cikin ɗari na waɗanda COVID-19 ta kashe maza ne.
Har zuwa Afrilu 2020, gwamnatin Amurka ba ta bin diddigin bayanan kamuwa da cutar COVID-19 da ke da alaƙa da jima'i.
Bincike ya nuna cewa cututtuka kamar Ebola, HIV, mura, da SARS suna shafan maza da mata a hanyoyi dabam dabam.
Mafi yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma suna iya kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020, cewa sunan cutar "COVID-19" ne.
Shugaban WHO Tedros Adhanon Ghebreyesus ya bayyana cewa "CO" na "corona", "VI", na "virus", "D", na cuta kuma "19" na lokacin da aka gano barkewar cutar: 31 ga Disamba, 2019.
An zaɓi sunan don kauce wa nassoshi ga takamaiman wuri (misali China), nau'in dabba, ko ƙungiyar mutane, daidai da shawarwarin ƙididdigar ƙasa da ƙasa don hana ƙyama. An kira kwayar cutar da ke haifar da COVID-19 mai tsanani mai saurin numfashi 2 (SARS-CoV-2).
WHO ta kuma yi amfani da "kwayar cutar COVID-19" da "kwayar cutar da ke haifar da COVID-19" a cikin sadarwa ga jama'a.
Ana kiran cutar da kwayar cutar "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an fi kiran kwayar cutar da cutar da "coronavirus" da "coronavirus na Wuhan".
A watan Janairun 2020, WHO ta ba da shawarar "2019-nCov" da " 2019-nCoV mai saurin numfashi" a matsayin sunayen wucin gadi don kwayar cutar da cutar, daidai da jagorar 2015 game da amfani da wurare a cikin sunayen cututtuka da ƙwayoyin cuta.
An buga sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iya aiki a cikin sarkar samar da kayan aiki, wasu masana'antun dijital suna buga kayan kiwon lafiya, kamar su hanci da hanci da kuma kayan numfashi.
Alal misali, a lokacin da asibiti a Italiya yake bukatar bawul na numfashi, kuma mai ba da shi bai iya ba da shi a lokacin da ya dace ba, wani kamfani da ke wurin ya yi aikin injiniya kuma ya buga bawul 100 da ake bukata cikin dare ɗaya.
Bayan barkewar COVID-19, ra'ayoyin maƙarƙashiya, rashin fahimta da rashin fahimta game da asalin, girman, rigakafi, magani da sauran fannoni na cutar sun tashi, wanda ya bazu cikin sauri ta Intanet.
A bayyane yake cewa mutane suna iya yada kwayar cutar ga wasu dabbobi.
Binciken bai sami wata hujja ba game da kwayar cutar a aladu, ducks da kaji.
Babu wani magani ko allurar rigakafi da aka amince da shi don magance cutar.
Bincike na duniya kan alluran rigakafi da magunguna don COVID-19 yana gudana a cikin ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta fara gwajin "SOLIDARITY" don tantance tasirin maganin da ya ƙunshi magungunan riga-kafi guda huɗu da ke da tasiri sosai.
Babu riga-kafi, amma hukumomi da yawa suna aiki sosai don samar da allurar rigakafi.
Ana amfani da ayyukan da aka yi a baya game da SARS-CoV saboda duka SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Akwai dabarun allurar rigakafi guda uku da ake bincike a kai.
Da farko, masu bincike suna son su yi allurar rigakafi da ke ɗauke da ƙwayar cutar.
Amfani da wannan kwayar cutar, ko ba ta aiki ko ta mutu, yana nufin haifar da saurin rigakafin jikin mutum ga sabon kamuwa da COVID-19.
Dabara ta biyu, allurar rigakafin ƙananan ƙwayoyin cuta, tana nufin ƙirƙirar allurar rigakafin da ke sa tsarin garkuwar jiki ya zama mai saurin kamuwa da wasu ƙananan ƙwayoyin cuta.
A game da SARS-CoV-2, wannan binciken ya mai da hankali ne kan furotin na spicular wanda ke taimaka wa kwayar cutar shiga cikin mai karɓar enzyme ACE2.
Dabara ta uku ita ce rigakafin nucleic acid (DNA ko RNA rigakafi, sabuwar dabara don ƙirƙirar allurar rigakafi).
An gwada gwajin gwaji na kowane irin waɗannan dabarun don tabbatar da aminci da inganci. A ranar 16 ga Maris, 2020, gwajin asibiti na farko na allurar rigakafi ya fara tare da masu sa kai huɗu a Seattle.
Wannan allurar ta ƙunshi kwafin kwayar halitta mai cutarwa wanda aka kwafe daga kwayar cutar da ke haifar da cutar. An nuna cewa ingantawar ƙwayoyin cuta yana iya zama ƙalubale ga haɓaka allurar rigakafin SARS-CoV-2, amma wannan yana da rikici.
Akwai gwaji sama da 300 da ke gudana tun daga watan Afrilun 2020.
An yi gwaje-gwaje bakwai da suka bincika maganin zazzabin cizon sauro da aka riga aka amince da shi, ciki har da gwaje-gwaje huɗu da suka shafi hydroxychloroquine ko chloroquine.
Sake amfani da magungunan rigakafin cutar ya fi yawa a binciken kasar Sin, tare da gwaji tara na gwaji na Remdesivir a kasashe da dama a ƙarshen watan Afrilu.
Ana nazarin ci gaban asibiti na magungunan da allurar rigakafi don COVID-19 a watan Afrilu na 2020. Ana nazarin magungunan antiviral da yawa don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir a hade tare da interferon beta.
An yi ƙoƙarin tabbatar da ingancin remdesivir tun daga watan Maris na 2020.
An lura da ci gaban asibiti a cikin marasa lafiya da ke karɓar remdesivir don amfani mai tausayi.
Ana gudanar da gwaji na asibiti na mataki na uku a Amurka, China da Italiya. An yi nazarin chloroquine, wanda aka riga aka yi amfani da shi don magance zazzabin cizon sauro, a China a watan Fabrairun 2020, tare da sakamakon farko.
Amma, akwai wasu da suke son a yi nazari a kan binciken.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayoyin Cutar Wuhan, duk da cewa tana ba da shawarar a sha gram ɗaya a rana, ta yi gargadin cewa ninki biyu na wannan adadin yana da haɗari sosai kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa na hydroxychloroquine da chloroquine a cikin shawarar likitocin da ke kula da mutanen da ke da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar ribavirin mai yawa don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar ƙarin nazarin in vivo na nitazoxanide bayan ya nuna ƙarancin ƙwayar cutar ta SARS-CoV-2. Nazarin ya nuna cewa furotin na farko na farko da aka shirya ta hanyar serine transmembrane protease 2 (TMPRSS2) yana da mahimmanci ga shigar SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da azithromycin ko ba tare da azithromycin ba yana da iyakancewa masu yawa waɗanda suka hana ƙungiyar likitoci karɓar waɗannan magungunan ba tare da ƙarin bincike ba. Oseltamivir baya hana SARS-CoV-2 a cikin vitro kuma ba shi da sanannen aiki a cikin maganin COVID-19.
Guguwar cytokine na iya zama matsala a cikin matakai na gaba na COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin anti-cytokine. Tocilzumab an haɗa shi cikin jagororin magani ta Hukumar Kiwon Lafiyar Kasa ta China bayan kammala ƙaramin bincike.
Ana gudanar da gwajin ba da izini ba a matakin ƙasa na 2 a Italiya, bayan ya nuna sakamako mai kyau a cikin mutanen da ke da mummunan cuta.
Idan aka haɗa shi da gwajin jini na ferritin na jini don gano guguwar cytokine, ana sa ran zai kawar da waɗannan ci gaban, waɗanda ake tsammanin sun haifar da mutuwar wasu mutanen da ke fama da cutar.
An amince da mai karɓar mai karɓar interleukin-6 ta FDA bisa ga nazarin shari'ar baya game da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan CAR T a cikin 2017.
Har zuwa yanzu, babu wata hujja da aka sarrafa ta hanyar bazuwar cewa tocilzumab magani ne mai tasiri don CRS.
Ana binciken canja wurin ƙwayoyin cuta da aka tsabtace da kuma ƙwayoyin cuta da tsarin garkuwar jiki na waɗanda suka warke daga COVID-19 zuwa ga mutanen da suke buƙatar su azaman hanyar rigakafin rigakafin rigakafi.
An gwada wannan dabarar a kan SARS, amma ba a sami sakamako mai kyau ba.
Kashewar kwayar cuta shine tsarin aikin da ake tsammani wanda maganin rigakafi na wucewa zai iya daidaita kariya daga SARS-CoV-2.
Sauran hanyoyin, duk da haka, kamar ƙwayoyin cuta na ƙwayoyin cuta da ke dogara da ƙwayoyin cuta da kuma / ko phagocytosis, na iya yiwuwa.
Ana kuma yin wasu hanyoyin maganin rigakafi, kamar amfani da rigakafin monoclonal.
Samun magani na warkewa, wanda ya ƙunshi ruwan jini na marasa lafiya da aka dawo dasu kuma yana ƙunshe da ƙwayoyin cuta na musamman ga wannan kwayar cutar, za a iya haɓaka don saurin aiwatarwa.
Cutar coronavirus, ƙungiyar cututtuka masu alaƙa da juna
Li Wenliang, likita a Babban Asibitin Wuhan, wanda daga baya ya kamu kuma ya mutu daga COVID-19 bayan ya fahimci yaduwar kwayar cutar.
